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Abstract
Very little is known about cellular signalling pathways involved in the regulation of 
growth in trypanosomes. In higher eukaryotes, members of the ras GTPase superfamily of 
proteins are involved in signalling pathways which regulate cellular growth and differentiation. 
Ras genes have been well conserved through evolution and can be found in a range of organisms, 
such as the slime moulds, yeasts and man. The aims of this thesis are to investigate ras 
subfamily GTPases in T. brucei and to develop tools necessary for the study of the role of these 
monomeric GTP binding proteins in trypanosomal growth regulation.
Two approaches were taken to identify monomeric GTP binding proteins in T. brucei. 
The first approach involved the identification of GTP binding proteins in trypanosomal detergent 
extracts, and the second, the cloning of a ras subfamily gene from T. brucei. Monomeric GTP 
binding proteins are normally found within a molecular weight range of 20-29 kDa and, using the 
in situ GTP binding assay of Coulter and Hide (1995), GTP binding proteins within the same 
molecular weight range were identified in trypanosomal detergent extracts. A 24 kDa GTP 
binding protein was partially purified from trypanosome extracts by HPLC fractionation, 
although this protein was in low abundance. A 681 bp gene encoding a ras like GTP binding 
protein (tbrlp) was cloned using degenerate primer PCR. It was expressed in both bloodstream 
and procyclic forms of T. brucei. Southern blot analysis indicated that tbrlp is a single copy 
gene, however, preliminary sequence data derived from a 1.4 Kb PCR product amplified from T. 
brucei genomic DNA using tbrlp specific 3’ and 5’ oligonucleotide primers, indicated the 
presence of at least one other tandemly linked copy of tbrlp. A restriction enzyme map 
constructed from Southern blot data is consistent with the other copy being located upstream of 
the originally identified tbrlp. Tbrlp has all the essential features of a ras subfamily GTPase, 
namely, a GTP binding domain containing three phosphate/magnesium (PM 1, 2 & 3) and three 
guanine nucleotide (Gl, 2 & 3) binding sites, a C-terminal extension domain which is the variable 
region of a ras gene, a C-terminal CAAX box (where C - cysteine, A - aliphatic amino acid and 
X - any amino acid) which is essential for post translational protein modification and a conserved 
C-terminal cAMP dependent protein kinase phosphorylation site. Tbrlp has 45 and 41 % amino 
acid identity to human rap 2 and H-ras respectively, but the regions of identity are interspersed 
throughout the gene, suggesting that it may be an ancestral raslrap gene. Evolutionary analysis 
of tbrlp confirmed that this is indeed the case.
Tools and reagents such as tbrlp specific anti-peptide sera and a fusion protein were 
developed for future studies on the role of the GTPase in trypanosomal growth regulation. The
ultimate goals of this project are to acquire a better understanding of signal transduction in T. 
brucei and explore new avenues of drug discovery.
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Chapter 1
Introduction
CHAPTER 1
THE STUDY OF SMALL GTP BINDING PROTEINS FROM Trypanosoma brucei
1.0 Introduction
Trypanosoma brucei, a digenetic parasite belonging to the group Salivaria, is responsible 
for the morbidity and mortality observed in both man and animals in a number of countries found 
within the tsetse belt of sub-Saharan Africa T. brucei is transmitted by haematophagous tsetse 
flies belonging to the genus Glossina and is responsible for either the West and Central 
(Gambian), or East and Southern (Rhodesian) African form of human sleeping sickness and 
Nagana in cattle. Trypanosomes fall into two different groups: the Stercoraria and the Salivaria. 
There are two main differences between these groups. Members of the group Stercoraria, which 
are responsible for South American Trypanosomiasis, develop in the hind gut of their vector host 
and transmission occurs via faecal contamination while members of the group Salivaria, develop 
in the mid gut of the vector and transmission occurs via the inoculation of the parasites into the 
mammalian host by the vector during a blood meal.
Figure 1.0 is an illustration of the classification of members of the group Salivaria 
(Hoare, 1972), with a few modifications, due to the isolation of one novel subspecies within the 
subgenus Nannomonas (Majiwa et al, 1993; McNamara et al, 1994; Garside and Gibson, 1995). 
There is currently a controversy on the status of T. b. gambiense (Gibson, 1986) and T. b. 
rhodesiense (Hide et al, 1996). This controversy has not yet been resolved and therefore only 
the classification as proposed by Hoare, 1972, will be considered. Members of this group, with a 
few exceptions, are transmitted via the saliva of the tsetse fly. Transmission normally occurs 
when the vector has a blood meal from a mammalian host. The exceptions are T. equiperdum, 
where the disease is sexually transmitted, and T. evansi and T. vivax, both of which can be 
transmitted mechanically by biting flies, such as tabanids, which play no role in parasite 
development and differentiation (Dirie et al, 1992).
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FIGURE 1.0
TRYPANOSOMA
SALIVARIA
DUTTONELLA NANNOMONAS TRYPANOZOON PYCNOMONAS
AE vivax
T. uniforme
T. evansiT. equiperdum
T. brucei
T. simiae*T. congolense
T. godfreyi
(McNamara et al, 1994)
AT. b. rhodesiense
T. b. gambiense
AT. b. brucei
Figure 1.0 is an illustration of the classification of members of the Group Salivaria (Hoare, 1972), with a 
few modifications. The subspecies belonging to the subgenus Trypanozoon are responsible for East and 
West African Trypanosomiasis in humans and Nagana in cattle. * indicates that the subspecies T. 
congolense can be divided into 4 subgroups (Majiwa et al, 1993; Garside and Gibson, 1995 and all 
references therein). A - species or subspecies that cause Nagana in cattle.
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Along with the other trypanosomatids, members of the species T. brucei possess a unique 
structure, the kinetoplast, an organelle which houses their mitochondrial DNA; this feature 
accounts for their classification as members of the Order Kinetoplastida. The three members of 
this species (T. brucei), T. b. rhodesiense, T. b. gambiense and T. b. brucei are the causative 
agents of the East and Southern, West and Central African human trypanosomiasis and Nagana 
in cattle respectively. The three subspecies are morphologically indistinguishable: T. b. 
rhodesiense and T. b. gambiense can be distinguished from each other by means of isoenzyme 
electrophoresis (Gibson et al, 1980; Tait et al, 1984) and molecular markers (Hide et al, 1990; 
reviewed by Hide and Tait, 1991). T. b. brucei, which is also known to infect goats and sheep, is 
susceptible to destruction by cytotoxic factors present in normal human serum. Both T. b. 
rhodesiense and T. b. gambiense are resistant to destruction by these components (Hajduk et al, 
1994) although there is a controversy as to whether the main lytic factors are high density 
lipoproteins (Rifkin, 1978) or less well defined, high molecular weight, non-lipoprotein factors 
(Raper et al, 1996; Tomlinson and Raper, 1996).
Members of the species T. brucei undergo a number of host dependent adaptive changes 
which ensure both survival and proliferation of the parasites within the host. The life cycle of T. 
brucei, together with some of the adaptive changes used by the parasite in the evasion of the hosts 
immune response, are discussed below (Section 1.1).
1.1 The life cycle
Changes in the genetic, physiological and physical structure of the trypanosome are a 
result of some of the adaptations of trypanosomes to either the mammalian or insect host e.g the 
repression and derepression of the mitochondria when the trypanosome migrates from the tsetse 
fly to the mammalian host and vice-versa (Vickerman, 1985; Vickerman et al, 1988; Hajduk et al 
1992). Some of these changes are found to be linked to the ability of the parasite to successfully 
evade immune destruction within its mammalian host. Figure 1.1 is a simplified illustration of 
the life cycle of T. brucei.
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FIGURE 1.1
Asexual propagation
Metacyclic
Long slender
Epimastigote
^ Salivary Gland
Mammal
Asexual propagationMidgut
Short stumpyProventricular
Procyclic
Asexual propagation
Figure 1.1 is an illustration of the different life cycle stages of T.brucei. Each stage is accompanied 
by physical and metabolic changes which enhance the parasites chances of survival in the host.
The final life cycle stages in either host are preadapted for the anticipated environmental switch 
(adapted from Vickerman, 1985).
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1.11 Developmental changes within the tsetse fly
The duration of the life cycle of the trypanosome within its vector host (i.e the tsetse fly) 
is approximately 3 - 5  weeks. Results from experiments in which flies were fed on trypanosome 
infected blood indicated that only 2 - 5 % of flies that ingest short stumpy trypanosomes become 
infected (Vickerman, 1985). The life cycle of the trypanosome within the tsetse fly can be 
divided into two stages: the midgut and the salivary gland stages.
Flies of the genus Glossina, specifically (G. morsitans), are highly susceptible to 
infection by trypanosomes inspite of the presence of a lectin defence system in their midguts 
(Maudlin and Welbum, 1987). Chitinases produced by rickettsia - like symbionts in the midgut 
release a sugar which appears to bind and, in effect, neutralise the action of lectin. This results in 
a breakdown in the defence system and the establishment of the infection within the fly (Maudlin 
and Welbum, 1987; Vickerman etal, 1988).
On entering the fly the trypanosome undergoes a number of morphological, genetic and 
metabolic changes. The short stumpy forms almost immediately shed their Variable Surface 
Glycoprotein (VSG) coat and replace it with a procyclic acidic repetitive protein (PARP) during 
the transformation to procyclic forms. The trypanosome uses its VSGs for the evasion of the 
mammalian hosts immune response (discussed in section 1.41), but does not require the use of 
antigenic variation for survival in the tsetse fly. The actual function of PARP is presently 
unknown (Hajduk et al, 1992). The following changes to the trypanosome occur in the midgut:
1) An overall increase in body length caused by the elongation of the post kinetoplastic portion of 
the body (Vickerman, 1985; Vickerman etal, 1988).
2) Termination of receptor mediated endocytosis in the flagellar pocket (Vickerman, 1985).
3) Activation of the mitochondrion and reduction in the use of glycosomes (Vickerman, 1985; 
Vickerman et al, 1988). These changes occur concurrently with a change in energy source from 
glucose to proline. The tubular cristae of the mitochondrion are replaced by a network of discoid 
cristae in order to accommodate the energy source switch. This results in an overall increase in 
volume of 5 - 25 %. The marked reduction in the use of glycosomes results in their morphology 
altering to yield bacilliform like structures.
The procyclic forms in the midgut penetrate the peritrophic membrane, migrate to the 
ectoperitrophic space and then into the salivary glands, where an increase in the rate of division is
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observed. There are four stages in the life cycle of the trypanosome on migration to the salivary 
gland:
1) Epimastigote stage:
The trypanosome is attached to the epithelial lining of the gland by flagellipodia. At this stage it
has no variable surface glycoprotein coat and undergoes an elevated level of cell division.
2) Trypomastigote stage:
This stage is also referred to as the pre-metacyclic stage. Proline is still used as an energy source 
and they are still attached to the epithelial cell lining.
3) Nascent metacyclics:
The trypanosomes acquire a surface coat, cease to divide and the mitochondrion and glycosomes 
become preadapted to the anticipated environmental switch (i.e.unbranched and spherical 
respectively). They, however, remain attached to the epithelial cell lining (Vickerman, 1985).
4) Mature or “free - swimming’’ metacyclics:
At this stage the trypanosomes are fully preadapted to life in the mammalian host. The
trypanosome acquires a surface coat with a limited number of metacyclic variant antigenic types 
(M - VATs). These M - VATs appear to be predetermined at an earlier stage in the salivary 
gland stage in the life cycle of the trypanosome (Barry, 1989; Graham and Barry, 1995) and 
serve as a first line of defence on entering the mammalian host. No cell division occurs at this 
stage.
1.12 Developmental changes in the mammalian host
Tsetse flies are haematophagous arthropods. It normally takes approximately 4 minutes 
for coagulation to occur at the site of tissue damage and less than 4 minutes for a fly to complete 
the uptake of a blood meal. The possible coagulation of the blood during the blood meal is, 
therefore, not a problem. However, an anti - coagulant is necessary, in order to ensure complete 
digestion of the blood meal and an unblocked proboscis for subsequent meals. An anti - thrombin 
has recently been isolated from the salivary glands of flies of the species G. morsitans and G. 
austeni (Stark and James, 1996). Therefore, while feeding, the tsetse fly inoculates the 
mammalian host with saliva containing preadapted trypanosomes. These trypanosomes enter into
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the draining lymphatics and migrate into the bloodstream. The bloodstream stage is referred to as 
“early stage” trypanosomiasis. From the bloodstream they migrate to the brain and cerebro­
spinal fluid (CSF), via the blood and lymph capillary walls, connective tissue and the choriod 
plexus. Late stage trypanosomiasis is the final stage of the disease. At this stage trypanosomes 
can be isolated from the CSF of infected patients.
In the mammalian host, the long slender trypanosomes have a doubling time of 6 hours 
and divide by binary fission. The levels of parasitaemia in an infected patient fluctuate over a 
time period. This is found to be due to the transformation of the long slender types to non - 
dividing short stumpy forms which are preadapted to life in the vector host (Pays, 1988). The 
trypanosome is covered by a “surface coat” composed of a homogeneous layer of a single type of 
glycoprotein - the VSG. The ability to change the VSG type coating the surface of the 
trypanosome results in a phenomenon known as VSG switching or antigenic variation. There are 
approximately 10'2 - 10~3 switches/trypanosome generation. The waves of parasitaemia observed 
are caused by the rapid doubling time, VSG switching and subsequent destruction of previous 
antigenic types by the host immune system. There is also the successive replacement of the 
original VSG by a series of immunologically distinct VSGs. This allows the trypanosome to be 
one step ahead of the host immune response. By the time the host is prepared to eliminate one 
generation of parasites, the next generation has already been established.
In the mammalian host, the mitochondria are repressed and the energy source is switched 
from proline to glucose. At this stage the glycosome, a single membrane bound organelle which 
contains the first nine enzymes of the glycolytic cycle, is activated and supplies the trypanosome 
with energy (Opperdoes and Borst, 1977).
All forms of trypanosomes within the mammalian host utilise receptor mediated 
endocytosis via the flagellar pocket for the uptake of larger molecules (e.g low density 
lipoproteins and transferrin).
1.2 Human African Trypanosomiasis or HAT
Within the mammalian host, trypanosomes are the causative agents of Human African 
Trypanosomiasis (HAT) or African sleeping sickness and Nagana in cattle. There are two forms 
of HAT; the chronic, slow developing, West and Central African form caused by Trypanosoma 
brucei gambiense and the more acute, East and Southern African form, caused by Trypanosoma 
brucei rhodesiense. The geographical distribution of these subspecies is not as rigid as the 
names of the different forms of the disease would have it seem. A number of cases of gambiense
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- like origin have been found in East and Southern Africa and similarly cases of rhodesiense - 
like disease have been found in West and Central Africa (Kuzoe, 1993; Pepin and Milord, 1994). 
The West African form of the disease appears to have two distinct phases. The initial phase is 
characterised by symptoms such as headaches, fever and lymphadenopathy and is known as the 
haemolymphatic stage (Jemigan & Pearson 1993). This phase produces symptoms characteristic 
of a number of tropical diseases such as malaria and dysentery and, therefore, patients usually 
only seek medical assistance after the onset of the second/late phase. The late phase is 
characterised by severe neurological disturbance, irregular sleep patterns and finally, a deep coma 
which leads to death. T. b. gambiense infections can last for several years before resulting in the 
death of the patient (TDR 12th Programme Report). T. b. rhodesiense infections, however, have 
a much shorter course and the patient often dies a few months to a year after the initial infection.
Approximately 55 million people in 36 sub-Saharan countries (Figure 1.2) are at risk 
from HAT (Kuzoe, 1993) but only 25,000 cases are reported annually. Massive epidemics are 
known to occur, and during such periods a large number of cases are recorded. An example, is 
the epidemic that occurred in the Busoga region of Uganda, which spans an area of 
approximately 130,000 Km2 (Abaru, 1985). During 1980, as many as 8000 cases were 
officially recorded in this region (Koemer et al, 1995), with a monthly incidence of 
approximately 1000 cases being reported at the peak of the epidemic (Abaru, 1985). The number 
of cases reported, however, appears to be a gross underestimation as many infected cases go 
undiagnosed and untreated. The disease almost exclusively affects inhabitants of rural areas, and 
as there are only occasional outbreaks, HAT is not considered to be a disease that requires the 
expense of regular surveillance (TDR news, 1994).
The lack of regular surveillance and, consequently, early diagnosis and treatment of the disease 
are only a few of the numerous problems encountered in the bid to control the spread of African 
Trypanosomiasis. The parasite has the ability to effectively evade the hosts immune response and 
it would appear that the use of chemotherapy is the only practical way to treat and control the 
spread of the disease. There are currently no easy methods for the diagnosis of a current 
infection of HAT or a previously cured infection and, when finally diagnosed, the drugs available 
for the treatment of the disease are either extremely toxic with several unpleasant side effects or 
too expensive to be used regularly (e.g DFMO costs approximately $500.00 per patient). Even in 
the case of DFMO, which has been referred to in the past as the resurrection drug, not only are 
there a few unpleasant side effects but it has also been found to be ineffective in the treatment of 
trypanosomiasis caused by T. b. rhodesiense (Kuzoe, 1993; Pepin and Milord, 1994; Chan and 
Fong, 1994). The following section is a summary of diagnostic kits and chemotherapy presently
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Figure 1.2 is a map showing the distribution of trypanosomiasis foci in subsaharan Africa. 
Trypanosoma brucei gambiense infected areas are to the left of the dotted line and Trypanosoma 
brucei rhodesiense infected areas, to the right. The geographical boundary is not rigid, patients 
infected with T. b. gambiense have been found in T. b. rhodesiense infected areas and vice versa. 
(Photocopied from Manson’s Tropical Diseases, 1996)
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1.3 Diagnosis, treatment and control of the spread of HAT.
The link between the incidence of HAT and its transmission by the tsetse fly, was first 
recorded in 1897 by Sir David Bruce. Approximately 30 years after, a number of drugs with 
trypanocidal activity were discovered and are presently still in use (Wang, 1995). The drugs used 
in the treatment of HAT are extremely toxic and produce very unpleasant side effects (Kuzoe, 
1993; Pepin and Milord, 1994). Problems are encountered in the diagnosis of the disease as the 
initial symptoms of HAT can easily be confused with those of other tropical diseases (WHO, 
1994). Initially the diagnosis of trypanosomiasis was dependent on the detection of parasites in 
wet blood films. Parasites are more readily detectable in stained thick blood films but can go 
undetected due to the low parasite numbers in the blood. New techniques involving the 
concentration of the parasites by either centrifugation or ion-exchange chromatography of the 
infected blood have since been developed. These techniques are more sensitive and are currently 
being used in the diagnosis of HAT, but there is still the need to develop more sensitive diagnostic 
kits that can be used effectively in the field (reviewed by Nantulya, 1991).
The only reliable form of control appears to be the use of tsetse fly traps and avoidance of known 
HAT foci (WHO, 1994).
1.31 Kits currently available fo r  the diagnosis o f  H A T
The key to proper management and control of the spread of a disease lies in making a 
proper diagnosis. Diagnostic kits should therefore be reliable, extremely sensitive, capable of 
being used in the field and, in the case of HAT, should be able to determine which species is 
causing the infection. In addition to these requirements, a kit should be simple, produce results 
promptly and, most of all, be cheap. These kits should be able to supply medical staff with 
enough information to make a proper diagnosis at the onset of the disease. Unfortunately, there 
are presently no kits with all these specifications for the diagnosis of HAT (reviewed by 
Nantulya, 1991).
Members of the species T. brucei, especially T. b. gambiense, are basically tissue 
dwellers. On inoculation into the mammalian host, the parasites are sequestered in various host 
tissues such as the liver, spleen, heart, kidneys and lymph nodes (Nantulya et al, 1992). The 
sequestration of the parasites in the tissues, therefore, leaves the blood with very few or no 
parasites in the early stages of the disease; normal procedures whereby the presence of 
trypanosomes in the blood could be used in confirming a diagnosis cannot therefore be used.
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Most of the kits presently available rely on the ability to either show the presence of 
trypanosomes within blood, lymph or the CSF or to detect antibodies generated against an 
infection. Examples of such kits are the card agglutination test or CATT which is routinely used 
in the diagnosis of trypanosomiasis; the mini anion exchange column or MAEC; the 
microhaematocrit centrifugation technique or HCT; the quantitative bufify coat technique (QBC) 
and the use of ELISA in the detection of T. b. rhodesiense procyclic trypomastigote antigens. All 
these kits do detect the presence of trypanosomes in the blood but are prone to producing false 
negative results, due to the fluctuating aparasitaemic phases observed in both chronic and acute 
infections (Molyneux et al, 1996). The antibody based kits cannot be used to differentiate a 
current infection from one that has already been treated and cured (Nantulya et al, 1992; Komba 
et al, 1992; Nantulya et al, 1992; Bailey and Smith, 1992).
KIVI or kit for isolating African trypanosomes in vitro is one of the kits used for the 
isolation of trypanosomes in the field and can also be used to confirm a diagnosis obtained by 
other methods. The kit is known to have produced positive results, in several cases, where other 
routinely used diagnostic kits have produced negative results e.g CATT (True et al, 1992). 
Unfortunately one of the main limitations of the use of KTVI routinely is the length of time needed 
to establish the absence or presence of trypanosomes in a patient. The average time taken for the 
test to show a positive result is approximately 7 -1 4  days. Therefore a patient in the early stages 
of the disease showing negative results with the other tests, might not be treated, thus giving the 
parasites the opportunity to establish themselves within their new host. Another limitation is the 
lack of adequate culture facilities.
In view of these limitations it appears as though there is a need for rapid, more sensitive, methods 
of detection of trypanosomiasis during the early stages and aparasitaemic periods of the infection. 
This would be quite useful as early detection could help to control the morbidity and spread of the 
disease.
1.32 Treatment currently available for HAT
Four anti - HAT drugs are available, three of which have been used for over 60 years. 
The actual mode of action of these drugs, with the exception of DFMO (the most recently 
discovered), is not unequivocally known. Most of them are found to be extremely toxic to the 
mammalian host and produce several side effect ranging from vomiting to severe neurological 
disorders and, in 1 - 5 % of melarsoprol treated patients, death (Kuzoe, 1993; Pepin and Milord,
1994). A number of strains of T. brucei have also developed resistance to the currently used anti
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- trypanosomal drugs. Due to these problems, there is a need for the production of new and less 
toxic drugs for the treatment of HAT. The following sections provide a brief summary of the 
drugs currently available and their limitations.
Suramin
This drug has been in use since 1922. It is a polyanionic naphthylamine sulphonate 
which is highly negatively charged at physiological pH. It is soluble in water but is poorly 
absorbed and is therefore administered by either intravenous or intramuscular injection. Suramin 
is only effective during the haemolymphatic/early stage of HAT before the sequestration of the 
parasites in the mammalian host organs. It cannot be used in the treatment of the late stage of the 
disease as it is unable to cross the blood-brain barrier. Suramin is used as a prophylactic and a 
curative drug in the treatment of both East and West African HAT. Very few strains of T. brucei 
are known to have developed a resistance to suramin (Wang, 1995). The actual mode of action of 
suramin is unknown. It appears to enter the trypanosome, bound to a variety of serum proteins, 
by receptor - mediated endocytosis via the flagellar pocket. On entering the trypanosome, its anti
- trypanosomal activity seems to be directed against a number of enzymes e.g dihydrofolate 
reductase and thymidine kinase. Suramin inhibits their activity by binding to their active sites 
(Fairlamb and Bowman, 1980; Wang, 1995). Suramin also acts on enzymes of the glycolytic 
pathway resulting in a gradual decrease in ATP production by the parasites and, eventually, 
parasite death (Fairlamb and Bowman, 1980). A number of studies have reported a fairly high 
relapse rate after treatment with suramin.
Melarsoprol
An arsenical, introduced in 1949, is insoluble in water and, therefore, is dissolved in 
propylene glycol. Until recently, it was the only drug used in the treatment of advanced/late - 
stage trypanosomiasis. It is administered intravenously over a period of four weeks. It is 
sometimes impossible to administer the drug due to solvent induced phlebitis. Other side effects 
include vomiting, encephalopathy and, in 1 - 5 % of treated cases, death (Wang, 1995). The 
exact mode of action of melarsoprol is currently not known. It however, appears to bind 
irreversibly to trypanothione (Simarro and Asumu, 1996). Studies have also shown that it blocks 
glycolysis by inhibiting trypanosomal phosphofructo-kinase and this results in cell lysis (Wang,
1995). There are presently several melarsoprol resistant strains of both T. b. gambiense and T.
13
FIGURE 1.3
C02
ORNITHINE 
ODC
C02
PUTRESCINE
SAM ----^  ► d SAM
SAMD
C02
SDS
MTA
SPERMIDINE
SAM ► d SAM
MTA
SPERMINE
A schematic illustration of the pathways involved in the biosynthesis of the polyamines putrescine, spermidine 
and spermine. These polyamines have been implicated in a number of functions in most eukaryotic cells 
including T. brucei. The polyamines are essential for normal cell growth and differentiation (Bacchi et al, 1983)
* indicates the point of inhibition of the spermine biosynthesis pathway; ODC - ornithine decarboxylase; SDS • 
spermidine synthase; SS - spermine synthase; SAM - S - adenosylmethionine; d SAM - decarboxylated S 
adenosylmethionine; SAMD - S - adenosylmethionine decarboxylase; MTA - methylthioadenosine.
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The decarboxylation of ornithine in the presence of ornithine decarboxylase is the rate - 
limiting step in the production of putrescine from ornithine. An aminopropyl group produced by 
the decarboxylation of S - adenosylmethionine in the presence of S - adenosylmethionine 
decarboxylase, binds to putrescine to produce spermidine. This reaction is catalysed by 
spermidine synthase. Spermine is produced by the addition of another aminopropyl group to 
spermidine in the presence of spermine synthase. DFMO inhibits the initial step in the pathway 
i.e the decarboxylation of ornithine, thus decreasing the levels of polyamines produced (Bacchi et 
al, 1983).
Elevated levels of polyamines in cancer patients, have been implicated in tumour 
formation. Unfortunately the drug was ineffective in the reduction of tumours, but was found to 
have a trypanostatic effect on trypanosomes. Its action is found to induce the transformation of 
trypanosomes from long slender to short stumpy forms which can then be eliminated by the host 
immune response (Bacchi et al, 1983; Bitonti et al, 1986).
The mild toxicity of DFMO to the mammalian host is exactly what accounts for its failure as an 
anti -tumourigenic drug (Schechter and Sjoerdsma, 1986). Trypanosomes have a slow in vivo 
ornithine decarboxylase (ODC) turnover rate and, therefore, the irreversible inhibition of the 
enzyme by DFMO lasts for a longer period of time. However, the high turnover rate of 
mammalian ornithine decarboxylase leads to all the DFMO being rapidly bound to the enzyme, 
thus resulting in the lack of effective inhibition of the action of ornithine decarboxylase. ’
1.33 Current control measures against the spread o f  H A T
There are currently 23 known species of the genus Glossina, which are capable of 
serving as vectors of parasites responsible for African trypanosomiasis. Two of these are 
commonly known to be capable of transmitting the disease. Trypanosoma brucei gambiense is 
transmitted by Glossina palpalis and T. b. rhodesiense by Glossina morsitans (Molyneux et al, 
1996). Flies of the group G. palpalis are normally found along rivers, lakes and forest regions, 
whereas those of the group G. morsitans are normally inhabit the savanna regions. One of the 
strategies employed for the control of the transmission of trypanosomiasis is by the use of fly 
traps. The earliest fly traps were actually designed for collecting flies for entomological studies. 
It was, however, observed that the reduction in the numbers of flies was closely linked to a 
reduction in the chances of being bitten by a fly. Based on this observation, several traps were 
designed for capturing tsetse flies, e.g the insecticide impregnated biconical trap produced in 
Burkina Faso and the use of attractants such as the natural odours of cattle in Zimbabwe. Trials
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in Cote d’Ivoire and Burkina Faso showed that impregnated traps were highly successful in 
capturing flies.
The measures being used presently are the safest and cheapest methods available for the 
control of the spread of HAT. Traps designed for attracting and killing the vector host at a cost 
of $ 6.00 / trap are currently being used. These traps have been found to be quite effective in 
capturing flies and seropositivity levels decreased from 8.5%  to l .7 % in  one case study (TDR 
twelfth Programme Report, 1995). There is the need, however, for regular surveillance, which in 
addition to a cost of approximately $ 550.00 / sq km results in a fairly expensive process. If the 
traps are properly maintained, in addition to regular surveillance, it appears as though it would be 
a safer and cheaper mode of control of the spread of HAT compared to any of the alternatives.
Dipping of herds of cattle into insecticides, such as deltamethrin, is an effective and 
cheap way of killing flies (reviewed by Hide, 1994). However dipping might have residual 
effects on the consumers and, therefore, may not be the safest way to eliminate the vector host.
There is a need for drugs which are, cheaper, less toxic and have greater bioavailability 
for the treatment of HAT. Unfortunately, as the disease is predominant in some of the poorest 
countries in the developing world, the production of new drugs would need to be a non -profit 
making venture for pharmaceutical companies, and therefore, it is not likely that any money will 
be invested in research into new drugs solely for the treatment of HAT. Merrell Dow, the 
manufacturer of DFMO, is no longer interested in its production due to its failure as an anti - 
cancer agent and in the treatment of AIDS - related pneumocystis infections (Pepin and Milord, 
1994; TDR Twelfth Programme Report, 1995). They are currently supplying WHO with the 
drug free of charge. Current trials are aimed at shorter durations of treatment (from 14 to 7 
days) in order to reduce the cost of the drug.
The only way money will be invested in research into new drugs for the treatment of 
HAT is by finding a drug that can be used in the treatment of some other diseases, which are 
more “commercially viable”. An example is pentamidine which was used in the treatment of 
early - stage HAT but has recently been used for the treatment of AIDS patients with 
opportunistic parasitic infections. As a result, the price was increased from $1 to $300 / 300mg, 
but is now supplied free where HAT is endemic.
In the long term there is a need to develop new drugs. One way of achieving this aim is 
by gaining a greater understanding of the mechanisms of immune evasion used by different 
pathogens and the signalling pathways involved in the regulation of growth and differentiation of 
the parasites.
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1.4 Mechanisms for the evasion of the host immune response
The mammalian immune system has evolved to control levels of infecting pathogens. 
The suppression or modulation of the host immune response by the pathogen therefore enhances 
the establishment of an infection. Human pathogens have evolved a number of mechanisms 
designed to enhance their chances of survival in their host and thus ensuring their propagation. 
An in depth understanding of these mechanisms of immune evasion is the first step towards 
finding an effective means to control the disease.
A number of pathogens evade complete immune destruction by the manipulation of the 
hosts immune response. An example of such a pathogen is the schistosome, a parasitic worm of 
the genus Schistosoma. Adult worms and larval stages have the ability to employ the use of 
antigenic mimicry by covering their surface coat with host antigens, thereby protecting 
themselves from the host immune response (Abath and Werkhauser, 1996). Parasitic nematodes, 
some of which are responsible for a number of severe intestinal infections in humans e.g Ascaris 
lumbricoides and Trichuris trichura, are known to enhance their chances of survival in the host 
by modulating the hosts cytokine response (Grencis, 1996). Kinetoplastids such as parasites of 
the genus Trypanosoma and Leishmania also use the modulation of the host immune response to 
enhance growth (Barcinski and Costa-Moreira, 1994; Reiner, 1994). Infections by the causative 
agents of both HAT and Chagas disease result in the suppression of the host immune response 
(Sztein and Kierszenbaum, 1993). There appears to be an overall decrease in IL-2 in both cases 
but the mechanism used to achieve this, seems to depend on the infecting trypanosome (Sztein 
and Kierszenbaum, 1993). Other parasites known to use more elaborate methods of immune 
evasion are, e.g Plasmodium falciparum and Babesia bovis. These parasites evade the immune 
response by hiding within host erythrocytes during their reproductive stages. This ensures both 
propagation and evasion of the immune response by the parasites (reviewed by Allred, 1995). 
Members of the genus Leishmania are also known to employ this strategy. They reside in 
macrophages instead of erythrocytes (Jemigan and Pearson, 1993; Brittingham and Mosser,
1996).
Strategies which result in structural changes in the parasite, can leave the immune 
response one step behind. Examples of structural changes used in the evasion of the immune 
response include: shedding of the surface coat (e.g Schistosoma mansoni, Pearce et al, 1986) and 
antigenic variation, a process which involves the successive replacement of the surface coat of the 
parasite by immunologically distinct VSGs (e.g T. brucei, Vickerman, 1985; Barry, 1989). 
Antigenic variation or switching of the Variant Surface Glycoprotein (VSG) is the main 
mechanism for immune evasion in trypanosomes. This process appears to be mediated by a
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number of possible mechanisms including gene rearrangements. A number of pathogens are 
known to exhibit antigenic diversity, in addition to several other evasive tactics. Antigenic 
diversity occurs as a result of an accumulation of point mutations in the genes that code for 
proteins recognised by the immune system (Borst, 1991). The reverse transcriptase of HTV has a 
high error rate, which results in the rapid accumulation of point mutations and, as a consequence 
of this, a large number of variants are found within a single host. The influenza viruses (Marrack 
and Kappler, 1994) employ the same strategy. Occasionally, the influenza virus evades the host 
immune response by mutation which occurs as a result of gene reassortments (Marrack and 
Kappler, 1994).
1.5 Putative drug targets
To date, most drugs have been discovered by large scale screens. There are currently 3 
major screening centres for the discovery and development of new drugs for the treatment of 
leishmaniasis and the trypanosomiases (TDR, 1995). However, a better understanding of the 
biological mechanisms unique to the parasite and the aspects of the parasite that regulate its 
growth could lead to the discovery of new drug targets which could be used in the treatment of 
disease. A number of such novel mechanisms or features are known in trypanosomes (e.g 
antigenic variation, glycosomes and RNA editing). A number of aspects of parasite growth 
regulation which could be also be targeted (e.g cell signalling, proteases, cell cycle) are currently 
known. The following sections highlight some of the mechanisms used by trypanosomes in the 
evasion of the host immune response and some biological features which could be used as drug 
targets. Gene rearrangements in surface antigen genes, which occur as a result of gene 
conversion and recombination, are known to play an important role in enhancing a parasites 
chances of survival in the mammalian host (Tobin et al, 1991; Weiden et al, 1991). These 
rearrangements result in the ability of the trypanosome to undergo VSG switching to generate 
variable antigenic types. This VSG switching allows the trypanosome to avoid immune 
destruction via complement mediated lysis. VSGs are first synthesised during the final life cycle 
stages of the trypanosome in the salivary gland (Cross, 1990), are homogeneous within a single 
trypanosome and the surface coat is made up of approximately 107 glycoprotein molecules 
(Hadjuk et al, 1992; Hadjuk et al, 1994). They are attached to the plasma membrane by a 
glycosyphosphatidylinositol (GPI) anchor. The genome has a 1000 or more VSG genes (Van der 
Ploeg, 1984; Hadjuk, 1994; Graham, 1995; Vanhamme and Pays, 1995). The large number of
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VSGs, the randomness of VSG switching and a doubling time of 6 hours (Barry, 1989) discounts 
the use of a cocktail of VSGs as a vaccination strategy.
Some important aspects of trypanosome biology lend themselves to further investigation 
in relation to developing methods of controlling trypanosome growth and developing new drugs. 
Below is a list of some of these aspects:
1) Procyclic acidic repetitive protein or PARP: this is the invariant glycoprotein surface layer 
which replaces the VSG coat after the insect is ingested into the vector host (Roditi et al., 1989; 
Roditi and Pearson, 1990; Graham, 1995). The expression of this glycoprotein layer appears to 
be linked to the change in temperature from 37° to 26° C. The function of PARP is presently 
unknown but an understanding of the role of PARP in the tsetse/trypanosome interaction could 
lead to new methods of control. Current knowledge of the structure of PARP indicates that it 
could be used as a potentially good transmission blocking vaccine. Antibodies raised against 
PARP, could be ingested into the fly and thus block subsequent transmission by the destruction of 
procyclic forms. A transmission blocking vaccine will not prevent a primary trypanosome 
infection but in the long term could lead to a decrease in the transmission of the disease.
2) Differentiation: environmental changes may act as triggers for the initiation of differentiation 
of the parasite on ingestion into the vector or inoculation into the mammalian host. Factors which 
contribute to the initiation of differentiation whilst within the mammalian host (long slender to 
short stumpy forms) or in the vector (short stumpy to mature metacyclic forms), if any, remain to 
be discovered.
3) Molecular mechanisms involved in trypanosome differentiation.
4) Factors controlling gene rearrangements of VSGs and expression site selection.
5) The mechanism by which the trypanosome carries out receptor - mediated endocytosis via the 
flagellar pocket without evoking an immune response.
These aspects cover broad areas which need to be investigated, however, more specific 
investigations are currently underway for the development of drugs for the treatment of HAT. 
One of the promising areas is the use of the GPI anchor as a target for the production of 
chemotherapeutic drugs due to the presence of myristate in the anchor. The plasma membrane 
GPI anchor is found in both lower and higher eukaryotes but trypanosomes differ in that 
myristate is essential for trypanosome GPI anchor formation but it is not required for GPI anchor
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formation in mammalian cells. Bloodstream form trypanosomes must acquire myristate from the 
host serum (Buxbaum et al, 1994 and all references therein). Analogues of myristate have been 
found to kill bloodstream but not procyclic trypanosomes (McConville and Ferguson, 1993; 
Buxbaum et al, 1996; Werbovetz et al, 1996). As myristate is a rarely used fatty acid in 
mammals, a drug designed to interfere with its synthesis within mammals could act specifically 
on bloodstream trypanosomes (Hadjuk, 1992).
A number of metabolic pathways are also being investigated to determine whether or not 
they can be used in the production of novel drugs for the treatment of trypanosomiasis. One of 
the pathways being investigated is the glycosomal pathway required for the conversion of host 
glucose to energy which is utilised by the trypanosome. The compartmentation of the glycolytic 
enzymes was initially attributed to the need to maintain a high rate of glycolysis for the 
production of energy required by bloodstream trypanosomes. This theory has since then been 
discarded as glycosomes have been discovered in both monogenetic, (e.g the Bodonidae) and 
other digenetic (e.g Phytomonas) kinetoplastids, the majority of which do not rely solely on 
glycolysis for their supply of energy (reviewed by Clayton et al, 1995; Clayton and Michels,
1996). Experiments have shown that the compartmentation of glycolysis is essential for normal 
growth of bloodstream trypanosomes, and, has a different pattern of regulation from its 
mammalian host. It therefore, could be exploited in the search for chemotherapeutic drug targets 
(reviewed by Clayton et al, 1995; Clayton and Michels, 1996).
The ornithine pathway for the biosynthesis of polyamines (such as spermine and 
spermidine) is one of the metabolic pathways which has currently provided the greatest 
breakthrough, in the quest for trypanocidal drugs. Difluoromethylomithine or DFMO, one of the 
drugs presently being used in the treatment of HAT, irreversibly inhibits the action of the enzyme 
ornithine decarboxylase (Schechter and Sjoerdsma, 1986; Bellafatto et al, 1987). This enzyme is 
essential for the decarboxylation of ornithine which is essential for the synthesis of polyamines. 
Polyamines are thought to play an important role in cellular proliferation and differentiation in 
most eukaryotic cells (Schechter and Sjoerdsma, 1986; Henderson and Fairlamb, 1987).
Another pathway which is presently being studied is the trypanothione pathway. Most 
prokaryotic and eukaryotic cells have glutathione (GSH) which has an important role in a number 
of physiological processes in the cell e.g amino acid transport, disulphide reduction and peroxide 
metabolism (Henderson and Fairlamb, 1987) just to name a few. Mammalian cells have 
glutathione reductase which is involved in the reduction of glutathione. This is an important step 
in several physiological pathways. Trypanosomes have the ability to reduce glutathione but the 
reduction is carried out by the trypanosome equivalent of the mammalian glutathione reductase
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known as trypanothione reductase. Studies have shown that the two reductases have different 
substrate specificities and, therefore, a trypanocidal drug, which could inhibit one of the 
substrates of the trypanothione pathway in trypanosomes, would not interfere with the glutathione 
pathway in the mammalian host. Exactly what trypanothione does within the trypanosome is 
presently unknown but, if it plays an essential role in cell growth and differentiation, it might be a 
useful chemotherapeutic target to exploit.
Information gathered from such studies emphasise the need to acquire a greater 
knowledge of the metabolic pathways used by these pathogens. Inspite of the fact that 
trypanosomes appear to be the most studied protozoan parasites there is still not extensive 
knowledge of their metabolic pathways. The knowledge acquired from two of the pathways (the 
trypanothione pathway and S-adenosylmethionine pathway for the polyamine synthesis) seems to 
have provided investigators with enough information to enable them to investigate the possibility 
of producing trypanocidal drugs which could interfere with the parasites normal cellular function 
(Henderson and Fairlamb, 1987; Bacchi et al, 1996). Further studies of their metabolic 
pathways, could shed light on strategic points at which the pathways could be blocked and result 
in the inhibition of normal cellular growth and differentiation as has been shown by DFMO. This 
might lead to the discovery of novel ways of controlling the spread of HAT or at least the 
discovery of new and cheaper drugs with less toxic side effects.
1.6 Evolutionary relationships
One of the oldest problems, encountered in the study of the evolution of organisms, is 
choosing the correct homologous characters for comparative purposes. Until quite recently, 
evolutionary classifications were based on morphological characters and behavioural patterns. 
This led to many cases where the classification of organisms has been incorrectly assigned. New 
molecular methods have revolutionised these issues as the phylogenetic “history” of organisms 
can be reconstructed from their DNA and amino acid sequences. The use of molecular data as a 
measure of divergence reflects the genetic relationships between organisms (inherited features) 
rather than the epigenetic relationships (features inherited as a result of morphological constraint, 
environment or behaviour). Genetic variability between organisms occurs as a result of one or a 
combination of a number of changes that take place at the DNA level. The four basic types of 
changes (mutations) that can occur are 1) substitutions; 2) deletions; 3) insertions and 4) 
inversions.
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Classical morphological studies have shown that organisms can be defined in terms of 
three fundamental groups: Eubacteria, Archaebacteria and the Eukaryota (Schlegel, 1994). The 
use of molecular methods such as DNA sequencing have substantiated this finding and are now 
able to provide evolutionary links between the three groups. However, some discrepancies occur 
when molecular data are used to construct a Universal tree of life. Several different molecular 
methods have been used to construct the universal tree (e.g the use sequences from large subunit 
rRNA (LSU rRNA); small subunit rRNA (SSU rRNA); actin and tubulin) and, while the overall 
shape of the tree is consistent, some individual branches show inconsistencies. These data, 
therefore, need to be treated with a healthy degree of caution.
The SSU rRNA is ubiquitous and is found in all protein synthesizing systems. The 
additional functional constancy of this subunit makes it an ideal candidate for use as a molecular 
clock (De Rijk et al, 1995 and all references therein). SSU rRNA has both conserved and 
variable regions of sequence and can therefore be used in the study of both ancient relationships 
and recent divergences amongst different life forms (Van de Peer et al, 1993).
Sequences from LSU rRNA have a longer chain length and are less prone to variation 
than SSU rRNA sequences. Data from studies carried out on closely related species (after 
computer based corrective measures) show a higher level of consistency and higher bootstrap 
values than trees based on SSU rRNA sequences. The trees show larger differences in branch 
lengths but still show the same major clusters as trees derived from SSU rRNA sequences. There 
is currently no LSU rRNA universal tree because of the unavailability of sequences from some 
taxonomic groups.
Sequences from actin (Doolittle, 1992; Drouin et al, 1995) and tubulin have also been 
used in the construction of a universal tree. These trees basically agree with the SSU and LSU 
rRNA derived trees and particularly in relation to the divergence of the kinetoplastids. The 
kinetoplastids appear to have diverged soon after the appearance of endosymbionts which have 
resulted in the emergence of life forms with mitochondria and other organelles. Figure 1.4 is an 
illustration of a currently accepted SSU rRNA universal tree.
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An illustration of a universal tree of life showing the order of divergence of Eukaryota, inferred from SSU 
(16s) rRNA. The life forms above the dotted line are descendents of mitochondriate eukaryotes. The life 
forms below the dotted line, do not possess mitochondria. Trees like this one, have been used as evidence 
for the acquisition and subsequent loss of mitochondria in some a mitochondriate protozoa. The numbers 
are the confidence levels of the points of divergence, i.e bootstrap values (adapted from Schlegel, 1994).
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1.61 Evolutionary relationships within the order kinetoplastida
All trees to date agree on the point of divergence of the kinetoplastida i.e close to the 
evolutionary endosymbiotic inclusion event(s) which led to the acquisition of mitochondria in 
higher eukaryotes. Molecular data suggest that all parasitic trypanosomatids have evolved from 
free - living bodo - like flagellates (Maslov and Simpson, 1995). Using sequences from LSU and 
SSU rRNA, in conjunction with a suitable outgroup (Bodo caudatus, a kinetoplastid from the 
family Bodonidae), it has been shown that T. brucei was one of the first kinetoplastids to diverge 
after the acquisition of mitochondria (Fernandes et al, 1993; Vickerman, 1994; Maslov and 
Simpson, 1995). A tree constructed by Maslov et al, (1994), based on 18S nuclear ribosomal 
RNA sequences with Euglena gracilis as the outgroup agrees with that of Fernandes et al. The 
order of divergence of the kinetoplastids therefore appears to be as follows; Bodonidae, T. 
brucei, T. cruzi, Blastocrithidia, Herpetomonas, Phytomonas, Leptomonas, Crithidia, 
Leishmania and Endotrypanum. The general order of divergence is shown in Figure 1.5, with 
either E. gracilis or B. caudatus as the outgroup.
Data acquired from the study of RNA editing of three genes namely, cytochrome c 
oxidase subunit III, NADH dehydrogenase subunit 7 and an unidentified maxicircle open reading 
frame from different trypanosomatids, suggest that RNA editing is a primitive or ancestral system 
found in trypanosomes (Maslov et al, 1994). The hypothesis put forward by Maslov et al is that, 
the phenomenon of total RNA editing may have been replaced by the partial editing observed in 
monogenetic trypanosomatids and Leishmania, which are less primitive. This hypothesis appears 
to support the findings of Fernandes et al, (1993), with regards to the point of divergence of T. 
brucei.
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Figure 1.5 is an illustration of the general order of divergence of Eukaryota, based on sequences from 
small subunit rRNA, using two different outgroups, namely Euglena gracilis (A) and Bodo caudatus (B). 
The numbers on top of the branches are the calculated branch lengths and the ones in italics (beneath the 
branches) are bootstrap values, which give an indication of the confidence levels at the points of 
divergence (adapted from Fernandes et al, 1993).
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1.7 Cellular signalling pathways in trypanosomatids
Currently little is known about cellular signalling pathways of trypanosomatids. The 
ability of trypanosomatids to undergo transformation (i.e from long slender trypanosomes to short 
stumpy forms or short stumpy forms to procyclics) in response to extracellular or environmental 
stimuli, indicates the presence, however primitive, of a system of cellular signalling. In higher 
eukaryotes such signals can be transduced by G proteins, protein phosphorylation and a variety 
of other mechanisms. The primitive origins of the trypanosomatids may therefore provide 
information on the origins of cellular signalling in eukaryotes and highlight some important 
differences, which could be exploited in the search for novel drug targets.
The following section is a review of what is known about cellular signalling in trypanosomatids.
1.71 Factors involved in the recognition and response of trypanosomatids to external stimuli
The ability of organisms to respond to extracellular stimuli is the main factor that 
contributes to their survival in the environment to which they are adapted. In trypanosomatids, 
such an ability could enhance not only their survival rate but also the assurance of the growth 
and propagation of the species. The trypanosome is in direct contact with host tissues and under 
normal circumstances, their presence elicits a powerful destructive immune response from the 
host. Antigenic variation has overcome that negative growth regulatory effect but it seems that 
more subtle host-parasite interactions could result in the regulation of growth and differentiation 
of the parasite (Pays et al, 1997).
Trypanosomes go through phases of elevated levels of growth and growth arrest at 
different stages of their life cycle. The long slender bloodstream and procyclic forms undergo 
rapid cell division, whereas the infective forms, i.e the mature metacyclic and short stumpy forms 
are always in a state of growth arrest (Matthews and Gull, 1994). The different stages may be 
subject to regulation by extracellular factors (host or parasite) which interact with the 
trypanosome cell surface. These interactions could activate intracellular signalling cascades. 
Knowledge of these signalling cascades could lead to the discovery of novel chemotherapeutic 
agents. In the following sections, I will review those factors involved in host-parasite 
interactions, which may play a role in cell growth and differentiation.
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Epidermal growth factor receptor (EGF-R)
In higher eukaryotes, the EGF-R is an important component of growth factor mediated 
growth regulatory pathways. The stimulation of this receptor results in a cascade of events, 
which results in the initiation or termination of cell proliferation and/or differentiation. Hide et 
al, (1989), found evidence for the presence of an EGF-like receptor in both bloodstream and 
procyclic life cycle stages of trypanosomes. The receptor binds to EGF and is found to influence 
the rate of growth of both procyclic (Hide et al, 1990) and bloodstream forms of T. brucei 
(Sternberg and McGuigan, 1994). Though no-one has been able to isolate an EGF-like receptor 
gene from T. brucei to date, the evidence suggests that, there could be a signalling pathway in 
trypanosomes similar to that found in mammalian cells. Such a pathway could be involved in 
cellular proliferation and differentiation of the parasite. The isolation of the receptor, its gene and 
a functional analysis need to be carried out to determine the role of this putative receptor in 
trypanosome growth and differentiation.
Low density lipoprotein receptor (LDL-R)
Studies on mammalian host cell-trypanosome surface interactions have shown evidence 
for the presence of receptor mediated uptake of LDL in both bloodstream and procyclic forms of 
the trypanosome (Coppens et al, 1988; Coppens et al, 1991; Lee et al 1990a). Trypanosomes 
lack the machinery for the de novo synthesis of sterols, which are essential nutrients for normal 
cell growth in trypanosomes (Bastin et al, 1996 and all references therein), and are, therefore, 
dependent on receptor mediated endocytosis of low density lipoproteins (LDLs) for the provision 
of sterols. The LDLs are endocytosed via an LDL-like receptor (Hadjuk, 1992) found on the 
flagellum and within the flagellar pocket. Studies are currently being carried out on a 145 kDa 
LDL receptor isolated from T.brucei (Bastin et al, 1994). The receptor has the ability to bind 
LDLs and is also conserved in other kinetoplastids (Bastin et al, 1996).
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The transferrin receptor (TR)
The flagellar pocket is the site of sequestration of receptors involved in the uptake of 
essential nutrients (Balber, 1990; Webster and Russell, 1993). Transferrin receptors are also 
found in the flagellar pocket and have the ability to bind transferrin (Schell et al, 1990).
The genes encoding a putative transferrin receptor have been cloned and sequenced. It is 
currently the only T. brucei receptor that has been characterised at the molecular level. The 
receptor differs both structurally (heterodimeric) and by its mode of membrane attachment from 
the human transferrin receptor (Ligtenberg et al, 1994; Salmon et al, 1994; Steverding et al, 
1994). It is a heterodimer, encoded by the expression site-associated genes (ESAGs) 7 and 6, 
which binds transferrin. The receptor is attached to the membrane by a glycosyl 
phosphatidylinostol anchored carboxyl tail (reviewed by Borst, 1991; Pays et al, 1997) and 
shows some sequence homology to VSGs.
The interesting aspect of the localisation of receptors involved in receptor-mediated 
endo/exocytosis is the fact that despite being in contact with host serum, they are not destroyed 
by the host immune response. The exact mechanism whereby endo/exocytosis occurs without the 
destruction of the parasite by the host immune response is yet to be determined.
Some cell surface receptors are used in the modulation of the host immune response to 
enhance cell proliferation and differentiation. Indirect evidence, i.e the response of trypanosomes 
to IFN-y, predicts the involvement of an IFN-y specific receptor (Olsson et al, 1993). A TNF-a 
specific receptor has been found on trypanosome cell surface (Lucas et al, 1993). The TNF-a 
receptor is localised in the lumen of the flagellar pocket where the transferrin receptor is also 
found (Salmon et al, 1994; Steverding et al, 1994).
These cytokines appear to be involved in the regulation of cell proliferation and most 
possibly differentiation. When trypanosome cultures are treated with IFN-y the rate of 
proliferation increases but when incubated with TNF-a they undergo lysis. It is postulated that a 
balance between these two processes ensures the survival of both the parasite and its host. 
Factors secreted by the trypanosomes, which activate the production of IFN-y and TNF-a from 
CD8+ cells and macrophages respectively (Olsson, 1993; Tachado and Schofield, 1994), allow 
trypanosomes to modulate the hosts cytokine response for their own benefit. The regulation of 
growth appears to be life cycle stage dependent (Pays et al, 1997).
Apart from the ability of the trypanosomatids to induce and make use of various host 
components in the regulation of cell growth, the trypanosome produces components which have 
been linked to cell growth. A few examples of such cell surface components are:
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1) Glycans of the GPI anchor of the VSG are directly involved in the activation of the production 
of TNF-a and IL-1 from macrophages (Tachado and Schofield, 1994). The released form of 
VSG has also been implicated as a strong inducer of TNF-a (Pays et al, 1997). The mode of 
activation and the components involved in the stimulation of IFN-y are yet to be determined for 
CD 8+ lymphocytes.
2) The role of cell surface lectin binding glycoproteins in the regulation of the developmental 
cycle of the trypanosome within its arthropod host. The glycoproteins are expressed on the outer 
membrane of both life cycle forms, i.e bloodstream and procyclic trypanosomes. They, however, 
only appear to be of obvious importance to the procyclic life cycle stage of the trypanosome. It 
has been proposed that the binding of lectins to the receptors could be involved in either cell 
growth or death, depending on which part of the surface receptor they bind (Maudlin and 
Welbum, 1994; Welbum et al, 1996). Growth of procyclic T. b. rhodesiense in the tsetse fly is 
maintained at a constant level which implies that trypanosomes maintain a fine balance between 
cell growth and death. It appears as though the procyclics have the ability to undergo apoptosis 
to maintain this balance. In order to carry out this process, host components are once again, used 
to the advantage of the parasite population (Welbum et al, 1996).
3) Trypanosomes are incapable of the de novo synthesis of sialic acid. To compensate for this, 
trypanosomes have cell surface trans-sialidases. These are enzymes which are needed for the 
transfer of sialic acid from the mammalian host to the parasite (Cross and Takle, 1993; 
Schenkman and Eichinger, 1993). In T. cruzi, sialic acid has been found to be essential for cell 
invasion and development. In T. brucei, cell surface trans-sialidases appear to be stage specific 
and have been observed on procyclic but not bloodstream forms. This would suggest a specific 
role for sialic acid in host-parasite interactions required solely for the development of procyclic 
trypanosomes. The exact role of the trans-sialidases in the development of procyclic 
trypanosomes is yet to be determined (Pays et al, 1997).
In higher eukaryotes, extracellular signals are known to be essential for the regulation of 
gene expression, cell proliferation and differentiation. This is made possible by the presence of 
membrane bound signal transducers (Karin, 1991). A limited amount of information is available 
on the role of such signal transducers in trypanosomatids, despite the considerable amount of data 
showing evidence of their presence.
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1.72 Membrane bound signal transducers
The following section is a review on membrane bound transducers in trypanosomatids 
and, where known, their role in the development of the parasite.
Adenylate cyclase receptors and factors involved in their activation
In mammalian cells the stimulation of adenylyl cyclase receptors results in the initiation 
of the cAMP cascade (Tang et al, 1992). The cascade in turn activates several target molecules 
which control a number of events e.g gene transcription and cell growth. Mammalian adenylyl 
cyclases undergo type specific stimulation or inhibition by the a  and Py subunits of heterotrimeric 
G proteins (Milligan, 1995; Neer, 1995) and Ca27calmodulin (Bourne et al, 1992). In 
Saccharomyces cerevisiae, adenylyl cyclase is stimulated by G proteins in a similar manner to 
mammalian adenylyl cyclases. This might lead one to conclude that the stimulation of the 
adenylyl cyclases by G proteins, has been conserved through evolution. However, adenylyl 
cyclase in yeast, is stimulated by monomeric GTP-binding proteins, whereas the mammalian 
adenylyl cyclases are stimulated by the heterotrimeric G proteins (Ives, 1991; Neer, 1995). 
Therefore one cannot draw any valid conclusions about the evolutionary significance of the 
stimulation of adenylyl cyclase until further studies have been carried out on the molecules 
involved in its stimulation in lower eukaryotes (Kataoka et al, 1985).
As in mammalian cells, a number of factors are essential for the activation of adenylate 
cyclase in trypanosomes. Despite the evidence available on the existence of heterotrimeric GTP- 
binding proteins in T. brucei (Coulter and Hide, 1995), T.cruzi (Eisenschlos et al, 1986b; Coso 
et al, 1992; Oz et al, 1994) and Leishmania (Cassel et al, 1991), there is no evidence for the 
activation of adenylate cyclase by this class of proteins. Activity of the cyclases in trypanosomes 
can still be induced even in the presence of non-hydrolysable analogs of GTP (Martin et al, 1978; 
Torruella et al, 1986; Eisenschlos et al, 1986a). These results suggest the absence of a G-protein 
specific binding site on trypanosomal adenylate cyclase (Chen et al, 1995). In Sacchromyces 
cerevisiae, and other yeasts, activation of the adenylate cyclases occurs after stimulation by 
monomeric GTP-binding proteins (Verzotti et al, 1994). The lack of involvement of G proteins 
in the activation of trypanosomal adenylate cyclase, could therefore be due to the existence of a 
more primitive mode of activation which has not yet been discovered.
Evidence is accumulating for the presence of small monomeric GTP-binding proteins in 
T. brucei (Coulter and Hide, 1995; Field et al, 1995; El-Sayed et al, 1995; Sowa and Hide,
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1997). A number of monomeric G proteins have been cloned e.g ran (Field et al, 1995), a 
number of rab GTPases (El-Sayed et al, 1995; Field and Boothroyd, 1995) and a member of the 
ras GTPase subfamily (Sowa and Hide, unpublished data). As yet the exact role of these 
proteins in the development of the trypanosome is not yet known. One can only speculate as to 
what role these proteins might have in the trypanosome, from studies in higher eukaryotes. It 
would be particularly interesting to determine the role played by the ras GTPase subfamily 
member in T. brucei, as studies in higher eukaryotes have shown that members of this subfamily 
are directly involved in cellular signalling pathways involved in growth regulation.
In T. cruzi, the adenylate cyclase receptor is activated by peptides present in the hind gut 
of the insect vector (Fraidenraich et al, 1993). Elevated levels of cAMP were observed in T. 
cruzi epimastigotes after the release of peptides by the proteolysis of fibronectin. This suggests 
that, the rise in cAMP concentration occurred as a result of the activation of adenylate cyclase. 
In T. brucei, these cyclases can be activated by tissue specific membrane extracts of the tsetse fly 
(Van Den Abbeele et al, 1995). There is currently no evidence for the direct involvement of 
peptides in the activation of T. brucei adenylate cyclase. T. brucei adenylate cyclase is encoded 
by ESAG 4 (Paindavoine, 1992). It is, therefore perhaps, not surprising that the activation of 
adenylate cyclase is linked to VSG release (Voorheis and Martin, 1982; Rolin et al, 1996). The 
initiation or inhibition of the two processes appear to be linked to varying concentrations of C a2+ 
(Rolin et al, 1990). The adenylate cyclase gene family is also found in T. equiperdum (Ross et 
al, 1991) and in Leishmania donovani (Sanchez et al, 1995).
The inhibition of T. brucei protein kinase C (PKC), is found to activate the adenylate 
cyclase receptor and cause VSG release. The inhibition of PKC was also found to block the 
differentiation of short stumpy trypanosomes to procyclic forms. The close relationship between 
the activation of adenylate cyclase and VSG release indicates that the activation of this cyclase 
could play an important role in the differentiation of bloodstream trypanosomes (Pays et al,
1997).
Studies on adenylate cyclases in Dictyostelium (Pitt et al, 1992), have shown that the 
cyclases might be involved in developmental regulation. This finding suggests that T. brucei 
ESAG 4 (i.e adenylate cyclase), which is bloodstream specific, might play a role in the 
developmental regulation of T. brucei.
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1.73 Intracellular signal transduction
The initiation of the adenylate cyclase cascade appears to be linked to a number of 
physiological changes in different organisms. In Saccharomyces cerevisiae, the stimulation of 
this cascade is essential for the progression and completion of the G1 phase of the cell cycle 
(Tokiwa et al, 1994; Morishita et al, 1995). In both yeast and mammalian cells, cAMP in 
conjunction with ras, is implicated in the regulation of the transcription of heat shock genes. The 
function of heat shock proteins has been well conserved through evolution and are known to be 
involved in the regulation of normal cellular function (Engelberg et al, 1994). Cyclic AMP is 
also known to be involved in the regulation of cell growth and differentiation in T. bracei. Levels 
of intracellular cAMP are increased immediately before the transformation of bloodstream long 
slender to short stumpy forms (Mancini and Patton, 1981; Reed et al, 1985) and before the 
transformation of short stumpy to procyclic forms (Rolin et al, 1993). Increased levels of cAMP, 
therefore, appear to be associated with growth arrest, a pattern that has also been observed in 
mammalian cells (Marx, 1993). One of the modes of activation of the adenylate cyclase cascade 
in T. brucei is calcium induced, but the exact mechanism is not understood (Rolin et al, 1990; 
Paindavoine et al, 1992). There is also evidence for the initiation of the adenylate cyclase 
cascade (and therefore increases in cAMP levels) and the onset of differentiation from 
epimastigote to mature metacyclic forms of T. cruzi (Gonzales-Perdomo et al, 1988; Rangel- 
Aldao et al, 1988; Fraidenraich et al, 1993).
Based on the information available on the role of cAMP in yeast and mammalian cells 
and the evidence for the presence of a cAMP pathway in T. brucei, one could conclude that a 
cAMP intracellular pathway exists in trypanosomatids. This pathway is most likely to be 
involved in the mediation of cellular signals essential for the developmental changes that the 
trypanosomatids undergo. Figure 1.6 is an illustration of a model of the glucose and 
acidification-induced signalling pathway in yeast. The pathway is involved in the regulation of 
the G1 phase of the yeast cell cycle. The activation of this pathway by extracellular glucose or 
intracellular acidification leads to the activation of ras which in turn activates adenylate cyclase 
(and hence increases levels of cAMP) and finally Protein kinase A. The pathway is regulated by 
feedback inhibition of Protein kinase A on the production of cAMP. The activation of Protein 
kinase A induces the cell to enter the GI phase of the cell cycle. A similar pathway may exist in 
trypanosomes, though the extracellular stimulus might not be the same as in yeast cells.
The inhibition of the cAMP pathway by the phosphoinositide pathway in T. cruzi 
(Docampo and Pignataro, 1991; Racagni et al, 1992) suggests the inverse regulation of the two 
pathways. There is currently no evidence for the presence of this pathway in T. brucei.
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However, it is possible that it has not yet been discovered, 
this pathway is currently unknown.
The actual function and regulation of
34
FIGURE 1.6
aaenyi cyciase 
{CYR1 * CDC3S)
/
GTP
Glucose ATP
GDP cAMPRAS
CDC25
protein 
kinase A
intracellular
acidification
cAMP
An illustration of the signalling pathway involved in the regulation of the G1 phase of the 
yeast cell cycle. The activation of this pathway leads to the activation of adenylate cyclase and 
cAMP. The activation of the cAMP cascade results in the activation of Protein kinase A 
(PKA). When activated the pathway induces the cell to enter the G1 phase of the cell cycle.
R and C - regulatory and catalytic subunits of PKA; CDC 25 - guanine nucleotide exchange 
factor. (Adapted from Thevelein et al, 1993)
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Intracellular protein kinases
Data is accumulating on the presence of protein serine and tyrosine kinases involved in 
developmental regulation in trypanosomatids (Pays et al, 1997; Boshart and Mottram, 1997). 
Developmentally regulated autophosphorylation of protein kinases has also been shown to occur 
in T. brucei (Parsons et al, 1993; Hide et al, 1994). Parsons et al, (1993), have identified at 
least 10 different threonine kinases in T. brucei, six of which have been found to be 
developmentally regulated. Preliminary evidence suggests the presence of protein kinase A 
(Boshart and Mottram, 1997), protein kinase C (Keith et al, 1990; Boshart and Mottram, 1997) 
and calmodulin dependent protein kinases (Ogueta et al, 1994). The ability of protein kinase C 
inhibitors to block in vitro transformation of bloodstream to procyclic forms of T. brucei (Pays et 
al, 1997) substantiate the view that it is involved in developmental regulation. Parsons et al, 
(1991), showed evidence for the presence of life cycle regulated tyrosine phosphorylation of T. 
brucei. The presence of these kinases indicate a possible association with cellular differentiation. 
A fairly large number of protein kinase and phosphatase genes have been cloned from T. brucei 
(Boshart and Mottram, 1997). Their functions are presently unknown but, as homologues of 
these proteins are involved in developmental regulation in higher eukaryotes, they could have the 
same role in T. brucei (Parsons et al, 1993).
Mitogen activated protein kinase or MAPK
A putative MAP kinase, with 37 % identity to rat MAPK, has been cloned from T. 
brucei (Hua and Wang, 1994). This is an extremely interesting finding, because the stimulation 
of the MAPK pathway in mammalian cells has been linked to external activation via a number of 
membrane bound receptors e.g the heterotrimeric G-protein coupled and epidermal growth factor 
receptors (Leevers and Marshall, 1992) of which there is preliminary evidence for both in T. 
brucei. The mitogen activated protein kinase, or MAPK cascade, plays a significant role in the 
transduction of extracellular signals into intracellular responses in mammalian cells (Cano and 
Mahadevan, 1995) and the pathway is highly conserved in eukaryotic evolution (Pelech and 
Sanghera, 1992; Guan, 1994). A large number of factors are involved in the activation of this 
highly conserved pathway (Nishida and Gotoh, 1993) and homologues of molecules involved in 
the cascade have been isolated in Caenorhabditis elegans and Drosophila melanogaster (Cano 
and Mahadevan, 1995).
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Studies carried out on mammalian cells present strong evidence for ligand-stimulated 
MAP kinase activation by p21r<w, a ras subfamily member. The ras protein lies upstream of ra f 
kinase which is a known MAP kinase kinase in mammalian cells. R af proteins are a family of 
cytosolic serine/threonine protein kinases (Moodie and Wolfman, 1993) involved in the 
transduction of signals from the cell surface to the nucleus (Daum et al, 1994). The activation of 
ra f is known to be involved in the regulation of cell proliferation and differentiation (Avruch et al, 
1994; Marais, et al, 1995). An interesting relationship exists between the stimulation of ra f 
kinase and members of the ras and rap subgroups. In mammalian cells an antagonistic 
relationship has been observed between some members of the ras and rap subfamilies (see section
1.7 for a review of the ras and rap subfamilies). The relationship entails the competition for the 
ras binding site on ra f by ras and rap proteins (Sprang, 1995; Block et al, 1996). When either 
ras or rap bind to the ras binding domain of ra f in mammalian cells, it results in the stimulation 
or termination respectively of downstream signals from ra f (e.g the MAP kinase cascade) 
(Leevers and Marshall, 1992; Minato et al, 1994; Burgering and Bos, 1995). There is evidence 
for the stimulation of protein kinase C by p21 ras. This is consistent with both kinases being 
downstream of the ras protein. However, there is evidence for PKC (indirect evidence found in 
T. brucei) being upstream of p21 ras in some cell types (Leevers and Marshall, 1992). Some 
MAPK related protein homologues have also been isolated from a number of trypanosomatids, 
for example from Leishmania chagasi and Leishmania major (Boshart and Mottram, 1997). 
These MAPK related proteins are known intracellular signal transducers involved in the mating 
pheromone response in Schizosacchromyces pombe and Saccharomyces cerevisiae respectively.
With the exception of the lack of evidence for the presence of a ra f homologue in 
T. brucei, (which could be yet to be identified in T. brucei, see Boshart and Mottram, 1997), most 
of the machinery required for the mammalian equivalent of a MAP kinase pathway in 
trypanosomatids, has been identified. What remains to be discovered is whether these 
homologues in the trypanosomatids have the same role in cellular signalling as do their 
mammalian equivalents. Figure 1.7 is an illustration of the complex relationship which exists 
between ras, rap and ra f in mammalian cells and the link between two major signalling pathways, 
i.e the MAP kinase and cAMP pathways, which result in the regulation of cellular proliferation 
and differentiation.
Levels of calmodulin-binding proteins appear to be life cycle dependent and are thought 
to be linked to the regulation of gene expression in the parasites. A number of immunophilins 
have been characterised in T. brucei and T. cruzi. These molecules are involved in the 
calcineurin signalling pathways of higher eukaryotes. Their presence in trypanosomatids suggest 
the presence of an equivalent pathway.
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Figure 1.7 is an illustration of the two pathways which are linked by the interactions of ras, 
rap and rafm  mammalian cells. The two pathways are the MAP kinase and the cAMP 
pathways. Both of the pathways are involved in the regulation of growth and 
differentiation in higher eukaryotes. GF - growth factor; RTK- receptor tyrosine kinase; 
GR132 - adaptor protein; SOS- guanine nucleotide releasing factor; PKA - Protein kinase 
A: TF - transcription factors; RFC - hormone receptor; FPI - hormone. In some cells the 
regulation of growth and differentiation is achieved by the activation of the cAMP 
pathway, fhis blocks the activation of ra f by ras. thus preventing the initiation of the MAP 
kinase pathway (copied from Marx. 1993).
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Summary o f  cellular signalling in trypanosomatids
Studies on the life and cell cycles of trypanosomatids have shown that the two cycles are 
closely linked. The different stages are found to be dependent on their extracellular surroundings. 
The presence of host molecules may serve as extracellular signals thus mediating host-parasite 
interactions. These interactions are found to have a direct effect on the growth regulation 
patterns of the parasites.
The extensive regulation of parasite development, by protein kinases and phosphatases, 
suggests that these molecules may play an important role in the regulation of cell growth and 
differentiation as has been observed in higher eukaryotes.
A number of pathways lead to the stimulation of the adenylate cyclase cascade (via cell 
surface receptors) in different organisms. In yeast a direct link has been established between the 
activation of the ras signalling pathway and the initiation of the adenylate cyclase cascade 
(Matsuura et al, 1994; Neuman-Silberberg et al, 1995; Hurwitz et al, 1995; Yin et al, 1996). 
Ras proteins are thought to be involved in the mediation of cellular signals which result in normal 
cellular growth and differentiation (Krengel et al, 1990; McCormick, 1993; Feig and 
Schaffhausen, 1994; Bokoch, 1996). The ras pathway appears to be an important link between 
the intracellular environment and its external surroundings i.e, the activation of molecules 
downstream of ras result in phenotypic changes. A number of ras - like genes have been cloned 
from T. brucei (Field et al, 1995; Field and Boothroyd, 1995; El-Sayed et al, 1995). Their 
presence indicates the possibility of the existence of signalling pathways which involve members 
of the ras superfamily.
Based on the current knowledge of cellular signalling in trypanosomatids, it appears that 
there are signalling pathways equivalent to those in higher eukaryotes (e.g mammals) which are 
involved in the regulation of cellular growth and differentiation. One of the key sets of molecules 
regulating the transduction of extracellular signals to the various intracellular kinase cascades in 
higher eukaryotes is the ras GTPase superfamily. As one of the approaches to finding new drug 
targets is by gaining a greater understanding of the regulatory mechanisms involved in cell 
growth, this project was designed with the aim to investigate the role of ras subfamily GTPases 
in the development of T. brucei.
The following section is a review of the members of the ras superfamily, with particular 
emphasis on the ras subfamily and their role in cellular signalling. The review is based on studies 
in mammalian cells unless otherwise stated.
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1.8 The Ras superfamily
The ras gene family encodes small monomeric GTP - binding proteins that belong to a 
large superfamily of GTPases. There are six subfamily members within this superfamily, and 
each subfamily is made up of a number of distinct groups (Zerial and Huber, 1995). The small 
GTPases form a family of molecular switches which have been implicated in the control of a 
number of physiological functions such as cytoskeletal organisation, proliferation and 
intracellular vesicle transport (Hall, 1990). The ras GTPase superfamily is made up six 
subfamilies: ras, rap, rho, rab, ran, a rf and sar. Members of the superfamily have 
evolutionarily conserved GTP binding domains. They are involved in the cyclical regulation of 
the transmission of signals to downstream effectors, the final result of which is the regulation of 
cellular growth, differentiation or secretion. The cyclical regulation is achieved through the 
activation of the proteins by binding GTP, or the termination of the transmission of the signal, 
brought about by the hydrolysis of GTP i.e in the GDP bound state. Members of the ras GTPase 
superfamily are found across a wide range of organisms and studies have shown that their 
function has also been well conserved through evolution.
Figure 1.8 is an illustration of the ras GTPase superfamily, showing in particular, the 
members of the ras subfamily which are involved in cellular signalling. A number of small GTP 
- binding proteins have been cloned from T. brucei namely, ran (Field et al, 1995) and several 
rab GTP -binding proteins (El Sayed et al, 1995). To date no members of the ras subfamily of 
GTP - binding proteins have been cloned from T. brucei despite the ubiquitous distribution of 
these proteins (Hall, 1990).
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FIGURE 1.8
RAS  GTPase SUPERFAMILY
RAS RHO RAB RAN ARF SAR
RAS YPT
RAP
RRAS
RAL
Figure 1.8 is a family tree showing the main subfamily members of the Ras GTPase superfamily namely, ras. 
rho, rab, ran, a r f and sar. Group members of the ras subfamily, namely, ras, rap , rras and ral are shown as 
the review is mainly focused on two member of the ras subfamily known to be involved in cellular signalling. 
Ypt is a subgroup of the rab subfamily.
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1.81 Nomenclature o f  small GTP - binding proteins
In 1992, Kahn proposed a method for naming small GTP - binding proteins, due to the 
increasing numbers of the genes encoding these proteins being cloned. Using these guidelines, a 
small GTP - binding protein is one that falls within a molecular weight range of 20 - 29 kDa 
(Bokoch and Der, 1993) and has a conserved, well defined GTP -binding domain. If a number of 
proteins share approximately 85 % or more identity, the same name with a different letter is 
assigned to the new protein. If the identity is less than 85 % but more than 35 % the new protein 
is given the same name but with a different number (Kahn et al, 1992; Zerial and Huber, 1995). 
The guidelines are, however, not very rigid, as illustrated by yeast ras 1 and 2, which have 
molecular sizes of 40 and 41 kDa respectively (Barbacid, 1987).
1.82 General structure of a ras GTP - binding protein
There are over 50 members of the ras GTPase superfamily which are known to regulate 
a wide range of cellular activities. The activities which are influenced by the presence of these 
small GTP binding proteins include cellular growth and differentiation, vesicular transport and 
cytoskeletal control, just to name a few (Bokoch and Der, 1993). Ras genes are well conserved in 
evolution and can be found in many eukaryotes, from yeast to man. It is the structure of a ras 
protein that defines it as a member of the ras GTPase super family. A protein belonging to the 
ras superfamily has four basic domains, 1) the amino - terminus; 2) the GTP binding/catalytic 
domain; 3) the C - terminal extension region and 4) the carboxyl terminus. Figure 1.9 is an 
schematic diagram of the general structure of a mammalian ras GTP binding protein, showing the 
four basic domains and their conserved sequence motifs.
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FIGURE 1.9
NT GBD C -T E CT
PM1 G l PM2 PM3 G2 G3
GxxxxGKs F T DxxG nKxD ExSA
Figure 1.9 is a schematic diagram of the general structure of a mammalian ras GTP -binding protein depicting the 
four main domains: NT - the amino terminus; GBD - the GTP - binding or catalytic domain;
C - TE - the carboxyl terminal extension region; CT - the carboxyl terminus; G - Glycine, K - Lysine. F - 
Phenylalanine, T - Threonine, D - Aspartic acid, n - Asparagine (a small letter is used to show that it is not 
conserved in all ras genes), E - Glutamic acid and x - any amino acid. Within the GBD there are six regions of 
highly conserved sequence motifs, which are essential for activation of the ras signalling pathway. PM1, 2 & 3 
denote the three phosphate/magnesium binding sites and Gl, 2 & 3, the three guanine nucleotide binding sites of the 
GTP-binding domain.
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The amino terminus
The length of the amino terminus (i.e the region immediately preceding the first 
phosphate/magnesium binding site) varies from 4 to more than 30 amino acids. The actual role 
of the amino terminus is unknown. It may be involved in interactions with other proteins but 
there is currently no evidence to this effect (Valencia et al, 1991).
The GTP - binding/catalytic domain (GBD)
The GTP - binding domain is the most highly conserved domain within a ras protein. 
There are six regions of conserved sequence motifs which are essential for the folding of the 
protein and its activity (the binding and hydrolysis of GTP). The six regions are involved in 
binding phosphate/magnesium and the guanine base of GTP and GDP. There are three 
phosphate/magnesium (PM 1, 2 and 3) and three guanine nucleotide (G 1, 2 and 3) binding sites 
within the GTP - binding domain (Valencia et al, 1991; Lowy and Willumsen, 1993). Conserved 
sequence motifs GxxxxGKs, T and DxxG correspond to PM 1, 2 and 3. The guanine base 
binding sites consist of the following conserved sequence motifs F, nKxD and ExSA (where G - 
glycine, T - threonine, n/s - asparagine/serine, the use of lower case letters indicate that the amino 
acid is conserved in most but not all ras genes. K - lysine, x - any amino acid, D - aspartic acid, 
E - glutamic acid, S - serine and A - alanine).
GxxxxGKs or PM 1
The sequence is highly conserved in all proteins belonging to the ras GTPase 
superfamily. The lower case “s” denotes the variability of the sequence at this position. In all 
members of the ras superfamily, the amino acid found at that position is either serine or 
threonine. Most members of the ras subfamily have the amino acid glycine at position 12 (based 
on mammalian ras gene amino acid positions, the general consensus is as follows: GxGxxGKs). 
Replacement of this glycine with any other amino acid (with the exception of proline), results in 
the formation of a mutant protein with transforming potential. Ras subfamily genes also tend to 
have Glycine at position 13, therefore the general consensus for a ras subfamily gene is 
GxGGxGKs (Valencia etal, 1990).
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PM 2
There is only one conserved amino acid within this site, threonine. Threonine (T) plays a 
regulatory role in the structural transition from the activated to the inactivated form of the ras 
protein (Valencia etal, 1991).
PM 3
This site contains the motif DTAGQE. In rap proteins, the glutamine (Q) is replaced by 
threonine (T). It appears as though this difference might account for different mechanisms of 
activation (Valencia et al, 1991).
Guanine base binding sites 1, 2 and 3 or G l, 2 and 3
The sequence motif essential for the binding of the ras GTPase to the guanine base of 
GTP (i.e the G l binding site) is phenylalanine (F ) (Valencia et al, 1991). This residue is 
replaced by tyrosine in rab GTPases. A considerable amount of variation is observed in the G2 
region and this depends on the subfamily to which the GTPase belongs. Mutants produced by the 
substitution of asparagine (N) have an increased rate of dissociation and an alteration in 
nucleotide specificity (Valencia et al, 1991). G 3 which has the motif ExSA is also highly 
conserved in all members of the ras superfamily. It does not bind directly to the guanine base, 
but appears to be essential for the maintenance of the stability of the protein (Valencia et al, 
1991). A considerable degree of amino acid variability is observed in other regions of the 
catalytic domain in the various subfamilies.
The carboxyl - terminal extension or C -T E  region
This region, containing over 40 amino acids, appears to be the most variable region of 
the ras GTPase genes. Yeast ras genes have uncharacteristically large molecular sizes and are 
known to have as many as 120 amino acids in the carboxyl terminal extension region. As yet a 
definite function for this region has not been determined.
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The carboxyl terminus or CT
The carboxyl terminus of members of the ras GTPase superfamily, is essential for post 
translational modification and subsequent subcellular localisation of the protein. The sequence 
found in this region is characteristic of the ras GTPase subfamily. Members of the ras subfamily 
have a CAAX box, where C - cysteine; A - aliphatic amino acid and X - any residue (Valencia et 
al, 1991; H ancocks al, 1991; Lerosy et al, 1991; Bokoch, 1993; Zerial and Huber, 1995). Rho 
subfamily members also have a CAAX box which undergoes isoprenylation (Zerial and Huber, 
1995). Members of the rab subfamily have at least six alternative terminal sequences; CXXX, 
CXC, CC, CCX, CCXX and CCXXX (Zerial and Huber, 1995). The carboxyl terminus 
sequence is involved in determining which transport pathway the rab proteins are involved in 
(Chavrier et al 1990).
1. 83 Three dimensional structure o f a mammalian ras GTPase
The three dimensional structures of mammalian p21ray in both the active (bound to GTP) 
and inactive (bound to GDP) forms are now known (Grand and Owen, 1991). The structure is 
being used to study the mode of activation of members of the ras superfamily and the residues 
involved in each of the interactions. Figure 1.10 is a three dimensional diagram of mammalian 
p21 ras, showing the a  helices and p sheets. A number of conformational changes occur in the 
structure of the protein when bound to GTP. In the GTP bound form, the hydrophobic core of 
the protein consists of six p sheets connected by hydrophilic loops and a  helices (Bourne et al, 
1991). The regions of the protein involved in the exchange of GTP for GDP and vice versa are 
the three phosphate/magnesium and guanine base binding sites.
PM 1 forms a loop which is closed by a non-covalent interaction between lysine (K) and 
the carbonyl groups of two residues in the main chain, namely glycine 10 and alanine 11 (where 
glycine 10 and alanine 11 are the two x’s found in the PM sequence motif GxxxxGKs, the first 
glycine is glycine 9) (Pai et al, 1989). Lysine, which also forms a side chain, is thought to be 
involved in catalysis as it is in contact with the P and y phosphate oxygens (Reinstein, 1990; Pai 
et al, 1991). The conformation of this region is the same in both the active and inactive forms. 
This is due to bonds formed between the s amino group of lysine and the a  and p phosphates of 
GTP or GDP. The loop formed in this region connects the first P sheet (p 1) to an amphipathic a  
helix referred to as a  1 (Valencia et al, 1991).
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PM 2 is involved in the stabilisation of the y phosphate of GTP (Marshall, 1993). A 
conformational change occurs in the hydrophilic loop, which precedes the second hydrophobic p 
sheet (p 2) on binding GTP. There is evidence that this region might be involved in the 
hydrolysis of GTP by positioning the water necessary for this process. It is also involved in the 
co-ordination of a magnesium ion to the p and y phosphate oxygens of GTP. The magnesium ion 
is essential for the inactivation of the protein or GTP hydrolysis.
The second a  helix (a 2) and the third hydrophobic p (P 3) sheet are found within the 
PM 3 region. The conformation of the helix is dependent on the state of activation of the protein. 
Aspartate (D) binds to the magnesium ion via a molecule of water, while Glycine (G), binds to 
the y phosphate of GTP by hydrogen bonds (Bourne et al, 1991). Glutamine (Q) in this region, is 
presumed to be involved in the catalytic reaction, due to its proximity to a water molecule which 
is thought to react with the y phosphate of GTP (Pai et al, 1990).
The most important of the three guanine base binding regions is G 2. The fifth 
hydrophobic p sheet (P5) is located just before G 2. A link between three of the nucleotide loops 
can be found in this region and serves to some extent as a stabilising factor for the whole protein 
(Valencia et al, 1991 and all references therein). G 3 contributes indirectly to the overall stability 
of the protein in both active and inactive states. The sixth p sheet (P 6) is found within this 
region. G 1 also contributes to the stability of the protein by binding to the guanine base of both 
the GTP and the GDP forms of the protein.
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FIGURE 1.10
Three dimensional representation of the structure of mammalian ras p21, showmg residuesl-166 (Pai et al, 
1990). Helices are represented by alpha 1-5 and beta sheets by beta 1-6. Loops are represented by L l- 
The highly conserved sequence motifs of the GTP-binding domain are found m loops L I, L4, L6 and L 
(on the nght hand side of the 3-D figure). The GTP nucleotide position and conformation have been 
approximated (photocopied from Valencia et al, 1991).
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1.84 Post-translational modification and subcellular localisation
All proteins of the ras and rho subfamilies have a C - terminal CAAX motif which 
serves as a signal for post translational modification (Hancock et al, 1991). The post 
translational modifications of members of the ras and rho subfamilies are found to be essential 
for membrane targeting, lipid binding (Willumsen et al, 1984; Willumsen, Christensen et al, 
1984) and function (Bokoch and Der, 1993). In other words the process of post translational 
modification is necessary for the subcellular localisation and normal function of the protein. The 
phenomenon of post translational modification is not only confined to members of the ras and rho 
subfamilies. Other proteins which have the C - terminal modifications that determine their 
subcellular location, include nuclear lamins, fungal mating factors and the y subunit of retinal 
transducin (Moores et al, 1991 and all references therein). Some rab subfamily members are 
also known to undergo post translational modification (Bokoch and Der, 1993).
The process of post translational modification occurs in three distinct stages:
1) the isoprenylation of the cysteine of the CAAX motif (Hancock et al, 1989; Hancock et al 
1991).
2) The peptide bond between the cysteine (of the CAAX motif) and the adjacent alanine is 
proteolytically cleaved (Gutierriez et al, 1989; Valencia et al, 1991; Lowy and Willumsen, 
1993).
3)The a  carboxyl group of the terminal isoprenylated cysteine (from the CAAX box), undergoes 
methylation (Gutierriez et al, 1989; Valencia et al, 1991; Lowy and Willumsen, 1993; Bokoch, 
1993). All three processes are essential for the subsequent membrane association, localisation 
and function of the protein. The exact order of these modifications is yet to be determined.
The isoprenylation of the protein may occur by the addition of a famesyl (C l5) or a 
geranylgeranyl group (C20). The reaction occurs in the presence of either famesyl transferase 
(for famesylation) or geranylgeranyl transferase (for geranylgeranylation). In general, a protein 
will undergo famesylation if the X of the CAAX motif is any one of the following amino acids; S, 
C, M or Q. If the X is L or F the protein will be geranylgeranylated (Moores et al, 1991; Bokoch 
and Der, 1993). Post translational modification results in the distribution of different subfamily 
members in different subcellular fractions and members of the subgroups ras and rap are never 
found in the same subcellular fractions (Beranger et al 1991; Kim et al 1990). Thus members of 
the ras subfamily are found on the inner surface of the plasma membrane (Lowy and Willumsen, 
1993), while rap subfamily members can be found on the endoplasmic reticulum and 
endosomal/lysosomal compartments (Zerial and Huber, 1995).
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1.85 Biochemical activation and function o f members o f  the ras subfamily
Activation of the ras protein occurs in conjunction with a number of proteins. These 
proteins are regulatory proteins, essential for the dissociation of GDP (the inactive form) and its 
replacement by GTP. These proteins are known as Guanine nucleotide exchange factors or GEFs 
(Boguski and McCormick, 1993)
In the GTP - bound state, the ras GTPase protein serves as a mediator of cellular signals. 
It has an intrinsic GTPase activity (Lowy and Willumsen, 1991) and therefore can be classified 
as an autoregulatory protein. When activated (in mammalian cells), members of the ras 
subgroup activate the mitogen activated protein kinase (MAPK) cascade via raf protein kinase 
(Zhang et al, 1993; Wame et al, 1993; Burgering and Bos, 1995; Farrar et al, 1996). In yeasts 
there is evidence for the activation of the adenylate cyclase pathway which is essential for normal 
cellular differentiation (Thevelein, 1991). There is evidence that shows that members of the rap 
subgroup when in the activated state (i.e bound to GTP) act in opposition to members of the ras 
subgroup (Lerosy, 1991; Nassar et al, 1995; Sprang, 1995).
The hydrolysis of GTP and the concomitant loss of a molecule of inorganic phosphate, 
returns the protein to its inactive state. A number of regulatory proteins are also involved in this 
process e.g the GTPase activating protein otherwise referred to as GAP (Gibbs et al, 1990; 
McCormick, 1990). The catalysis of the ras - GTP to ras - GDP reaction by GAPs have been 
observed in both mammalian and yeast cells. Figure 1.11 is a schematic diagram showing the 
cycling of a ras protein between its active (GTP-bound) and inactive (GDP-bound) states.
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FIGURE 1.11
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Figure 1.11 is a model of the activation and inactivation of ras. Extracellular signals induce the 
guanine nucleotide exchange factors (GEFs) and/or the GTPase activating proteins (GAPs) to initiate 
or terminate the binding of GTP to ras. In the activated form, GDP is physically replaced by GTP.
The inherent GTPase activity immediately starts to function and in conjunction with the GAPs, GTP is 
hydrolysed with the concomitant loss of a molecule of inorganic phosphate (Pi). The protein at this 
stage returns to its inactive state, i.e it binds GDP.
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1.9 The evolution of the ras gene family
The ras superfamily has evolved by a succession of gene duplication and divergence 
events over evolutionary time. Estimates suggest that the gene duplication rate of the ras 
subfamily is very slow, at 0.33 duplications per 100 million years (Iwabe et al, 1996). This 
highlights the extent to which the subfamily has been conserved throughout evolution. The 
subfamily is known to have been in existence, prior to the divergence of vertebrates and 
invertebrates (Valencia et al, 1991; Iwabe et al 1996). Experiments carried out on E. coli 
showed that no ras superfamily homologues exist. This suggests that the superfamily evolved 
subsequent to the divergence of the eukaryotes from the Eubacteria or (possibly) the 
Archaebacteria.
Ras genes are known to exist in higher eukaryotes. Recently a number of them have been 
cloned in the lower eukaryotes. Dictyostelium has 7 ras and 1 rap gene; two ras and two rap 
genes have been cloned from Entamoeba histolytica-, two ras and one rap from Physarum 
polycephalum. Only a few ras superfamily genes have been cloned from the kinetoplastids. A 
ypt gene has been isolated in Leishmania (Cappai et al, 1993) and, one ran gene and nine rab 
genes have been cloned from T. brucei (Field and Boothroyd, 1995; Field et al, 1995; El Sayed et 
al, 1995). To date no ras genes from the ras GTPase subfamily have been cloned from T. brucei 
or any other kinetoplastids.
1.10 Aims and Objectives
There is evidence for the presence of membrane bound signal transducers but a very 
limited amount of information is available on their role in trypanosomatid development e.g the 
adenylate cyclase receptors. The factors involved in the activation of these receptors are yet to be 
determined. In higher eukaryotes the adenylate cyclase cascade is activated by heterotrimeric 
GTP-binding proteins. There is, however, no evidence for its activation by heterotrimeric G 
proteins in trypanosomes, even though there is evidence for their presence in the parasites. In 
yeasts, monomeric GTP-binding proteins have been implicated in the activation of the adenylate 
cyclase cascade. There is mounting evidence for the presence of monomeric GTP-binding 
proteins in the trypanosomatids. A number of small GTP-binding proteins have been cloned from 
Leishmania and T. brucei.
To date none of the monomeric GTP-binding proteins that have been cloned from T. brucei are 
from the ras subfamily. Members in this subfamily are known (from studies in higher
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eukaryotes) to be directly involved in the transduction of extracellular signals into intracellular 
responses. Coulter and Hide, (1995) found evidence for the presence of small GTP binding 
proteins in T. brucei, using an in situ GTP binding assay. The identities of the monomeric 
GTPases were unknown, but as they have been highly conserved through evolution, the project 
was designed to characterise the monomeric GTPase subfamilies present in T. brucei. This was 
undertaken with the aim of isolating a ras subfamily GTP binding protein. The main objective of 
the project was to determine the role of ras subfamily GTP binding proteins in the regulation of 
trypanosomal growth, by isolating, cloning and fully sequencing a ras GTPase subfamily gene 
from T. brucei and developing tools and reagents for the analysis of the function of the ras gene. 
A secondary objective was to determine the relationship between present day ras GTPases (of 
eukaryotes higher up the evolutionary scale than the kinetoplastids) and ras GTPases from T. 
brucei, as T. brucei belongs to the Order Kinetoplastida, one of the first groups of eukaryotes to 
diverge after the acquisition of mitochondria.
1.11 Overview of the results chapters
Chapter 3: Detection of monomeric GTP binding proteins in Trypanosoma brucei
In this chapter, small GTP binding proteins were identified in T. brucei using the GTP 
binding assay of Coulter and Hide, 1995. A slot blot GTP binding assay was developed and used 
for screening large numbers of HPLC fractions. Results from the use of anion exchange 
chromatography in the purification of a ras like GTP binding protein from spun detergent 
extracts of bloodstream T. brucei (strain TREU 869) showed the presence of a 24 kDa peptide 
capable of binding GTP but, due to its low abundance, there was a need to considerably scale up 
the amount of starting material. The use of heterologous ras antibodies for the detection of small 
GTP binding proteins in T. brucei proved inconclusive due to the excessive cross reactivity of the 
antibodies.
53
Chapter 4: Cloning, sequencing and identification of tbrlp, a ras like GTPase gene
This chapter concerns the isolation of a ras like GTPase gene, tbrlp from T. brucei. 
Trypanosoma brucei ras like protein or tbrlp has an open reading frame of 681 bp (227 amino 
acids) and all the highly conserved sequence motifs of a member of the ras GTPase superfamily. 
PCR amplification of tbrlp using a specific set of 3’ and 5’ tbrlp primers suggests that there is an 
identical copy of tbrlp, with the second copy located upstream of and tandemly linked to tbrlp. 
The first gene was therefore renamed tbrlp I and the second copy, tbrlp II. Low stringency 
hybridisation provided no evidence for related genes.
Chapter 5: Evolutionary analysis of tbrlp I
In addition to the highly conserved sequence motifs characteristic of members of the ras 
GTPase superfamily, tbrlp has a number of unusual features. The GTP binding domain has 45 
% amino acid identity to human rap 2 and 41 % identity to human ras h, both of which are 
members of the ras subfamily. The mixed ras and rap features of the GTP binding domain of 
tbrlp I, suggest that it may have an interesting evolutionary relationship with the ras and rap 
genes of higher eukaryotes. In Chapter 5, six possible hypotheses explaining the evolutionary 
origin of tbrlp I are proposed and tested.
Chapter 6: Development of tools for functional analyses of tbrlp I
From the nucleotide and amino acid sequence of tbrlp I, it is difficult to determine the 
exact subgroup of the ras subfamily to which it belongs. Studies of the function of ras and rap 
GTPases in mammalian cells, indicate that the two proteins function in opposition to each other 
i.e ras function is activated when rap function is inhibited and vice versa. Both of these proteins 
are known to be involved in cellular proliferation and differentiation. From the sequence of tbrlp 
I, it is therefore difficult to determine the possible function of tbrlp I i.e whether the function of 
tbrlp I is predominantly ras like or rap like. It was therefore necessary to develop tools for 
functional analyses of tbrlp I, which would, in the long run, give an insight into its role in the 
development of T. brucei. Chapter 6 describes the approaches taken in the development of tools 
for the functional analyses of tbrlp I.
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Chapter 2 
Materials and Methods
CHAPTER 2
MATERIALS AND METHODS
Materials and methods used in protein manipulations
The following materials and methods, were used for all protein manipulations described 
in chapters 3 and 6.
2.0 Preparation of T. brucei bloodstream and procyclic spun detergent extracts
Sprague-Dawley or Wistar rats were inoculated with T. b. brucei cloned monomorphic 
stock TREU 869. Bloodstream form trypanosomes were harvested at maximum parasitaemia 
(approximately 4 days after inoculation), separated from host blood by anion exchange 
chromatography (Lanham and Godfrey, 1970), washed twice in phosphate buffered saline at pH
8.0 containing 1 % glucose (PBSG) and used in the preparation of bloodstream spun detergent 
extracts. Procyclic T. brucei of the stock EATRO 1125 were grown in culture using SDM-79 
medium (Brun and Schonenberger, 1979). The cultured procyclic trypanosomes were also 
washed twice in PBSG and frozen as packed cell pellets at -70°C until required for the 
preparation of spun detergent extracts.
Spun detergent extracts of both bloodstream and procyclic trypanosomes were prepared 
in the following way:
(a) 1 ml of packed whole trypanosomes were thawed homogenised with a glass homogeniser in 
an equal volume of the following on ice: ice cold HEPES/sucrose/EDTA pH 7.4 (HSE) buffer 
(lOmM HEPES, pH 7.4, 0.25M sucrose and ImM EDTA) containing the following protease 
inhibitors: aprotinin and leupeptin added to a final concentration of 25 pg ml _1 and ImM 
benzamidine. Triton X-100 and Nonidet P40 were added to a final concentration of 0.1 %.
(b) The homogenate was centrifuged at 38K for 45 minutes at 4°C in a precooled Beckman 
70.1 Ti rotor.
(c) The supernatant was removed and stored at -70°C. The pellet was resuspended in 1 ml of 
HSE buffer (or the equivalent amount for a lower volume of procyclics) and also stored at -70°C
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2.1 HPLC purification
Purification by anion exchange chromatography was performed using a pre-packed 
(Protein-Pak 8HR resin) Waters AP-1 glass column with a diameter of 1 cm. The column was 
set up with a 0.8 ml min'1 flow rate and samples were collected every thirty seconds. Separate 
bottles containing the following reagents: 100 mM Tris-HCl, 100 mM Tris-base, 1 M NaCl and 
distilled water, were mixed in the HPLC fluid handling system as required for each of the 
purification procedures. After use, the column was regenerated by elution in 0.5 M NaCl 
followed by washing through with distilled water.
2.2 In situ GTP-BINDING ASSAY
The in situ GTP-binding assay was carried out as described in Coulter and Hide, (1995). 
Briefly, spun detergent extracts of both bloodstream and procyclic T. brucei were separated on 
15% SDS polyacrylamide gels in Bio-Rad Mini Protean II apparatus for 2 hours at lOOv. The 
proteins were either visualised by silver staining or the gel was pre-soaked in Tris/Glycerol 
buffer (50mM Tris-HCl - pH7.5 and 20% Glycerol) for an hour before setting up the transfer 
onto PVDF membranes. The PVDF membranes were rehydrated in the following way: the 
membranes were presoaked in methanol for 10-15 minutes, distilled water for 10-15 minutes and 
then in transfer buffer (lOmM NaHC03 and 3mM Na2C 03 pH 9.8) for 10 minutes. The 
proteins were then transferred onto the membranes using lOmM NaHC03 and 3mM Na2C 03 pH
9.8 as the transfer buffer. The transfer was carried out at 50 volts for 2 hours at 4°C in a Bio- 
Rad Mini Protean II apparatus.
After the transfer, the membranes were blocked for either 1 hour at room temperature or 
overnight in a blocking buffer made up of the following: 50mM NaH2P 0 4, lOmM MgCl2, 2mM 
dithiothreitol (DTT) and 0.3% Tween 20 pH 7.5. The blocked membranes were then incubated 
in hybridisation bottles containing lOmls of blocking buffer and 30pCi of [a32-P]GTP (specific 
activity: 3000 Ci mmole'' , NEN Research Products) for 2 hours at room temperature. After the 
incubation period the membrane was washed 3 times for 10 minutes in blocking buffer and 
exposed to X-Omat XS-1 film at -70°C. The autoradiograph was developed after 1 hour.
56
2.21 Slot blot GTP binding assay
PVDF membranes were cut to fit into a slot blot apparatus (Gibco BRL 24-well filtration 
manifold). The membranes were rehydrated as previously described (section 2.2). The 
rehydrated membranes were placed on the lower half of the apparatus and the upper half was 
screwed down into place on top of the membrane. The slots were then loaded with 100 pi 
aliquots of the HPLC fractions and the samples were transferred onto the PVDF membranes by 
briefly applying a vacuum to the slot blot apparatus. After the transfer, the membranes were 
blocked in blocking buffer (50mM NaFyPO^ lOmM MgCb, 2mM dithiothreitol and 0.3% Tween 
20 pH 7.5) for 1 hour at room temperature. The membranes were assayed for GTP binding by 
incubation in hybridisation bottles containing lOmls of blocking buffer and 30pCi of [a32-P]GTP 
(specific activity: 3000 Ci mmole A , NEN Research Products) for 2 hours at room temperature. 
After incubation, the membranes were washed 3 times for 10 mins and exposed to X-Omat XS-1 
film at -70°C. The autoradiograph was developed after 1 hour.
2.3 Polyacrylamide gel electrophoresis and immunoblotting
Polyacrylamide gel electrophoresis was carried out using standard procedures (Laemmli, 
1970). 12 or 15 % gels with a thickness of 1.5 mm, were prepared in Bio-rad Mini Protean II 
apparatus. 12 % resolving gels were prepared as follows: 3.35 ml of distilled water, 2.5 ml of
1.5 M Tris-HCl (Sigma) pH 8.8, 100 pi of 10 % w/v SDS (Sigma), 4.0 ml of 
Acrylamide/Bisacrylamide (30 % stock, Sigma), 50 pi of fresh 10 % ammonium persulfate 
(Sigma) and 5 pi of tetra-methyl-l,2-diaminoethane (TEMED, Sigma). The resolving gels were 
overlaid with 1 ml of distilled water and allowed to set for 1 hour. 4 % stacking gels were used 
routinely and were prepared as follows: 3.05 of distilled water, 1.25 ml of 0.5 M Tris-HCl, pH 
6.8, 50 pi of 10 % w/v SDS, 1.3 ml of Acrylamide/Bisacrylamide, 50 pi of fresh 10 % 
ammonium persulfate and 10 pi of TEMED, making a total volume of 5 ml. The protein samples 
were prepared for separation by the addition of SDS-PAGE sample buffer (without p- 
mercaptoethanol for samples to be assayed for GTP binding), boiled for 5 minutes and loaded 
into the wells. Protein molecular weight markers were either from Sigma or New England 
Biolaboratories (NEB) and used according to the manufacturers instructions. Gel electrophoresis 
was undertaken in a buffer consisting of the following: 50 mM Tris-base, 384 mM glycine, 2 mM 
EDTA and 0.1 % SDS at room temperature for 2 hours at 100 volts.
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15 % gels were prepared in the following manner:
2.3 ml of distilled water, 2.5 ml of 1.5 M Tris-HCl (Sigma) pH 8.8, 100 yl of 10 % w/v SDS 
(Sigma), 5.0 ml of Acrylamide/Bisacrylamide (30 % stock, Sigma), 100 pi of fresh 10 % 
ammonium persulfate (Sigma) and 4 pi of tetra-methyl-l,2-diaminoethane (TEMED, Sigma). 
The resolving gels were overlaid with 1 ml of distilled water and allowed to set for 1 hour. 4 % 
stacking gels were used routinely and were prepared as follows: 3.05 of distilled water, 1.25 ml 
of 0.5 M Tris-HCl, pH 6.8, 50 pi of 10 % w/v SDS, 1.3 ml of Acrylamide/Bisacrylamide, 50 pi 
of fresh 10 % ammonium persulfate and 10 pi of TEMED, making a total volume of 5 ml. 
Protein samples were prepared as described for 12 % gels.
The resolved proteins were visualised by staining in Coomassie blue or transferred by 
Western blotting onto rehydrated PVDF membranes at 4°C, for 2 hours at 100 volts. The 
membranes were blocked for 1 hour at room temperature (or 4°C overnight), using a buffer 
containing the following reagents: 20mM Tris, 137mM NaCl (TBS) pH 7.6, containing 0.1 % 
Tween 20, 10 % dried milk and 10 % horse serum. Filters were washed 2 times for 15 minutes in 
TBS/0.1 % Tween 20 and incubated in a 1:200 dilution of anti-serum for 1 hour. The filters were 
washed 6 times for 5 minutes in TBS/0.1 % Tween 20 after 1 hour and incubated in a 1:400 
dilution of goat anti-mouse IgG peroxidase conjugate (Sigma) for 1 hour. The membranes were 
washed 6 times for 5 minutes in TBS/0.1 % Tween 20 and, the anti-mouse IgG peroxidase 
conjugate was detected by using the enhanced chemiluminescence (ECL) kit, (Amersham) as 
described in the manufacturers manual.
2.31 Modifications used in peptide binding studies in Chapter 6
Peptide blocking studies were carried out in the following way: total bloodstream 
trypanosome spun detergent extracts were separated in triplicate on 12 % SDS polyacrylamide 
gels. The samples were transferred onto PVDF membranes and the membranes were cut into 
three separate blots after the transfer, resulting in a lane of the separated SDE of bloodstream 
trypanosomes on each blot. The same procedure as described in section 2.3 was used with the 
following modifications:
1) Blocking buffer - 20 mM Tris, 137 mM NaCl (TBS), pH 7.6 containing, 0.5 % Tween 20, 10 
% dried milk and 10 % horse serum.
2) The blots were blocked for 1 hour at room temperature (or 4°C overnight), using a buffer 
containing the following reagents: 20 mM Tris, 137 mM NaCl (TBS), pH 7.6 containing, 0.5 % 
Tween 20, 10 % dried milk and 10 % horse serum. Blots were washed 2 times for 15 minutes in
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blocking buffer and incubated in the following solutions: Blot A - a 1:200 dilution of preimmune 
serum; blot B - 1:200 dilution of immune serum; blot C - 1:200 dilution of immune serum, 
preincubated for 1 hour at 4°C with 12 pg ml"1 of tbrlp-pep. After the incubation period, the 
membranes were washed in blocking buffer, 6 times for 5 minutes.
3) The membranes were subsequently incubated in a 1:800 dilution of anti-rabbit IgG peroxidase 
conjugate (Sigma) for 1 hour, washed 6 times for 5 mins in TBS/0.5 % Tween 20 and detected 
using the ECL (Amersham) method.
Materials and methods used for molecular cloning techniques
The following materials and methods were used in the molecular cloning techniques 
described in Chapters 4 and 6.
2.4 Preparation of T. brucei genomic DNA and RNA
Standard procedures were used in the preparation of bloodstream and procyclic T. brucei 
genomic DNA (Borst et al, 1980). RNA was extracted from TREU 869 and EATRO 1125 
bloodstream and procyclic trypanosomes using the single step acid guanidinium thiocynate phenol 
chloroform extraction method of Chomczynski and Sacchi, 1987.
2.5 Growth and transformation of Escherichia coli
The E. coli strains used routinely were either XL-1 Blue, INVaF’ (Invitrogen) or 
supercompetent cells (SURE) from Stratagene and 25-100 ng of ligated DNA. Transformed cells 
were grown on LB agar plates supplemented with 0.004 % X-gal and 34 pM IPTG which 
enabled blue/white colony selection in E. coli strains with a lacZAM15 mutation (a- 
complementation of the lacZDMIS mutation results in blue/white colony selection, where white 
colonies contain plasmids with inserts). Transformants/overnight cultures were grown in LB ( or 
2 YT/super broth, to enhance rapid growth of the transformed cells) medium (Sambrook et al, 
1989), with a final concentration of 100 pg ml"1 ampicillin (or 50 pg ml'1 kanamycin, when 
required). Transformations were carried out according to the manufacturers instructions. E. coli
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strain Y1090(f) was transfected with phage and grown on LB plates supplemented with 10 mM 
MgS04.
2.6 Plasmid vectors
The following plasmid vectors were used for cloning DNA into plasmids, according to 
the manufacturers instructions: pCRU (Invitrogen), pTAG (R&D Systems), Bluescript II SK (+) 
(Stratagene), pTZ18R (Stratagene), pGEX-5X-l, 2 and 3 (Pharmacia Biotech), pMAL-c2 (NEB) 
and pQE 30 (Qiagen). DNA from cells containing these plasmids was prepared according to the 
manufacturers instructions.
In cases where there were no instructions, DNA was extracted by using either the Wizard 
miniprep kit (Promega) or the appropriate Qiagen miniprep kit.
2.7 Plasmid DNA
Plasmid DNA was routinely calf intestinal phosphatase treated (as described in 
Sambrook et al, 1989) before ligating, to prevent self ligation. Ligations were carried out 
overnight at 16°C using T4 ligase and ligase buffer from either Gibco BRL or NEB. Restriction 
enzymes used in subsequent manipulations of plasmid DNA, were either from Gibco BRL or 
NEB. All reactions were set up according to the manufacturers instructions.
2.8 Electrophoresis
0.6-2.0 % agarose gels were prepared from Seakem agarose and run in 40 mM Tris 
acetate and 1 mM EDTA (lx  TAE) containing 0.5 pg ml'1 ethidium bromide. Mini or midi gel 
tanks from Pharmacia or Gibco BRL were used in running the gels. The 1 Kb ladder molecular 
marker (Gibco BRL) was used routinely, in the determination of molecular sizes on gels. Bands 
were visualised under UV light and photographed as required.
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2.81 Southern and Northern blots
Standard procedures were used for the preparation of agarose gels for Southern and 
Northern blotting. Briefly, for Southern blot analysis, 2-5 pg of genomic DNA from 
trypanosome strains TREU 869, 927 or STIB 247 and 386, was digested with the appropriate 
enzymes and fractionated by agarose gel electrophoresis (0.8 %). The gels were washed three 
times (fifteen minutes per wash) in denaturation buffer and three times (fifteen minutes per wash) 
in neutralisation buffer (see section 2.15). The DNA was transferred onto nylon filters (same size 
and placed on top of the gels) overnight by placing the gels on a platform covered with a layer of 
3 MM filter paper and with the ends of the filter paper immersed in 20x SSC. The Hybond-N 
membranes were in turn covered with 3x SSC soaked 3 MM paper, a stack of paper towels and a 
weight. The DNA was cross-linked to the nylon membranes by placing on a UV transilluminator 
(DNA side down) for 7 minutes and then was hybridised to T. brucei specific 32P labelled probes. 
Probes (PCR products or double stranded DNA) were prepared using random primed labelling 
(Prime-it kit, Stratagene), using the manufacturers instructions. Oligonucleotides (Strathclyde 
University or Cruachem) were end labelled with T4 polynucleotide kinase (Gibco BRL) as 
described by Sambrook et al, (1989). DNA hybridisations were performed as described by 
Sambrook et al (1989). The hybridisations were performed overnight at 65°C (hybridisations 
were also performed at 60°C and 55°C). The hybridisation solution (Church and Gilbert) 
contained the following reagents: 1 mM EDTA, 7 % SDS and 0.5 M Phosphate buffer pH 7.0. 
Membranes were washed 3 times for 15 minutes in 0.1 % SDS, 2x SSC and at 65°C
For Northern blot analysis, 10 pg of the extracted RNA was fractionated on 1 % 
agarose formaldehyde gels, transferred onto nylon filters, baked for 2 hours and cross-linked in 
the ultraviolet cross-linker (UVP) for 30 seconds. The RNA was hybridised to 32P labelled 
probes at 68°C for 24 hours. RNA hybridisations (as described by Sambrook et al, 1989) were 
carried out in the following buffer: 6x SSC, 2x Denhardts reagent and 0.1 % SDS. The blots 
were washed 3 times for 15 minutes in 0.1 % SDS and 2x SSC. Blots were sealed in polythene 
bags and exposed to X-Omat XS-1 film at -70°C.
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2.9 Polymerase chain reaction
All PCR amplifications were performed using the 11.1 x PCR buffer, which is made up 
of the following: 45 mM Tris-HCl (pH 8.8), 11 mM ammonium sulphate, 4.5 mM magnesium 
chloride, 6.7 mM 2-mercaptoethanol, 4.4 pM EDTA (pH 8.0), 1 mM dATP, 1 mM dCTP, 1 mM 
dGTP, 1 mM dTTP and 113 pg ml"1 BSA. 0.9 pi of the 11.1 x PCR buffer was used per 10 pi 
reaction. The following conditions were routinely used (unless otherwise stated) for each 10 pi 
reaction: Hot start - 95°C, oligonucleotides - 0.5 pM, genomic DNA - 5-10 ng. Annealing 
temperatures used were chosen using the Tm of the oligonucleotides. Annealing temperature 
titrations were performed to determine the optimum annealing temperature required for each 
reaction. Taq or pfu polymerase were routinely used in amplification reactions. An example of 
the conditions used in the amplification of tbrlp from genomic DNA is as follows:
Hot start:
95°C - 3 minutes 
No. of cycles: 1
Main run:
95°C - 30 seconds 
70°C - 30 seconds 
72°C - 2 minutes 
No. of cycles: 25
Final extension:
72°C - 5 minutes for Taq (7 minutes for Pfu)
No. of cycles: 1
5’ and 3’ RACE techniques (Gibco BRL) were performed according to the 
manufacturers protocol. A slight modification in the use of the 5’ RACE method involved the use 
of a 35-mer spliced leader primer in the PCR amplification steps after cDNA synthesis with an 
anti sense gene specific primer. The conditions used for this reaction were as follows:
Hot start:
94°C - 5 minutes
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80°C - 10 minutes 
No. of cycles: 1
Main run:
95°C - 1 minute 
44°-58°C - 1 minute 
70°C - 2 minutes 
No. of cycles: 30
Final extension:
70°C - 10 minutes 
No. of cycles: 1
2.91 Modifications for long range PCR
A 15:1 mixture of Taq.pfu was used in the amplification reactions. The reactions were 
performed exactly as described by Barnes, 1994.
2.92 Chromosomal walking
The 3’ end DNA sequence was obtained by chromosomal walking, and was performed 
exactly as described by Screaton, Bangham and Bell, 1993. Briefly, genomic DNA was 
deliberately misprinted by using a single gene specific primer, low annealing temperature and 
several PCR cycles. The sequence of the gene was obtained by sequencing, using a second gene 
specific primer downstream of the first gene specific primer. Sequencing reactions were prepared 
using the finol sequencing kit (Promega) according to the manufacturers instructions.
2.10 DNA Sequencing
DNA sequencing was performed either manually, using the Sequenase version 2.0 
reaction kit (USB) and [a-35S]dATP (Dupont), which makes use of the dideoxynucleotide chain 
termination method of Sanger et al (1977) or, by automated sequencing, using the ABI automated
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sequencer. Reactions were performed using double stranded DNA as the template and either 
vector specific or gene specific sequencing primers. The reactions were prepared according to the 
manufacturers instructions in both cases. The following gels were used routinely (for manual 
sequencing): in order to improve resolution at the top half of gels, 4 % gels run in 1 M sodium 
acetate in lx  TBE (in lower sequencing apparatus tray), or gradient gels were used. 6 % (or 8 
%) gels were run in either lx TBE or lx TTE. All gels were run for a minimum of 2 or 
maximum of 6 hours, depending on the amount of sequence required. Gels were fixed for 20 
minutes in 10 % methanol and 10 % acetic acid, the fixing solution drained and then, transferred 
onto Whatman 3 MM filter paper. Gels were dried at 80°C in a Bio-Rad gel dryer and exposed 
to Kodak X-Omat S film overnight at room temperature.
2.11 cDNA and genomic library screening
Standard methods were used as described in Sambrook et al, 1989 with no modifications. 
Briefly, a 50 ml culture of E. coli strain Y 1090, grown to an optical density (650 nm) of 0.5 in 
LB medium and 50 pg m l o f  ampicillin was prepared for transfection and plating as follows: 
the pelleted cells were resuspended in 5 ml SM buffer (5.8 g NaCl, 2 g MgS04.7H20, 50 ml 1M 
Tris-HCL pH 7.5 and 2 % gelatin made up to 1 litre with distilled water). Serial dilutions of the 
phage stocks were prepared and 100 pi aliquots of each dilution were added to an equal volume 
of plating cells and incubated in a water bath at 37°C for 15 minutes. 2.5 ml of top agarose 
(containing 50 pg ml"1 of ampicillin) at a temperature of 55°C were added to each tube and 
immediately poured onto 8.5 cm (diameter) plates containing bottom agar. After overnight 
incubation at 37°C the plaques were counted to titre the phage stocks. The plaques were blotted 
onto nylon filters (Hybond-N, 0.45microns, 82 mm, Amersham) in duplicate, labelled, cross- 
linked in a ultraviolet cross-linker for 30 seconds and hybridised overnight at 65°C as previously 
described. Filters were washed 3 times for 15 minutes in 1 x SSC and 5 % SDS. The filters 
were sealed in polythene bags (DNA face up) and exposed to X-Omat XS-1 film at -70°C. A 
total of 20,000 plaques were screened in each case. The following libraries were screened for the 
presence of a ras-like subfamily gene in T. brucei: Sau 3A partial genomic DNA libraries of; 
Trypanosoma brucei rhodesiense EATRO 795 ILTat 1.2, Trypanosoma brucei rhodesiense 
EATRO 2340 Pop 339, Trypanosoma brucei rhodesiense EATRO 2340 Gug 340 and 
Trypanosoma brucei rhodesiense Eco20Eco complete genomic DNA library, all of which were 
gifts from Mr V.S. Graham of the Wellcome Unit of Molecular Parasitology. The T. brucei 
strain EATRO 1125 Sau 3A cDNA library was a gift from Professor E. Pays.
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2.12 Preparation of anti peptide sera
A desalted and lyophilised keyhole limpet haemocyanin (KLH) conjugated peptide 
(Genosys Biotechnologies), was used in raising anti peptide sera, as recommended by the 
manufacturer. The conjugated peptide was dissolved in PBS at a concentration of 1 mg m l1, an 
equal volume of a suspension of Alum (Pierce Ltd) was added dropwise with stirring and the 
suspension stirred for 30 minutes. Two New Zealand white rabbits were each immunised with 
500 jag of the peptide in alum by multiple site subcutaneous injections. After four weeks, boosts 
of 250 pg peptide suspension in alum were given to each rabbit at intervals of three weeks and 
test bleeds made 8-10 days after each boost, until a satisfactory immune response was observed.
The following expression systems were used in the production of fusion proteins from 
tbrlp\ The GST fusion protein Expression System (Pharmacia), The Maltose Binding Protein 
Purification System (NEB) and the Qiaexpressionist Fusion Protein System (Qiagen). All fusion 
proteins were prepared as described in the manufacturers protocol.
2.13 Computer programs used in sequence and phylogenetic analysis
Nucleotide and peptide sequence analysis was carried out using the GCG and Phylip 3.5 
suites of programs. Briefly, the GCG program MAP, was used to translate nucleotide sequences 
into peptide sequences and for checking that they were in frame. FASTA and BLAST searches 
were conducted to find related sequences from GENEMBL and SWISSPROT databases. 
Sequences from different clones were assembled using the GELASSEMBLE program and 
visualised using PRETTYOUT. In this way the sequences from different clones could be 
compared and corrected. MOTIFS was used to determine the significant motifs present in the 
sequence of tbrlp. PROFILE was used to determine the predicted molecular size and isoelectric 
point.
For phylogenetic analysis, sequences were aligned using the GCG PILEUP program and 
manually corrected using the GCG LINEUP program. TOPHYLIP was used in formatting the 
aligned sequences into input files for PHYLIP 3.5 phylogeny inference programs. SEQBOOT 
was used to bootstrap the input file from TOPHYLIP. Both bootstrapped and non bootstrapped 
trees were used in the generation of distance matrix trees from PROTDIST using the Dayhoff 
PAM option, maximum parsimony using PROTPARS and maximum likelihood trees using the 
PUZZLE program. Trees were constructed from the output file of PROTDIST using the 
NEIGHBOR program. All three options from the NEIGHBOR program were used: Neighbor
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Ethidium Bromide: 10 mg ml'1 stock in distilled water. Final working concentration 0.5 fig ml"1 
IPTG: 0.5 M stock in sterile distilled water. Stored at -20°C.
Herrings testes DNA: 10 mg ml-1 stock in sterile distilled water and sheared with a hypodermic 
needle and syringe (19 gauge). Stored at -20°C.
Kanamycin: 50 mg ml'1 in sterile distilled water. Stored at -20°C.
L-Broth: 1 % Bactotryptone (Difco), 0.5 % yeast extract (Difco), 0.5 % NaCl in distilled water. 
Stored at room temperature.
L-Broth agar: 1 % Bactotryptone (Difco), 0.5 % yeast extract (Difco), 0.5 % NaCl, 1.5g 100ml- 
1 of bacto-agar (Difco) in distilled water. The agar is sterilised by autoclaving, and antibiotics 
added if required, after cooling to 55°C. Plates stored at 4°C.
Neutralisation buffer: 1.5 M NaCl, 0.5 M Tris-HCl pH 8.0 in distilled water. Stored at room 
temperature.
SDS-PAGE Sample Buffer (4x): 0.5 M Tris-HCl pH 6.5, 0.08 % SDS, 0.2 M EDTA, 0.4 % 
glycerol in distilled water.
SDS: 10 and 14 % stock solutions in sterile distilled. Stored at room temperature.
SM Buffer: 50mM Tris-HCl (pH 7.5), 0.1 M NaCl, 8mM MgS04, 0.01 % gelatin in distilled 
water. Autoclaved and stored at room temperature.
SSC (20x): 3 M NaCl, 0.3 M tri-sodium citrate pH 7.0 (using NaOH) in distilled water. Stored 
at room temperature.
Super Broth: 3.5 % Bacto-tryptone, 2 % Bacto-yeast, 0.5 % NaCl pH 7.5 in distilled water. 
Autoclaved and stored at room temperature.
TAE (50x): 40 mM Tris-acetate, 1 mM EDTA in distilled water.
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TBE (lOx): 0.9 M Tris-HCl, 0.9 M Boric acid, 25 mM Na2EDTA in distilled water. Stored at 
room temperature.
TE Buffer: 1 mM EDTA, 10 mM Tris-HCl, pH 7.5, in distilled water. Autoclaved and stored 
at room temperature.
Tetracycline: 12 mg ml"1 in 50 % sterile distilled water and 50 % ethanol. Stored at -20°C.
TTE (20x): 1.8 M Tris-HCl, 0.6 M Taurine, 0.01 M Na2EDTA in distilled water. Stored at 
room temperature.
X-gal (lOOx): 2 % dimethylformamide (DMF). Wrapped in aluminium foil and stored at -20°C. 
2xYT Broth: 1.6 % tryptone (Difco), 1 % NaCl, 1 % yeast extract (Difco), pH 7.6 with NaOH. 
Autoclaved and stored at room temperature.
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Chapter 3
Detection of monomeric GTP binding proteins in Trypanosoma brucei
CHAPTER 3
DETECTION OF MONOMERIC GTP-BINDING PROTEINS IN Trypanosoma brucei
3.0 Introduction
A large number of members of the ras superfamily of monomeric GTP-binding proteins 
have been identified in a wide range of eukaryotic organisms, including some as widely divergent 
as Dictyostelium, yeast and man (Lowy and Willumsen, 1993). A ras GTPase is defined as a 
small molecular weight GTP binding protein (i.e within a molecular weight range of 20-29 kDa) 
which is capable of binding to and hydrolysing GTP. The general structure of ras GTPases can 
be roughly divided into three domains, the GTP binding or catalytic domain, the C-terminal 
extension domain and the carboxyl terminal isoprenylation domain. Two of these domains are 
essential for normal ras activity, i.e the GTP binding domain and the carboxyl terminal 
isoprenylation site, ras GTPases are involved in a range of cellular functions which include; 
cytoskeletal organisation, intracellular vesicular transport, protein translocation (Hall, 1990; 
Bokoch and Der, 1993) and the control of cell growth and differentiation (Barbacid, 1987). They 
are also known to serve as central regulatory points in a number of signalling pathways which are 
essential for normal cellular function (Hall, 1990). Utilising both GTP hydrolysis and GDP/GTP 
exchange reactions, monomeric GTP-binding proteins act as two-way molecular switches (see 
introduction) which are active in the GTP bound state and inactive in the GDP bound state.
A number of studies on Trypanosoma brucei have provided evidence for the presence of 
both heterotrimeric and small monomeric GTP-binding proteins. Using a GTP-binding assay, 
Coulter and Hide (1995) identified a number of small GTP-binding proteins in T. brucei. 
Furthermore, both full length and partial cDNA sequences for members of the rab (El Sayed et 
al, 1995; Field and Boothroyd, 1995) and ran (Field et al, 1995) GTPase subfamilies have been 
isolated from T. brucei.
To date, GTPases belonging to the ras subfamily have not yet been identified in T. 
brucei. Using biochemical and immunological methods, the experiments described in this 
chapter, were designed to determine whether evidence could be obtained for the existence of ras- 
like GTP-binding proteins in T. brucei.
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3.1 Detection of GTP-binding proteins in T. brucei
Using an in situ GTP-binding assay, Coulter and Hide (1995) identified trypanosome 
polypeptides which bind GTP. The authors postulated that these polypeptides, of molecular mass 
14 - 29 kDa, could represent members of the ras GTPase superfamily of GTP-binding proteins. 
As the sizes of mammalian p2 lras and ras proteins from several other organisms (Valencia et al, 
1991) are consistent with the sizes of the polypeptides identified by Coulter and Hide (1995), 
such an hypothesis is plausible. To confirm these results, the GTP-binding assay of Coulter and 
Hide was repeated to investigate whether GTP-binding polypeptides of the 14-29  kDa molecular 
size range could be detected in T.brucei.
Detergent extracts (see Materials and Methods) were made from both bloodstream and 
procyclic stage trypanosomes. The extracts (supernatant and pellet) were fractionated by SDS 
polyacrylamide gel electrophoresis (SDS-PAGE), transferred onto PVDF membrane and 
incubated with [a32-P]GTP (as described in Materials and Methods). Due to the ability of ray- 
like proteins to catalyse GTP hydrolysis, [a32-P]GTP is used for this assay instead of the more 
commonly used [y^-P] to prevent the loss of radioactive phosphate by hydrolysis. Figure 3.0 
shows an example of a typical set of results. The following radioactively labelled bands were 
detected: In lane 1 (procyclic stage pellet) 22 kDa, 24 kDa, 26 kDa, 29 kDa; lane 2 (procyclic 
stage, supernatant), 16 kDa, 20 kDa, 22 kDa and 24 kDa; lane 3 (bloodstream stage pellet), 16 
kDa, 18 kDa, 20 kDa, 22 kDa, 24 kDa, and 27 kDa while the following bands were observed in 
lane 4 (bloodstream stage supernatant), 18 kDa, 20 kDa, 22 kDa, 24 kDa, 26 kDa, 28 kDa, 32 
kDa, 35 kDa and 45 kDa. Replicate experiments produced similar results. The GTP-binding 
polypeptides identified in a series of experiments are summarised in Table 3.0.
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[GURE 3.0
Detection of GTP binding proteins in T. brucei.
Figure 3.0 shows the results compiled from 3 in situ GTP binding assays performed on SDS-PAGE 
fractionated T. brucei spun detergent extracts. The following T. brucei extracts were fractionated and 
assayed: in lane 1, procyclic stage pellet; lane 2, procyclic stage supernatant, lane 3, bloodstream pellet 
and in lane 4, bloodstream supernatant. Sigma molecular markers were used in the determination of the 
molecular sizes of the observed bands.
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TABLE 3.0
Summary o f  sizes o f  GTP-binding proteins in T. brucei identified by in situ binding assay
BLOODSTREAM PROCYCLIC
MOLECULAR SUPERNATANT PELLET SUPERNATANT PELLET
SIZE (kDa)
16* ♦ ♦
18» ♦ ♦
20* ♦ ♦ ♦
22* ♦ ♦ ♦ ♦
24* ♦ ♦ ♦ ♦
26* ♦ ♦
27 ♦ ♦
28* ♦
29* ♦
32* ♦
35* ♦
♦ STAGE SPECIFIC
♦ NON-STAGE SPECIFIC
♦  GTP-BINDING POLYPEPTIDE PRESENT
Most of the bands listed in Table 3.0 were observed in all replicate experiments although 
occasionally some were not observed in the same extracts in all experiments. Their absence may 
have been due to either the lack of good separation of the polypeptides on SDS polyacrylamide 
gels, in which case two bands may have been mistaken for a single band, a lack of intensity of 
signal, which may have resulted in the band being overlooked or a slight difference in sample 
preparation.
These results confirm those of Coulter and Hide (1995) and the observed molecular sizes (18 
kDa-35 kDa) are similar to those of higher eukaryotic ras-like proteins (Valencia et al, 1991 and 
Kahn et al, 1992).
While many cellular proteins are capable of binding both ATP and GTP, the monomeric 
GTPases of the ras subfamily only bind GTP. It was therefore important to confirm the
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specificity of the GTP-binding reaction. If the GTP-binding proteins had sole specificity for GTP, 
binding would be competed out by excess unlabelled GTP but not by excess unlabelled ATP. To 
test this the following GTP-binding assays were carried out: spun detergent extracts of 
bloodstream and procyclic stage trypanosomes were run on 15% SDS polyacrylamide gels and 
transferred to PVDF membranes as previously described. The samples were run in triplicate thus 
producing three identical sets of immobilised extracts and each membrane was incubated under 
different conditions as follows: Panel A, 3(iCi [a32-P]GTP + 10 pM unlabelled ATP; Panel B, 
3pCi/ml (0.1 pM) [a32-P]GTP; and Panel C, 3pCi [a32-P]GTP + lOpM unlabelled GTP. Figure
3.1 shows an autoradiograph obtained from one of these experiments. All the bands on panel A 
(assay in the presence of 10 pM unlabelled ATP), can be seen on panel B (radiolabelled GTP 
alone). No bands were observed on panel C (GTP-binding assay in the presence of 10 pM 
unlabelled GTP), which shows that radiolabelled GTP-binding was competed out by excess 
unlabelled GTP. However, approximately eight of the radiolabelled GTP-binding bands were 
competed out by excess unlabelled ATP (compare the intensities of the bands present in panel A 
to those on panel B) and therefore not all the bands observed on panel B are present on panel A. 
Bands of the following sizes were competed out by the unlabelled ATP: 43, 55, 17 and 19 kDa 
from the bloodstream supernatant and pellet respectively and 18, 20, 17 and 19 kDa from the 
procyclic supernatant and pellet respectively. Therefore not all the aforementioned bands, 
summarised in Table 3.0, are strictly GTP binding proteins due to their additional ability to bind 
ATP. The remaining polypeptides, ranging from 20- 36  kDa, however, bind specifically to GTP. 
This experiment, therefore confirms that GTP-binding proteins with high specificity for GTP are 
found in T. brucei.
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FIGURE 3.1
A B C
Figure 3.1 is an autoradiograph of GTP bindmg proteins separated by SDS-PAGE, 
showing 3 membranes, A , B and C with immobilised, bloodstream supernatant (1), 
procyclic supernatant (2), bloodstream pellet (3) and procyclic pellet (4). Panel A was 
mcubated in 3 p.Ci of 32P labelled GTP + 10 pM unlabelled ATP. Panel B was incubated 
in 3 p.Ci of 32P labelled GTP. Panel C was mcubated in 3 p.Ci of 32P labelled GTP + 10 
pM of unlabelled GTP.
74
3.2 Purification of GTP-binding proteins
To further identify and characterise the properties of the monomeric GTP binding 
proteins from T. brucei, it is necessary to generate reagents, such as gene clones or antibodies. A 
first step towards obtaining antibodies is to purify a monomeric GTP-binding protein (the gene 
cloning approach is the subject of Chapter 4). Two basic requirements are necessary for the 
purification of GTP-binding proteins: (i) a GTP-binding assay system suitable for analysing a 
large number of chromatography fractions and (ii) the development of a suitable fractionation 
system.
3.21 Development o f a routine GTP-binding assay
An ideal assay for HPLC purified GTP-binding proteins, would be one which could be 
used to concentrate and screen large numbers of fractions simultaneously, as the system 
previously described (Coulter and Hide 1995 - see Chapter 3, section 3.1) may not have sufficient 
sensitivity to identify GTP-binding proteins in the dilute fractions produced by HPLC 
fractionation. Furthermore, the large number of fractions generated would entail running and 
blotting a large number of gels which would be time consuming, cumbersome and require the use 
of considerable amounts of radioactivity.
Based on these requirements, an assay was developed which made use of the slot blot 
technique. PVDF protein binding membranes were cut to size and prepared as described in the 
Materials and Methods section, placed (individually) on the lower half of the HibriSlot manifold 
[Gibco BRL 24-well filtration manifold] and the upper half of the manifold was screwed down 
onto the lower half. The 24-well manifold allows samples of up to 200 pi to be drawn through 
the PVDF membrane under vacuum. Wells were loaded with 100 pi from each HPLC fraction 
and connected to a vacuum pump. The shape of the wells is such that proteins contained within 
each sample are concentrated onto a 5 mm2 area of the membrane after brief application of a 
vacuum. To test this approach, lOOpl aliquots of decreasing concentrations of BSA (which does 
not bind GTP) were loaded into the first row of 12 wells and serial dilutions of a bloodstream 
supernatant loaded into the second row of 12 wells. After the vacuum was applied, the proteins 
were concentrated and immobilised onto the PVDF membrane. Decreasing concentrations of 
bloodstream supernatant and BSA on PVDF membrane were made in triplicate and incubated in 
[a32-P]GTP ( Figure 3.2 panel 1), [a32-P]GTP + lOpM unlabelled GTP (Figure 3.2, panel 2) and 
[a32-P]GTP + lOpM ATP (Figure 3.2, panel 3). In this way both the sensitivity of the system
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and the specificity of the GTP-binding reaction were determined. Figure 3.2 shows that GTP- 
binding activity can be detected using this system, and furthermore the unlabelled GTP 
completely abolished the a -32P[GTP] binding activity of the test sample, while the unlabelled 
ATP removed a large amount of activity. The results show that in the presence of unlabelled 
ATP, a minimum protein concentration of 9.37 |ug/ml is required for the detection of specific 
GTP-binding. BSA showed no GTP-binding activity.
A total protein content of 20 fig/well is required for the routine detection of GTP-binding 
proteins by SDS PAGE and blotting (Coulter and Hide 1995), whereas, only 0.937 |ag is 
required for the detection of specific GTP-binding using the slot blot technique. The results 
suggest that the slot-blot GTP-binding assay is suitable for the specific assay of GTP-binding 
activity. In addition to this, the system can be used to concentrate and screen large numbers of 
dilute HPLC samples, making it ideal for GTP-binding assays of HPLC fractionated 
trypanosome extracts.
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FIGURE 3.2
A slot blot assay was used to test HPLC fractions for the ability to bind GTP. The panels had two 
rows (A and B), of decreasing protein content. The sample in row A is a bloodstream spun detergent 
extract (SDE) supernatant. 100 pi aliquots of decreasing concentrations equivalent to final protein 
concentrations of 18.75, 9.37,4.68,2.34, 1.17,0.58 and 0.29 pg m b1 respectively were loaded into 
the wells. Row B contained the negative control, bovine serum albumin (BSA). The highest protem 
content of the negative control was 60 pg and the lowest 0.23 pg m l'1. Panel 1 was mcubated in 3 
pCi/ml of 32P labelled GTP; panel 2 in 3 pCi/ml of the radiolabelled GTP + 10 pM unlabelled GTP 
and panel 3 in 3 pCi/ml (0.1 pM) of radiolabelled GTP + 10 pM ATP.
18.75 pg
4.68 pg
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3.22 Development o f  a fractionation system.
A number of different types of HPLC fractionation systems are available for protein 
purification such as, anion exchange, cation exchange, size exclusion, hydrophobic interaction 
and affinity based methods. As little is known about the properties of ras-like GTP-binding 
proteins in T. brucei (size and hydrophobicity etc), it was decided to use anion exchange 
chromatography as a first approach. A number of features of anion exchange chromatography 
make it suitable for a first purification step: (1) it has a high binding capacity; (2) all charged 
proteins can bind to it; (3) specific elution can be achieved by using appropriate pH or ionic 
conditions and (4) a relatively high concentration can be maintained in eluted fractions.
To determine conditions suitable for the elution of GTP-binding proteins, an initial 
HPLC run was carried out using a DEAE-Cellulose anion exchange column [Waters AP-1; 
prepacked with Protein-Pak DEAE 8HR resin; internal diameter 1 cm]. In the first instance, a 
NaCl step gradient elution strategy was employed to determine approximate elution conditions. 
The column was equilibrated with 20 mM Tris - HC1 at pH 7.6 and elution was achieved by 
addition of NaCl (Figure 3.3). 7.5 mg of the supernatant from a spun detergent extract
(bloodstream) was applied to the column. A buffer flow rate of 0.8 ml/min was maintained 
throughout the run and the sodium chloride concentration increased in a step-wise manner at 20 
min intervals over a 1.3 hour period from 0 mM to 200 mM, 400 mM and finally 500 mM at 20, 
40 and 60 min respectively (Figure 3.3). The column was regenerated as described (see 
Materials and Methods). Fractions were collected at 0.5 min intervals into eppendorfs containing 
1 pi aliquots of a cocktail of protease inhibitors, consisting of 2.5 pg/ml aprotinin, 1 mM 
benzamidine and 2.5 pg/ml leupeptin (see Materials and Methods). A total of 160 fractions were 
collected and fractions 1-132 (see Figure 3.3 for details) were assayed for GTP-binding activity, 
using the slot blot system immediately after collection. Fractions 133-160 were stored at -70°C.
Following autoradiography, the radioactive signal from each individual slot, from the slot 
blot assay, was scored on a scale ranging from - to ++++, where - represents no signal and + to 
++++ indicate increasing degrees of signal intensity. Only fractions with labelling intensities 
greater than ++ were used in the subsequent GTP-binding assays. Fractions 59 - 67 were eluted 
within a NaCl concentration range of 200 mM - 400 mM and had a labelling intensity of ++++. 
The fractions obtained after the step-wise increase of the NaCl concentration from 200 mM to 
400 mM showed labelling intensities less than ++ and were, therefore, stored at -70°C for 
subsequent analysis. Results from this HPLC run showed that most proteins with high 
specificities for GTP-binding were eluted within a NaCl concentration range of 200 mM - 400 
mM (see figure 3.3).
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A linear NaCl gradient elution regime was carried out to further improve the separation 
of GTP-binding proteins. A gradient of 0 mM - 250 mM was chosen as results from the step 
gradient showed that most GTP-binding proteins were eluted following the 200 mM NaCl step. 
7.25 mg of bloodstream stage supernatant spun detergent extract was applied to the column, and 
the salt concentration linearly increased from 0 mM - 250 mM, after which the concentration was 
maintained at 250 mM for 30 min to ensure complete elution of the GTP binding proteins. A 
final salt concentration of 500 mM NaCl (Figure 3.4) was maintained for 20 minutes to ensure 
that all proteins were eluted from the column in preparation for the regeneration of the column. 
Fractions were collected as previously described. Fractions 1-96 corresponded to the fractions 
eluted during the linear increase in salt concentration (Figure 3.4) and were assayed for GTP- 
binding activity.
Figure 3.5 shows the fractions positive for GTP-binding, B 2-5, E 8-12, F 1-12, G 1-12 
and H 1-10 obtained from the linear HPLC run. The positive fractions correspond to HPLC 
fractions 14 - 17 (B 2 -5) and 56 - 93 (E 8 - 12, F 1 - 12, G 1 - 12 and H 1 - 9), which were 
eluted within a NaCl concentration range of 150 - 200 mM. However only fractions 5 9 - 8 1  
(which correspond to fractions E l l - 1 2, F 1 - 1 2  and G 1 - 9), were subsequently separated by 
SDS polyacrylamide electrophoresis and reanalysed for GTP-binding activity, to assess the level 
of purity of the fractions, as they were observed to have labelling intensities greater than ++. 
The fractions positive for GTP-binding and the corresponding HPLC fraction numbers are 
summarised in Table 3.1.
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FIGURE 3.3
500 mM
400 mM I
200 mM I
0 mM I
TIME:
0 min 20 mins 40 mins 60 mins
FRACTIONS:
1 40 80 120 160
4 slot blot GTP-binding ■ ►
assay
A profile of the step NaCl gradient used in the separation of GTP-binding proteins from the 
spun detergent lysates of bloodstream trypanosomes. The concentration was increased 
from 0 mM to 200 mM, 400 mM and finally equilibrated at 500 mM at time intervals of 
20, 40, 60 and 80 minutes respectively. The column was put through a regeneration cycle 
after 80 mins. Samples 1-132 were immediately assayed for GTP-binding, while samples 
133 - 160 were stored at -70°C.
column regeneration 
cycle
80 mins
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FIGURE 3.4
500 mM
250 mM
wash cyclepH 7.6
0 8020 50 60
Fractions 0 40 100 120 160
Figure 3.4 is an illustration of the relationship between the fractions derived from the linear gradient HPLC 
run (profile) and the peaks at which they were eluted from the bloodstream spun detergent extract The NaCl 
concentration was maintained at 250 mM and then 500 mM to ensure the complete elution of the proteins. 
Fractions 1-96 were assayed for GTP-binding using the slot blot technique. Time - in minutes. After the 
purification the column was regenerated (wash cycle).
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FIGURE 3.5
Figure 3.5 shows the results from a slot blot GTP-binding assay of the HPLC purified fractions. 4 panels of 
PVDF membrane were used in the concentration and immobilisation of the fractions. Each panel had two 
rows of concentrated protein, labelled A-H. Each row had 12 slots, numbered 1-12 and each slot was 
loaded with 200 p.1 of the HPLC derived GTP-binding protein fractions. Fractions E ll-1 2  (HPLC fractions 
56-60), F I -12 (HPLC fractions 61-72) and Gl-12 (HPLC fractions 73-84) were subsequently assayed for 
GTP binding activity after separation on 12 % SDS polyacrylamide gels.
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Table 3.1
Summary ofpositive GTP-binding fractions and their corresponding HPLC (linear gradient)
fraction numbers.
POSITIVE GTP-BINDING CORRESPONDING LINEAR
FRACTIONS HPLC FRACTIONS
B 2 - 5 14-17
• E l l - 12 56 -60
• F 1 -12  61-72
• G 1 - 12 73 -84
H 1 - 9 85 -93
POSITIVE SLOT BLOT GTP-BINDING FRACTIONS, WHICH WERE 
SUBSEQUENTLY FRACTIONATED ON SDS POLYACRYLAMIDE GELS AND 
ASSAYED IN ORDER TO CONFIRM THEIR DEGREE OF PURITY.
In order to confirm that the fractions, eluted by HPLC anion exchange chromatography, 
contain GTP-binding proteins, the positive fractions identified by the slot blot technique were 
assayed using the in situ GTP binding assay. 30 pi of each of the HPLC positive fractions E 11 - 
12, F 1 - 12, G 1 - 12, were loaded on SDS polyacrylamide gels and transferred to PVDF 
membrane and incubated with a  -32P labelled GTP. Autoradiography was carried out overnight 
and the data analysed. Linear HPLC gradient fractions 73-81, which correspond to positive 
GTP-binding fractions G 1-9 (Figure 3.5), were each observed to contain a 24 kDa band (Figure 
3.6A). All other fractions contained no radiolabelled bands. The positive fractions were also 
analysed by SDS polyacrylamide gel electrophoresis followed by silver staining, to determine the 
profile of proteins present in each fraction, in order to assess the level of purity of the eluted 24 
kDa polypeptide. Figure 3.6B shows that a minimum of six other polypeptide bands were in each 
of the fractions. No silver stained bands were observed at the expected position of the 24 kDa 
polypeptide. As silver staining detects polypeptides at levels as low as 10 ng (Guillmette and 
Lewis, 1983), this suggests that the amount of the 24 kDa polypeptide present in each fraction is 
less than 10 ng.
Despite the fact that several other proteins are detected in the various HPLC derived 
fractions, the 24 kDa small GTP-binding protein is not present in high enough concentrations to 
be detected by silver staining. However, partial purification of one of the GTP-binding
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polypeptides was achieved and this was detected by the in situ GTP-binding assay. The low 
amounts of protein present in each fraction indicated that large amounts of trypanosome material 
would be required for a full scale purification and it was, therefore, decided at this point to 
investigate other possible means of purification.
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FIGURE 3.6
A
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29 kDa 
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Figure 3.6 (A), shows the results of an in situ G TP-binding assay of anion exchange HPLC purification of T. 
brucei spun detergent extracts. Fractions 73 -8 1  were positive for GTP-binding, each of the fractions show a 
radiolabelled band with a molecular weight (Mw) of approximately 24 kDa. Figure 3.6 (B) is a silver stamed 
gel of fractions 73 - 81. The 24 kDa GTP-binding protein observed in (A), is not observed on the silver 
stamed gel.
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3.3 Detection of ras-like GTP-binding proteins in T. brucei by immunoblotting with 
heterologous antibodies.
Many reagents are available for the analysis of ras-like GTP-binding proteins in higher 
eukaryotes. These reagents include a number of antibodies (both monoclonal and polyclonal) 
which recognise higher eukaryotic ras-like proteins. Immunoblots with heterologous antibodies 
have previously been used to identify other signalling molecules in T. brucei e.g Protein kinase C 
(Keith et al, 1990) and the Goa subunits of G-proteins (Coulter and Hide, 1995). If such an 
approach could be used with antibodies to ras-like proteins, it would permit the identification of 
ras-like proteins in T. brucei crude extracts and also determine whether the 24 kDa GTP-binding 
protein cross reacts with ras-like polypeptides. A number of considerations need to be taken into 
account when choosing a suitable antibody: (1) The need to distinguish ras subfamily members 
from other members of the ras superfamily e.g. rab, ran, rho etc and (2) The need to maximise 
the chances of the antibody cross - reacting with a homologue (which may be evolutionarily 
divergent) in T. brucei. Based on these criteria, the ideal antibody would be one which recognises 
a highly conserved region of ras (an enzymatic/catalytic active site), which is absent or altered in 
other ras family proteins. On this basis, the monoclonal antibody which was chosen, was highly 
specific for mouse H- K- and N-ras oncogene proteins (anti-ras pan, Boehringer Mannheim 
Biochemica). Goat anti-mouse IgG peroxidase conjugate (Sigma Immunochemicals) was used as 
a second antibody for the immunoblotting experiments.
To determine whether any of the HPLC anion-exchange fractions contained ras-like 
polypeptides, fractions 1 - 96 from the HPLC run (step-wise NaCl elution gradient, 0 - 400 mM; 
see section 3.22, Figure 3.3) were examined by immunoblotting with anti- ras pan. All fractions 
derived from the initial HPLC purification were concentrated and immobilised on PVDF 
membranes by slot blotting and incubated in blocking buffer overnight (see Materials and 
Methods). After blocking, the membranes were incubated in a 1:400 dilution of the primary 
antibody in blocking buffer for 1 hour at room temperature. After two 15 minute washes in TBS- 
Tween, the membranes were incubated in a 1:400 dilution of the second antibody in blocking 
buffer for 1 hour at room temperature. The membranes were washed, as described above, and 
the ECL detection method (see Materials and Methods) was used to assay whether the anti-ras 
pan antibody bound to any of the fractions. The results, shown in Figure 3.7, indicate that 
fractions A5-10, C4-12, D4-10, F3-10, G4-5, 7-8 &10-11, Fl-8, G5-11 andH6-10 cross reacted 
with anti-ras pan antibodies, suggesting that these fractions contain ras-like polypeptides. In 
many cases it has been observed that heterologous antibodies can sometimes have cross-
86
reactivities with many polypeptides in T. brucei (Coulter and Hide, personal communication). It 
was, therefore, important to determine the specificity of the antibody.
Results from the immunoblot analysis of the HPLC fractions, indicated the presence of 
ras like GTPases in fractions which had previously been shown to lack GTP binding proteins by 
both the slot blot and in situ (Coulter and Hide 1995) GTP binding assays e.g fractions A5-9 
(refer section 3.3, Figure 3.7). This was a clear indication that the monoclonal antibody may 
have crossed reacted with polypeptides other than ras GTPases in T. brucei. As anti-ras pan 
normally recognises a 21 kDa polypeptide, the following experiment was performed in order to 
determine (a) the molecular size(s) of the polypeptide(s) in T. brucei which cross react with anti- 
ras pan; and, (b) the trypanosomal polypeptides which are specifically recognised by the 
antibody, using preimmune serum as the negative control.
Bloodstream spun detergent extracts (SDEs), were separated by SDS polyacrylamide gel 
electrophoresis and transferred onto nitrocellulose membranes. This procedure resulted in three 
sets of identical panels of immobilised bloodstream detergent extracts: Panel A 1, from the first 
set of membranes, was incubated in a 1:400 dilution of the first antibody (anti-ras pan) and the 
other panel (A 2), was incubated in preimmune serum, and therefore served as a “negative” 
control. Both panels (A 1 & 2) were subsequently incubated in a 1:1600 dilution of the second 
antibody . Panels numbered 1 from the second (B) and third (C) sets were also incubated in a 
1:400 dilution of the primary antibody, whilst Panels B 2 and C 2 were incubated in preimmune 
serum, and therefore served as “negative” control membranes. Panels B (1 & 2) and C (1 & 2) 
were incubated in 1:4000 and 1:10,000 dilutions of the second antibody respectively. In a 
separate experiment, performed with the aim of determining whether the observed cross reactivity 
was due to the second antibody recognising epitopes other than that of anti-ras pan, bloodstream 
SDEs were immobilised on three separate membranes (D 1, D 2 & D 3) and incubated in the 
following dilutions of the second antibody, 1:10,000, 1:4000 and 1:1600 respectively, without 
prior incubation in the first antibody/preimmune serum. The resulting bands were visualised by 
the ECL detection method (see Figure 3.8). After a 1 minute exposure, polypeptides with 
molecular sizes greater than 21 kDa, were observed on almost all the membranes. The observed 
bands, however, did not correspond to the expected molecular size of small GTP binding proteins,
i.e 20 - 29 kDa. Even though no positive bands were observed on the membrane incubated in the 
1:10,000 dilution of the second antibody in the absence of the first antibody (D 1), the results 
showed that the reactions were not specific for ras GTPases in T. brucei. At dilutions lower than 
1:10,000, the second antibody appeared to cross react with a component of the nitrocellulose 
membrane. Further manipulation of the dilutions of the antibodies i.e. using lower dilutions of 
the first and second antibodies and washing the membranes with the blocking buffer instead of
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TBS -Tween (to ensure continuous blocking of non-specific binding sites), in between antibody 
binding incubation periods did not solve the problem of cross-reactivity.
The results obtained from immunoblots of SDS-PAGE separated bloodstream SDEs, 
indicated that non-specific binding was responsible for the cross reactivity observed between the 
positive HPLC derived GTP-binding fractions, and the anti-ras pan antibody. Based on these 
results, it was not possible to determine whether the cross-reactivity on the slot blot was due to 
the presence of ras like GTP-binding proteins or not. Further purification or characterisation of 
ras like GTP-binding proteins from T. brucei could therefore not be achieved by this approach.
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FIGURE 3.7
Figure 3.7 is an autoradiograph, showing the cross-reactivity of the anti- ras pan antibody with 
HPLC purified slot blot samples. 96 fractions from the step-wise NaCl gradient were loaded and 
immobilised on 5 different PVDF membranes (see section 3.22 for details). Each panel had two 
rows (A-H) with 12 wells, numbered 1-12. 200 pi of fractions 1-96 were loaded into the wells in 
rows A1 to H12.
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FIGURE 3.8
A B D
2
Figure 3.8 shows the results from the immunoblot analysis of bloodstream trypanosome spun detergent 
extracts (SDEs) using anti- ras pan as the first antibody. Panel A (second antibody dilution - 1:600) lane 1: 
bloodstream SDE incubated in a 1:400 dilution of preimmune serum; lane 2: bloodstream SDE incubated in a 
1.400 dilution of anti-ras pan. Panel B (second antibody dilution - 1:4000) lane 1: bloodstream SDE 
incubated in a 1:400 dilution of preimmune serum; lane 2 bloodstream SDE incubated in a 1:400 dilution of 
anti-ras pan. Panel C (second antibody -1:10 000) lane 1: bloodstream SDE, incubated in a 1:400 dilution of 
preimmune serum; lane 2, bloodstream SDE mcubated in a 1:400 dilution of anti-ras pan. Panels D l, D2 and 
D3: bloodstream SDEs incubated in 1:10 000, 1:4000 and 1:600 dilutions of the second antibody respectively, 
without prior incubation in anti-ras pan.
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3.4 Discussion
The presence of low molecular weight monomeric GTP-binding proteins in T. brucei was 
confirmed by means of the in situ GTP-binding assay of Coulter and Hide (1995). The proteins 
fall within a molecular weight range of 16 kDa - 35 kDa which is consistent with members of the 
ras GTPase superfamily (Kahn, Der and Bokoch, 1992). A number of polypeptides larger than 
29 kDa were observed in some but not all gels. These higher molecular weight polypeptides of 
32 and 35 kDa were observed in the bloodstream spun detergent extract supernatant. Even 
though the general guidelines on nomenclature state that ras -like GTP-binding proteins must fall 
within a molecular weight range of 20 - 29 kDa, allowance is made for proteins which may fall 
outwith this range but still possess other small GTP-binding properties, e.g. yeast ras which has a 
molecular weight of 40 kDa. Over thirty small molecular weight GTP binding proteins of 
different classes and similar molecular masses are thought to exist within the 20 - 30 kDa 
molecular weight range (Field et al, 1996). Results from the GTP binding assays on bloodstream 
and procyclic trypanosomes showed that some of these polypeptides are stage specific, with the 
following polypeptides being bloodstream stage specific, 18, 28, 32 and 35 kDa, whilst the 27 
and 29 kDa polypeptides appeared to be procyclic stage specific. Polypeptides of the following 
sizes were competed out by the presence of unlabelled ATP: 55 kDa, 43 kDa, 17 kDa, and 19 
kDa from bloodstream supernatant and pellet respectively and, 20, 18, 17 and 19 kDa from the 
procyclic supernatant and pellet respectively, indicating that not all of the observed polypeptides 
bind exclusively to GTP. Results from the experiment also showed that polypeptides within the 
range of 20-36 kDa, bind specifically to GTP.
A routine GTP-binding assay, capable of handling and concentrating large sample 
numbers, was designed to complement the in situ GTP-binding assay. This was shown to be 
suitable for identifying HPLC fractions positive for GTP-binding. Anion-exchange 
chromatography was used in an initial attempt to isolate and purify small GTP-binding proteins 
from T. brucei and a series of active fractions identified by the in situ GTP-binding assay were 
found to contain a 24 kDa polypeptide. Despite the presence of other polypeptides (visualised on 
Coomassie and silver stained SDS polyacrylamide gels), the 24 kDa polypeptide was not 
observed on silver stained SDS polyacrylamide gels. This result suggests that the 24 kDa 
polypeptide is not highly abundant in the T. brucei spun detergent extracts. In order to visualise 
the 24 kDa polypeptide on a silver stained gel, there would be the need to considerably scale up 
the amount of protein used for purification.
A number of studies, in which small GTP-binding proteins have been purified to near 
homogeneity from human placenta and bovine brain extracts (Evans et al, 1986 and Waldo et al,
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1987), show that a reasonably high initial total protein concentration is required in order to 
ensure that the final concentrations of the eluted fractions of small GTP-binding proteins are 
reasonably high. Bovine brain contains 5 - 1 0  fold more ras GTP-binding protein then any other 
mammalian tissue (Yamashita et al, 1988) and therefore following the successive purification 
steps, detectable amounts of ras GTP-binding proteins were obtained from the HPLC eluted 
fractions. Kawata et al, 1988 and Yamashita et al, 1988, both initiated purification with 858 mg 
of crude membrane protein from bovine brain and purified amounts of 11 and 10 pg of GTP- 
binding proteins respectively.
The initial total protein content of the bloodstream spun detergent extract used in the 
purification steps was approximately 14 mg obtained from 1 ml of packed bloodstream 
trypanosomes. Therefore, based on the results of Kawata et al, approximately 60 ml of packed 
bloodstream trypanosomes would be required to produce extracts with a high enough initial 
protein content from which a detectable amount of small GTP-binding proteins could be purified. 
Furthermore, this could be a minimum estimate as further material would have been required to 
develop the purification protocol. Given this considerable requirement for trypanosome material 
and the limited resources available, it was decided not to continue with the purification approach. 
However, had this approach had been continued, slightly modified versions of the purification 
strategies used by Kawata et al, 1988 and Yamashita et al, 1988 would have increased the 
chances of isolating small GTP-binding proteins by HPLC purification. They both made use of 
sequential chromatography steps using concentrated fractions capable of binding [35S] GTPyS. A 
number of HPLC resins are commercially available and therefore anion exchange 
chromatography which was used in the partial purification of small GTP-binding proteins from 
bloodstream spun detergent extracts would have been the first in a series of purification rounds. 
The fractions positive for GTP-binding would have been concentrated and then further purified 
by means of a size exclusion column. Bearing in mind that all fractions positive for GTP-binding 
would not necessarily be small GTP-binding proteins (i.e. they could be heterotrimeric GTP- 
binding proteins or EGF etc), the size exclusion column would serve not only as a second 
purification step, but also as a means of estimating the molecular size of GTP-binding proteins 
present in the starting material. Further purification by means of hydrophobic interaction 
chromatography would separate the membrane bound small GTP-binding proteins from the 
soluble ones (found in the cytosol). A fourth chromatography resin could be used to further 
purify the eluant. The eluant at this point, is likely to be highly enriched with small GTP-binding 
proteins, which could then be further characterised by means of immunoblot analysis using 
commercially prepared antibodies, or for the preparation of specific antibodies.
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An antibody against a member of the ras subfamily, was used to determine the presence 
or absence of the subfamily in T. brucei. Preliminary results of Western blotted polypeptides, 
probed with different dilutions of the antibody, anti-ras pan, showed a high degree of cross 
reactivity. The observed cross-reactivity, therefore, made it difficult to interpret the results with 
any certainty. The cross reactivity may have been due to non-specific binding of the first 
antibody to other polypeptides or the second antibody to a component of the nitrocellulose 
membrane. This could have been due to the use of ineffective blocking buffers. Future work 
would be aimed at exploring different blocking buffers which may have been more effective e.g 
the use of BSA instead of horse serum. With cells known to have small GTP-binding proteins of 
the ras subfamily (such as bovine brain or human placenta) a method for immunoblotting could 
be developed and used to test the system. This system could then be used as a model for the 
development of a suitable assay to help in the interpretation of the results obtained from T. 
brucei.
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Chapter 4
Cloning, sequencing and identification of tbrlp, a ras like small GTPase
CHAPTER 4
CLONING, SEQUENCING AND IDENTIFICATION OF tbrlp, A  RAS-LIK E
SMALL GTPase GENE
4.0 Introduction
The ras GTPase superfamily is made up of six subfamilies namely a rf rab, ran, ras, rho 
and sar (see introduction). The six subfamilies have four features in common: (1) The ability to 
bind and hydrolyse GTP; (2) Their genes encode proteins with a molecular size range of 20 - 29 
kDa; (3) They all possess six highly conserved non-contiguous sequence motifs in the GTP- 
binding domain and (4) various subfamilies have conserved sequence motifs that are 
characteristic for members of the subfamily (Kahn, Der and Bokoch, 1992). In order to 
characterise the small GTP binding proteins of T. brucei, given the lack of feasibility of using a 
purification approach (see Chapter 3), a gene cloning approach was investigated. This approach 
was considered to be a good option for the isolation of a specific ras like protein, unlike the 
HPLC approach, in which the isolated low molecular weight GTP binding fractions could be 
contaminated with a number of proteins other than ras subfamily GTPases, e.g members of the 
rab, rho, ran and a r f subfamilies, and low molecular weight heterotrimeric GTP binding protein 
a  subunits. Three commonly used approaches are available for gene cloning, these are: the 
probing of genomic and/or cDNA libraries with a related/homologous gene from a different 
organism; the probing of expression libraries with heterologous antibodies, or, the use of PCR 
based methods for the amplification of genes from either genomic or cDNA using degenerate 
and/or gene specific primers.
As already stated, ras genes have been well conserved throughout evolution and are 
found in a range of organisms, making heterologous probing a possible method for isolating a 
related gene in T. brucei. The disadvantage with this method is that if the homology is very low, 
a T. brucei ras gene homologue may go undetected.
The screening of expression libraries with heterologous ras antibodies could also be used 
to clone a ras subfamily member from T. brucei. Problems could occur with this approach. 
Firstly, it was shown (Chapter 3) that heterologous ras antibodies are prone to extensive non­
specific cross-reactivity. Secondly, success of this approach is dependent on the abundance of a 
suitable clone in the cDNA expression library. As ras proteins are typically not very abundant, 
suitable clones may be significantly under represented in such a library. Probing of genomic
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expression libraries would be a more promising approach as the problem of the lack of 
abundance of the protein, would not be an issue.
The third approach is the amplification of DNA (either genomic or cDNA), by means of 
the polymerase chain reaction (PCR), using degenerate oligonucleotide primers to the conserved 
sequence motifs found in the GTP-binding domain. This method has been successfully used in 
the isolation of low molecular weight GTP binding proteins (rab and ran) from T. brucei 
previously (Field and Boothroyd, 1995; Field et al, 1995), and was, therefore, considered to be an 
appropriate approach for the isolation of a ras subfamily GTPase from T. brucei. Trypanosomes 
are evolutionarily distinct from higher eukaryotes and, therefore, their ras genes (if present) could 
have divergent sequences. The use of degenerate oligonucleotide primers and low annealing 
temperatures for the reaction, would result in the amplification of unrelated genes, but would also 
maximise the chances of isolating a ras subfamily member from this organism. Again, there is 
the possibility that the gene might not be highly abundant in the cDNA, but as PCR is good for 
the amplification of genes of low abundance such an approach may be a suitable method of 
isolating a ras-like gene from T. brucei. The problem of low abundance genes can also be 
overcome by the use of T. brucei genomic DNA as a template for the PCR amplification of a ras 
like gene.
A degenerate primer PCR approach was adopted, after considering all the methods 
available for the isolation of a member of the ras subfamily, for the following reasons: (1) 
Amplification by means of the polymerase chain reaction is a highly sensitive and powerful 
technique and, therefore, would be ideal for the amplification of genes which are expressed at low 
levels in cDNA; (2) The use of degenerate primers would increase the chances of isolating a gene 
of related sequence; (3) It is a rapid and relatively easy method which has been previously used 
successfully in the isolation of ras superfamily genes (Field et al, 1995; Field and Boothroyd, 
1995); (4) It is a relatively more environmentally friendly process as it does not require the use 
of radiolabels.
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4.1 Amplification of T. brucei cDNA using degenerate oligonucleotides
Genes that encode members of the ras GTPase superfamily have five well conserved 
sequence motifs which are extremely important for the proper folding and functioning of the 
proteins they encode. The conserved motifs offer good opportunities for designing degenerate 
oligonucleotides for PCR amplification of a T. brucei ras gene. These motifs are shown in 
Figure 4.0.
Using the highly conserved sequence motifs found in ras subfamily genes, four 
degenerate oligonucleotide primers were designed for use in the amplification of a ras-like gene 
from T. brucei, by the polymerase chain reaction. Degenerate primers and low annealing 
temperatures were used in the amplification, so as to enhance the chances of isolating a ras 
subfamily member. Most ras subfamily members have glycine residues at positions 12 and 13 of 
the PM 1 binding site (Valencia et al, 1991). The PM 1 binding site therefore has a general 
consensus of GxGGVGKS (where G is glycine, K is lysine, S is serine and V is valine). As the 
aim of this project was to isolate and study the role of a ras subfamily GTPase in trypanosomal 
growth regulation, a primer (Primer 1) incorporating glycine residues 12 and 13 
(GGVGKSALT), was designed so as to enhance the chances of isolating a ras subfamily 
member. Primer 2, was also designed to specifically amplify a ras subfamily gene. All members 
of the ras subfamily have a general consensus sequence of YDPTIEDSY in this region (see 
Figures 4.0 and 4.1). The amino acid threonine (T) is highly conserved in all members of the ras 
GTPase superfamily, therefore in order to specifically amplify a ras subfamily gene from the T. 
brucei DNA template, it was essential to design a primer with the general consensus sequence of 
a ras subfamily member. Phenylalanine (F, see Figure 4.0), a single amino acid which is highly 
conserved in all members of the ras superfamily, could therefore, not be used in the specific 
amplification of ras subfamily genes. The two other primers, (i.e 3 and 4) were also designed to 
specifically amplify ras subfamily genes. The amino acid sequences from which the 
oligonucleotides were designed are shown in Figure 4.1 and the oligonucleotide primers and their 
degeneracies are summarised in Table 4.0.
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TABLE 4.0
Summary of the oligonucleotide primer nucleotide and amino acid sequences and their
degeneracies
OLIGONUCLEOTIDE AMINO ACID SEQUENCE DEGENERACY
1 GGVGKSALT 16-FOLD
2 YDPTIEDSY 192 -FOLD
3 LDTAGQE 8 -FOLD
4 VGNKC/ADL* 128 - FOLD
* C/A - implies that the nucleotide sequence codes for either a cysteine or an alanine residue at 
that position.
The nucleotide sequence for the oligonucleotide primers were as follows (listed as 5’ to 3’; I - 
Inosine):
1. CCC AAG CTT GGIGGIGTIGGI AAAg TaCgI GCI Ct TI AC.
2. CCC AAG CTT TATC GATC CCIACI ATTC/a GAAg GATC TACGITA.
3. GGC CTC GAG TcTC TCTG ICC IGC IGT AgTC LA.
4. GGC CTC GAG AGaAg TCI GcCATc TTAg TTI CCI AC.
The letters in subscript are the alternative bases that could bind to the complementary genomic/ 
cDNA sequence and account for the different degrees of degeneracy displayed by the primers. 
The orientation of the 4 oligonucleotide primers are shown in Figure 4.1. 5’ Hind III and 3’ Xho 
I restriction sites were added to the ends of the oligonucleotide primers to facilitate the subsequent 
ligation and cloning steps.
To maximise the chances of amplifying a T. brucei ras gene, four different combinations 
of the oligonucleotides were used in the amplification from T. brucei cDNA. These combinations 
are shown in Figure 4.2, together with the expected (approximate) molecular sizes of the 
amplified fragments, calculated from mammalian ras gene sequences (summarised in Table 4.1).
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FIGURE 4.0
AMINO - 
TERMINAL
GTP-BINDING DOMAIN
CARBOXYL - 
TERMINAL
GXXXXGKS F T DXXG nKXD
Schematic diagram of the conserved motifs of the GTP-binding domain of a mammalian ras gene. The 
diagram also shows the general consensus of the conserved non-contiguous regions of the gene. The single 
amino acid code is used, where D - aspartic acid, F - phenylalanine, G - glycine, K - lysine, n - asparagine (a 
small letter is used because it is conserved in most but not all ras genes), T- threonine (this represents the 
effector binding domain and was used in designing primer 2, see Figure 4.1). X - any amino acid.
FIGURE 4.1
AMINO- 
TERMINAL
GTP-BINDING DOMAIN CARBOXYL - 
TERMINAL
GGVGKSALT YDPTIEDSY LDTAGQE VGNKC/ADL
*
1 2 3 4
Schematic diagram of the GTP-binding domain of a mammalian ras gene showing the 
four non-contiguous conserved sequence motifs/degenerate oligonucleotides (1-4) and 
their orientations, used in the amplification of T. brucei cDNA by the polymerase 
chain reaction.
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FIGURE 4.2
GTP-BINDING DOMAIN
H2N- _____________________________________________________
Ig g v g k s a l t  y d p t i e d s y  l d t a g q e  v g n k c / a d l  \-
EXPECTED
MOLECULAR
SIZE.
= 90 bp
= 270 bp
= 150 bp
= 330 bp
Figure 4.2 is an illustration of the oligonucleotide primers (1-4), together with the primer 
combinations used in the amplification of T. brucei cDNA and the expected PCR product sizes, 
based on conserved domains in mammalian R-ras genes. -H2N - amino terminal, -COOH - 
carboxyl terminal
-COOH
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FIGURE 4.3
1 2 3 4 Mwt
1.6Kb 
1.0 Kb
500 bp
Figure 4.3 shows the results from the separation of four different PCR amplifications on an agarose gel. 
The PCR products (molecular sizes in the range of 500-1.6 Kb) were excised and gel purified. The 
products in lane 1 were amplified using degenerate oligonucleotide primers 1 and 4; in lane 2 degenerate 
oligonucleotide pnmers 2 and 4 were used in the amplification. Oligonucleotide pnm er combinations 1 & 
3 and 2 & 3 were used in the amplification of products in lanes 3 and 4. Mwt - molecular weight marker 
(Gibco).
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TABLE 4.1
Summary of the oligonucleotide combinations used in the amplification of T. brucei cDNA
and the expected PCR product sizes
OLIGONUCLEOTIDE
COMBINATION
EXPECTED PCR PRODUCT SIZE 
(APPROXIMATE SIZE)
1+ 3 150 bp
2 + 3 90 bp
1 + 4 330 bp
2 + 4 270 bp
1 + 2 + 3 + 4 150 bp, 90 bp, 330 bp, 270 bp
Using PCR conditions described in the Materials and Methods section, the degenerate 
oligonucleotides were used in the amplification of T. brucei bloodstream cDNA (prepared by the 
reverse transcription of poly (A+) RNA). Briefly, the PCR conditions were derived by varying 
the number of cycles (for the main run only) and annealing temperatures, to determine the . 
optimum annealing temperature and number of cycles necessary for the amplification of PCR 
products with the minimum of smearing. These conditions were used and the resulting PCR 
products were separated on 1.5 % low melting point agarose gels by electrophoresis; the results 
are shown in Figure 4.3. Bands of the expected sizes could not be visualised i.e 150-300 bp (see 
Table 4.1), which was probably due to the low abundance of the gene in the cDNA used in the 
amplification. The visualised bands, from 500 bp - 1.6 Kb (see Figure 4.3) were excised, gel 
purified and digested using Hind III and Xho I. The digested PCR products were then ligated into 
pTZ18R pre-digested with the same enzymes, and transformed into XL 1-blue E. coli, to generate 
a series of clones for sequencing analysis.
No transformants were recovered despite control ligations and transformations producing 
colonies. This could have been due to a number of reasons: 1). The loss of PCR products during 
gel purification; 2) The presence of inhibitors in the agarose used in the purification step, which 
could have been carried over into the ligation reactions and thus inhibited the ligations from 
taking place; or 3). The digests were not complete and therefore due to the absence of the 
necessary restriction sites the ligations could not occur. In order to improve the chances of 
cloning the PCR products different brands of low melting point agarose were tested. Longer
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restriction digest periods and the use of different methods for the isolation/cleaning of the PCR 
products did not produce clones with inserts . The vector was therefore replaced by one which 
does not require gel purification or digestion of PCR products before ligation.
4.11 Screening o f  clones derived from  ligation into the TA cloning vector
The TA cloning vector (Invitrogen) has a single 3 ’ T - overhang which is required for the 
ligation of PCR products. The vector relies on the “A overhang” which is added to 3’ ends of 
PCR products produced by Taq DNA polymerase. Ligations can, therefore, be carried out 
without a PCR product purification step, which might result in the loss of the product, or the 
introduction of inhibitors, which may be present in the agarose used in gel purification (section
4.1). The disadvantage of using the TA cloning vector is that no prior size selection of the PCR 
product is made, so that a range of products will be cloned. As degenerate primers and low 
annealing temperatures were used in the amplification step, many PCR products were generated, 
some of which could have been due to mispriming. The use of the TA cloning vector therefore 
led to the production of a large number of clones with different insert sizes which had to be 
screened for appropriate inserts (see Table 4.1). Using the TA cloning system approximately 150 
recombinant clones were recovered.
More than 80 DNA minipreps, each from different clones, were digested with Eco RI and 
the products separated on 1.5% agarose gels. Table 4.2 is a summary of the oligonucleotide 
primer combinations used in the amplification reactions and the observed insert sizes of 40 clones 
derived after ligating aliquots of the PCR mixes into the TA cloning vector.
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TABLE 4.2
Oligonucleotide primer combinations used in PCR mixes and the resulting insert sizes 
derived after ligation into the TA cloning vector
PCR PRIMERS OBSERVED INSERT SIZES
1+3 200, 250, 344, 396, 400, 500, 600, 800, 900 bp, 2.0 Kb
1+4 200, 298, 344, 500, 600, 700 bp, 2.0, 3.0 Kb
2+3 200, 250, 344, 396, 400, 600, 900 bp, 2.0 Kb
2+4 298, 344, 396, 400, 500, 600 bp, 1.0, 1.2 Kb
1+2+3+4 200, 250, 344, 700, 900 bp, 2.0 Kb
Based on the knowledge available on the sizes of small molecular weight GTPases in T. brucei 
(see Chapter 3, section 3.1), and bearing in mind that ras genes in yeasts are known to have 
molecular sizes that fall outwith the range stipulated by the guidelines to nomenclature of low 
molecular weight GTPases (Kahn and Der, 1992), insert sizes above the expected (150-300 bp, 
see Table 4.1) could not be discarded without prior screening.
Initially several DNA minipreps were prepared and screened by manually sequencing the 
ends, this was a slow and laborious task. In order to speed up the process a new approach was 
taken. The TA cloning vector was used, as it contains a LacZa gene, which allows for blue- 
white selection when grown in the presence of X-gal and IPTG (white colonies represent clones 
with plasmids containing inserts). White colonies were picked, grown up overnight and digested 
to check insert sizes. Plasmids with insert sizes of up to 500 bp were separated by agarose gel 
electrophoresis, transferred to nylon membranes by Southern blotting and hybridised sequentially 
with 32P end labelled degenerate oligonucleotides (as used in the amplification step). Clones 
positive for the correct combinations (see Table 4.1) were sequenced in order to determine 
whether or not they were ras-like. In summary, if after probing with all 4 labelled 
oligonucleotides, a clone was positive for oligonucleotides 3 and 4, but not 1 or 2 (see Figure
4.2) then, the clone would not be sequenced. The blots were stripped of radioactivity by boiling 
in 0.1% SDS for 3 x 15 mins before rehybridisation. Photographs showing the results derived 
from hybridising 37 clones with oligonucleotides 2 and 3 are shown in Figures 4.4a and b and 
summarised in Table 4.3.
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TABLE 4.3
Summary of the results obtained from hybridisations with oligonucleotides 2 and 3
CLONE N2 PCR PRIMER 
COMBINATION
SIGNAL INTENSITY AFTER 1 HR 
OLIGO 2 OLIGO 3
1 1 + 4 - -
2 1 + 4 - -
3 1 + 4 - -
4 1 + 4 - -
5 1 + 4 - -
6 1 + 4 - -
7 1 + 4 - -
8 1 + 4 - -
9 1 + 4 - -
10 1 + 4 - -
11 1 + 4 - -
12 1 + 4 - -
13 1 + 4 - -
14 2 + 3 +++ +++
15 2 + 3 +++ +++
16 2 + 3 - +++
17 2 + 3 - +++
18 2 + 3 - +++
19 2 + 3 - -
20 2 + 3 - -
21 2 + 3 - +++
22 2 + 3 - +++
23 2 + 3 - ++
24 2 + 4 - +++
25 2 + 4 +++ +
26 2 + 4 - -
27 2 + 4 - -
28 2 + 4 - -
29 2 + 4 +++ -
30 2 + 4 - -
31 2 + 4 - -
32 2 + 4 - +++
33 2 + 3 - +++
34 1, 2, 3 & 4 — ++
35 1, 2, 3 & 4 - -
36 1, 2, 3 & 4 - -
37 1, 2, 3 & 4 - +++
+,++ & +++ - increasing signal intensity.
- no signal.
40 clones were found to be positive for appropriate combinations of oligonucleotide 
hybridisations and these were manually sequenced using the USB sequenase reaction (see 
Materials and Methods). Of the 40 clones only one had the DNA sequence of a ras-like GTP- 
binding protein (labelled clone number 411). One reason for the low recovery of appropriate 
clones, is probably due to the fact that degenerate oligonucleotides were used in the amplification 
process, together with a low annealing temperature. This may have greatly reduced the
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specificity of the reaction and therefore the oligonucleotides probably led to the amplification of 
non ras-like genes by mispriming.
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FIGURE 4.4A
Mwt 1 2  3 4 5 6 7 9 10 11 12 13 14 15 16 17 18 19
500 bp 
369 bp
Mwt 1 2  3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
500 bp 
369 bp
Figure 4.4A shows an autoradiograph of the results derived from hybridising 19 out of 37 Eco RI 
digested clones, usmg 32P labelled oligonucleotide numbers 2 (for the top gel) and 3 (for the 
lower gel) (refer section 4.1, figure 4.1). Mwt - molecular weight markers.
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FIGURE 4.4B
20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37
500 bp 
369 bp ►
20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37
Figure 4.4B shows an autoradiograph with the results from the hybridisation of Eco RI 
digested clones 20 -37. Radiolabelled oligonucleotide numbers 2 and 3 (refer section 
4.1, figure 4.1), were used in probing the samples (2 was used in probing the top gel and 
3 the lower gel). Clone number 411 is equivalent to sample number 25. Mwt - 
molecular weight markers.
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4.12 Clone 411 - partial sequence o f a ras-like GTPase gene
Clone 411 was amplified from T. brucei cDNA with degenerate oligonucleotide primers 
2 and 4 (see Figure 4.2 and number 25 in Figure 4.4 b). Sequencing showed that it has a 280 bp 
(or 93 amino acid) open reading frame (ORF). Fasta searches confirmed that 411 has 37 % and 
39 % amino acid identity to the same region within mammalian N-ra.s and Dictyostelium 
discoideum ras b genes respectively. Further examination showed that 411 did not have a 
significant level of amino acid identity to any of the small GTP-binding proteins that had been 
previously cloned from T. brucei (El Sayed et al 1995 and Field et al, 1995; Swissprot and 
Genembl databases, 1996).
Based on the full length of mammalian Yl-ras gene, 411 appears to account for a third of 
the full length sequence. To characterise a full length copy of 411, it was necessary to determine 
the 5’ and 3’ flanking sequence of clone 411. There were two options 1) to determine the 5’ and 
3’ flanking sequence of clone 411 by using methods designed for the amplification of unknown 
cDNA ends with gene specific primers, design gene specific primers for the 5’ and 3’ ends and 
then amplify up the full length gene from either genomic or cDNA; or 2) To isolate the full length 
gene by screening genomic or cDNA libraries with the partial ras-like GTPase gene, clone 411. 
The following sections discuss the theory of the methods used and the results achieved in the 
isolation of a full length gene.
4.2 Amplification of the 5’ flanking sequence of 411 using the 5’ random amplification of 
cDNA ends (RACE) method.
5 ’ RACE involves the synthesis of cDNA from poly A+ or total messenger RNA and an 
antisense gene specific primer (5’ GSP 1). Poly A+ RNA, was used in the isolation of the 5’ - 
end of the gene containing clone 411, as it is less likely to be contaminated by genomic DNA than 
total trypanosome RNA. The synthesised cDNA was purified and a poly dT tail added using 
terminal transferase. The cDNA was then used as a  template in a PCR reaction with a second 
gene specific primer, 5’ GSP 2, located further towards the 3’ end of 5’ GSP 1 and an anchor 
primer complementary to the poly dT tail. A nested reaction using a third gene specific primer 5' 
GSP 3 and the anchor primer was then carried out to complete the process. The procedure 
should have produced a PCR fragment with the 5’ sequence, which, even if not complete, could 
be used to design more gene specific primers, and used repeatedly until the full 5 ’ end sequence 
was achieved.
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The oligonucleotide sequences of the three gene specific primers and the anchor primer are shown 
below (listed 5’ to 3’ ):
1. 5’ GSP 1 - CGC GAC AAA GTT GCGTGT GAA TCG CC
2. 5 ’ GSP 2 - GGA GAA GCT TTC AGC GTC TAT CAC GC
3. 5 ’ GSP 3 - CAC CGA ATA CAT CCT GCC CGG AAG TG
4. Anchor primer - AGG CCA CGC GTC GAC TAG TAC GGG
Products of the 5’ RACE method were analysed by gel electrophoresis and despite 
several attempts using a range of annealing temperatures, no products were obtained. As a result 
of this lack of success, another approach was taken to obtain the 57 end sequence of 411. A 
unique feature of trypanosomes is the presence of a spliced leader at the 5 ’ ends of all mature 
mRNAs. A slightly modified version of the 5’ RACE method was used in conjunction with a 
primer for the spliced leader in the second approach used to obtain the 5’ end sequence of 411.
4.21 Amplification of the 5’ flanking sequence of 411 using the 5* RACE principle and a 
spliced leader primer
Almost all mature messenger RNAs in T. brucei are attached to a spliced leader sequence 
(Agabian, 1990). Bearing this in mind, T. brucei cDNA was synthesised using the antisense 
oligonucleotide 5’ GSP 1. A PCR amplification was then carried out using 5’ GSP 2 and a 35- 
mer primer representing the spliced leader, with the previously synthesised cDNA as a template. 
A nested PCR reaction was then carried out using 5’ GSP 3 and the spliced leader primer to 
obtain specific products for 411. A second set of reactions with a 1:10 dilution of the spliced 
leader primer was run alongside the first set, this was done in order to increase the specificity of 
the reaction by decreasing the chances of mispriming due to the presence of a low concentration 
of the spliced leader primer. PCR reactions were carried out using an annealing temperature 
range of 44 - 58° C to determine the optimum annealing temperature required for the 
amplification steps. Figure 4.5A and B are negative images of photographs of the different PCR 
products obtained after the second amplification step. Aliquots of the PCR products from each of 
the annealing temperatures were transformed into XL 1 - Blue E. coli after ligation in the TA 
cloning vector. Glycerol stocks of clones from reactions 46°C, 48°C and 50° C (products from 
the transformation of the ligation mixes of the products from the 1:10 dilution of the spliced 
leader /5’ GSP 3 amplification reaction and the TA cloning vector) were made and stored at -70° 
C. Several colonies from the 46° C reaction (produced by the transformation of the ligation mix
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of the product of the 1:10 dilution of the spliced leader primer and 5’GSP 3 reaction, into the TA 
cloning vector) were picked and grown up overnight in LB medium. DNA was prepared from the 
overnight culture according to the Wizard DNA miniprep protocol (Promega), digested with Eco 
RI and checked for the expected insert size i.e, approximately 200 bp, by separating the 
restriction digest products on 1.5 % agarose gels. All the plasmids had the expected insert size 
and four of these were randomly picked and sequenced. The sequence from clone 46-2 (hereafter 
referred to as clone 462) showed a region of overlap at the 3 ’ end which corresponded to the 5 ’ 
end of 411. Figure 4.6 is an illustration of the different gene specific primers used in the 5’ 
RACE/spliced leader PCR amplification protocols, which resulted in the amplification of 462, 
together with the region of overlap between clone 411 and 462.
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Figure 4.5 shows an ethidium bromide stained gel of two sets of PCR amplifications earned out at different 
annealing temperatures (44-58° C). Gels A and B show the different PCR products obtained after the nested 
reaction. The reactions in Gel A were carried out with neat spliced leader primer and the appropnate 5' gene 
specific pnmers (GSP). A 1/10 dilution of the spliced leader primer used in A, was used in the amplification 
of samples in B (see matenals and methods for details).
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FIGURE 4.6
Clone n° 411
5’ GSP 1
(S) 5’ GSP 2
(S)
5’ GSP 3
Clone no. 462
= 195 bp
ATG
An illustration of the different gene specific primers (5’ GSPs 1, 2 & 3) and the spliced leader 
primer (s), used in the production of clone 462. 5’ GSP 1 (an anti-sense oligonucleotide) was 
used in the synthesis of cDNA, which served as a template in the subsequent amplification steps 
with the spliced leader primer and 5’ GSPs 2 and 3.
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4.21a Identification ofT. brucei clone n~ 462
DNA sequencing was carried out to further characterise the insert of T. brucei DNA in 
clone 462. The sequence showed that clone 462 had an open reading frame of 195 bp and a start 
codon, ATG at the beginning of the sequence. A short untranslated region of 56 bp was observed 
between the spliced leader and ATG start codon. The 3’ end of clone 462 has an overlap of 86 
bp with the 5’ end of 411. Having obtained the 5’ end of the gene, it was necessary to recover the 
3’ end. A number of approaches are currently available for the determination of unknown 3’ end 
sequences. The first one that was attempted was the 3’ RACE method.
4.3 Amplification of the 3’ end of clone number 411 by the 3’ RACE method
The 3 ’ RACE method relies on the presence of a poly dA tail at the 3 ’ end of the mRNA 
and was used in the attempt to obtain the 3’ end nucleotide sequence of the full cDNA containing 
the sequence of clone 411. cDNA was synthesised using total trypanosome RNA and the anchor 
primer (according to the manufacturers instructions). The sequence of the anchor primer was as 
follows: 5’CGG TGG CAG CAG CCA ACT TTT TTT TTT TT 3’. The cDNA was then used 
as a template for the subsequent rounds of PCR, together with a universal anchor primer with the 
following sequence: 5’ CGA GAA TTC GGT GGC AGC AGC CAA CT 3’ and the first 3’ gene 
specific primer, 3’ GSP 1. Two nested reactions were carried out using the PCR product from 
the first round as the template. Gene specific primers 3’ GSP 2 and 3’ GSP 3 were used with the 
universal primer in each of the nested reactions. The gene specific primer sequences were as 
follows (listed 5’ to 3’ ):
1. 3 ’ GSP 1 - ACT TCC GGG CAG GAT GTA TTC GGT GG
2. 3’ GSP 2 -  TCA TGG CGT TAT TCT CGT GTA CAG CG
3. 3’ GSP 3 -  GCG ATT CAC ACG CAA CTT TGT CGC GC
Several bands, none of which were the expected size i.e approximately 400 bp, were 
observed after the PCR products had been run out on 1.2 % agarose gels. After several months 
of manipulating the conditions required for the technique, this line of action was abandoned. A 
new approach was taken, which involved the screening of genomic and cDNA libraries with 
clones 411 and 462.
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4.4 Screening of genomic and cDNA libraries using clones 411 and 462
Inserts from the two clones (411 and 462) were digested using Eco RI, gel purified and 
32P labelled by random priming, using the Stratagene Prime-it kit. The EATRO 795 ILTat 1.2 
genomic DNA library, a gift from Mr V.S Graham, had an average insert size of 18 Kb. The 
library was constructed from fragments of partial digests of Sau 3 A ligated into Bam HI digested 
arms of A.DASH II (Stratagene). An EATRO 1125 procyclic cDNA library, a gift from 
Professor E. Pays, was also screened. Duplicate lifts were made and hybridised separately with 
each labelled insert. Approximately 20,000 plaques were screened in each case. Using this 
approach no recombinant phage hybridised to either of the probes. This could have been due to a 
number of reasons; 1) the low message level of 411/462 in the procyclic cDNA library; 2) the 
possibility that the expression of 411 and 462 is stage specific, i.e, bloodstream, not procyclic 
stage specific and 3) their absence in the genomic DNA library. The screening process was 
abandoned after 3 unsuccessful attempts were made. Two more PCR based methods were 
attempted concurrently in order to determine the 3’ end sequence of 411, these were: 1) Short 
chromosomal walks using gene specific primers and 2) Long range PCR.
4.5 Amplification and sequencing of the 3’ end of 411 by means of short chromosomal 
walks with gene specific primers
Chromosomal walking, a technique described by Screaton, Bangham and Bell, 1993, 
involves the deliberate mispriming of genomic DNA by using a single gene specific primer, a low 
annealing temperature and several PCR cycles. As the conditions for this technique encourage a 
decrease in the overall specificity of the amplification step, many PCR fragments are produced. 
The sequence for the gene is finally isolated by means of an increase in specificity which requires 
the use of a second gene specific primer as a sequencing primer. A single chromosomal walk can 
produce at least 200 base pairs of very good sequence. Based on the open reading frame (ORF) 
sizes of mammalian ras genes, it could be postulated with some degree of certainty, that the 
combined nucleotide sequences of clone number 462 and 411 represent approximately half of the 
full length ORF of the T. brucei ras-like GTPase. Therefore at least two chromosomal walks 
would be required in order to obtain the rest of the 3’ end ORF nucleotide sequence, the first one 
would provide sequence data which would be used to design an additional gene specific primer. 
This primer would be used as a sequencing primer for the second chromosomal walk, which 
should cover the region up to the stop codon.
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Two 5" —» 3’ facing primers from 411 (the same primers as those used in the 3’ RACE 
technique) were used: 3’ GSP 2 was used in the first mispriming PCR amplification using TREU 
927 DNA as a template and 3’ GSP 3 was used for the specific sequencing from the amplified 
products. Approximately 200 bp of good sequence were derived from the initial chromosomal 
walk, and a gene specific primer downstream of 3 ’ GSP 3 was synthesised (3 ’untbrlp) based on 
this sequence ( the 5’ to 3’ sequence of 3’untbrlp is as follows: CCG TGC GGT GAG TAG 
TGA AGA GGC AAG CAA). In a second amplification designed to extend the sequence further, 
3 ’ GSP 3 was used as the primer for the mispriming phase of the chromosomal walk (also using 
TREU 927 DNA), and 3 ’ untbrlp was used as the specific sequencing primer. The rest of the 
gene sequence 3 ’ of the clone 411 sequence was obtained by using this strategy. Figure 4.7 
shows an illustration of the principles of chromosomal walking and gives details of the 3 ’ gene 
specific primers 2 and 3. Two gene specific primers which corresponded to the beginning of the 
ras like gene, i.e 5’ of 411 (5’ end of clone 462), where the start codon (methionine) is situated, 
and the 3’ end of 411 (sequence derived from the chromosomal walks), where the sequence 
terminates (indicated by the presence of a stop codon and a large untranslated region), were 
synthesised and used in an amplification reaction which involved the use of TREU 927 DNA as 
the PCR template and resulted in a product of approximately 700 bp. The product was ligated 
into pBluescript, and subsequently transformed into XL-1 Blue E. coli. Positive colonies (i.e 
white colonies) were picked and DNA was prepared from overnight cultures according to the 
Qiagen DNA miniprep protocol. The DNA was digested with Eco RI and Xho I (the same 
enzymes were used in the ligation reaction) and checked for plasmids with inserts of the expected 
size (i.e 700 bp). DNA from two of the colonies with inserts of the expected size was prepared 
(as previously described) and sequenced using the ABI automated Sequencer and two 
complementary pBluescript primers. The sequence from both strands of the insert showed that 
the ras like gene has an open reading frame of 681 bp, and the six highly conserved sequence 
motifs of a ras subfamily gene (see Chapter 4, section 4.7 for details).
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FIGURE 4.7
GTP-BINDING DOMAIN
HoN- -COOH
Iy d p t ie d s y  l d t a g q e  v g n k c /a d l
3 ’ GSP 2
Deliberate mispriming of genomic DNA by using a single gene 
specific primer, 3’ GSP 2, a low annealing temperature and 
several PCR cycles
1
3 ’ GSP 2 US
^  Nested sequencing reaction using 3 ’ GSP 3
GSP2 GSP3
An illustration of the principle of chromosomal walking as described by Screaton, Bangham and 
Bell, 1993. It also shows the gene specific primers, 3’ GSP 2 and 3’ GSP 3, used in the mispriming 
of T. brucei genomic DNA, the various PCR products including some with the unknown sequence. 
(US) and in the subsequent “nested sequencing” of the misprimed PCR product. NH2 - amino 
terminus; -COOH - carboxyl terminus.
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4.6 Amplification of the 3’ end of 411 from T. brucei by means of long range PCR
As a complementary approach to obtaining the 3’ sequence, long range PCR was 
employed to specifically amplify the 3’ end of 411 from a genomic DNA library. This procedure 
was carried out concurrently with the chromosomal walk (see section 4.5). For a period of time, 
the ability to amplify large fragments of DNA of about 35 Kb, was limited by the low fidelity of 
Taq (Thermus aquaticus) DNA polymerase. Barnes, 1994 showed that fragments of up to 35 Kb 
in size could be accurately produced by using Pfu (Pyrococcus furiosus) DNA polymerase 
instead of Taq. Pfu is a thermostable enzyme with high fidelity and the additional ability to 
proof-read. It is found to decrease the rate of mutations per base from 10 A to 10 5 per cycle. 
This technique was therefore used in the amplification of DNA from a Trypanosoma brucei 
rhodesiense (EATRO 795 ILTat 1.2) AD ASH II, Sau 3 A partial digest genomic DNA library, 
(average insert sizes of 18 Kb).
Four T. b. rhodesiense size selected libraries in ADASHII (Stratagene) namely, EATRO 
(EA) 795 ILTat 1.2, EA2340 Pop 339, EA2340 Gug 339 (all of which were Sau 3A partial 
genomic DNA libraries) and EA2340 Gug 339 (an Eco20Eco complete genomic DNA library, 
which is a library construct from a size selected subset of Eco RI restriction fragments cloned 
into Embl 4) with different average insert sizes were initially screened for the presence of 411 by 
means of PCR. 5’ GSP 2 and 3’ GSP 2 were used in the preliminary amplification step. The 
PCR products were separated on a 2% agarose gel and a band of the expected size, (80 bp) was 
observed in one of the libraries. Figure 4.8 is a photograph of the gel with the separated PCR 
products. Based on these results this Trypanosoma brucei rhodesiense strain EATRO 795 
ILTat 1.2 (in ADASH II) genomic DNA library was used as a template in subsequent PCR 
reactions. A number of PCR reactions were set up using two ADASH II primers, T3 and T7. 
This initial reaction was used to determine the optimum conditions necessary for the amplification 
of a DNA fragment of approximately 18 Kb. A second set of PCR reactions was carried out, as 
the orientation of 411 within the library was not known, using the following PCR primer 
combinations:
1. 3’ GSP 2 + T7
2. 3 ’ GSP 2 + T3
A nested reaction was carried out after the preliminary PCR amplification. 1 pi of the 
PCR product was used as a template and a primer downstream of 3’ GSP 2 was used in the 
second amplification step. The combinations used were as follows:
3. 3’ GSP 3 + T7 and
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4. 3’ GSP 3 + T3.
Combination 3 was used in the amplification of the PCR product from 1 and combination 4 in the 
amplification of the PCR product from 2.
After determining the orientation of 411 within the library, the experiment was repeated, 
using vector primers as positive controls. The results from the long range amplification of T. b. 
rhodesiense are shown in Figure 4.9. Two PCR products were observed one of approximately 7 
Kb and the other 2 Kb (products from the use of 3’ GSP 2 + T3 and 3’ GSP 3 + T3), no bands 
were visualised in the lane with the negative control (no DNA). Direct ligation of the PCR 
products using the TA cloning vector system produced only one clone with an insert size of 2 Kb. 
The 2 Kb insert contained the 3’ end sequence of the ras-like gene from T. brucei and, other 
DNA sequence from the T. brucei genome 3 ’ of the ras-like gene and for which no sequence data 
was obtained. The sequence of this clone was determined and found to have a region of sequence 
overlap which was almost identical to that derived from the chromosomal walks, thus confirming 
the 3’ end sequence. The observed difference which is a conservative amino acid change (Serine 
to Threonine) appears to have been due to the use of different strains of T. brucei. A number of 
sequencing errors, one of which caused a visible frame shift, were not resolved as the full length 
ras gene was amplified from TREU 927 DNA, using primers from the 5’ end of 462 and the 3’ 
end of the long range PCR/chromosomal walk sequence. Figure 4.10 is an alignment of the 5’ 
and 3’ flanking sequence of 411 derived from 1) Clone 462, which was amplified from T. brucei 
cDNA with a gene specific primer from 411 and a primer for the spliced leader; 2) A 2.0 Kb 
long range PCR product, which was amplified from a T. b. rhodesiense Sau 3A partial genomic 
DNA library with gene specific primers from 411 and T7 (vector primer); 3) two chromosomal 
walks using gene specific primers from 411 for the “mispriming reaction” and for the sequencing 
reaction (the second sequencing primer was derived from the sequence of the first chromosomal 
walk); 4) the full length sequence of the ras-like gene in two different cloning vectors amplified 
from T. brucei strain TREU 927 genomic DNA, with primers from the 5’ end of 462, and the 3’ 
end of the long range PCR product/chromosomal walk sequence. Figure 4.10 also shows the 
regions of overlap of 462 and 411; 411, the long range PCR product and the sequence from the 
two chromosomal walks.
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FIGURE 4.8
Mwt 1 2  3 4
Primer dimers
Figure 4.8 shows an ethidium bromide stained gel of PCR products separated on a 2 % 
agarose gel. The following templates were used in the amplification reactions, in lane 
1, T. b. r. EATRO 2340 Pop 339; lane 2, T. b. r. EATRO 795 ILTat 1.2; lane 3, T. b. r. 
EATRO 2340 Gug 339; and in lane 4, T. b. r. EATRO Gug 340 (see Materials and 
Methods for details). A band of the expected size, 80 bp can be visualized in lane 2, 
between the 500 bp marker and the primer dimers. No bands were observed in the 
other lanes. Mwt - molecular weight marker.
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FIGURE 4.9
Mwt 1 2  3 4
Figure 4.9 shows the PCR products from the long range PCR amplification separated on a 1.0 % 
agarose gel in lane 1; There were no bands in lane 2 which was the negative control (no DNA). 
Primers for the vector were used in the amplification of PCR products in lanes 4 and 5. Mwt - 
molecular weight marker.
120
FIGURE 4.10
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Figure 4.10 shows an alignment of the 5’ and 3’ flanking sequence of clone 411. The blank spaces indicate 
regions where sequence data are unavailable, the dashes represent identical amino acids (compared to the topmost 
sequence in each set of sequences) and * represents the stop codon. The bordered areas (with grids) represent 
changes due to sequencing errors in the 462/869 sequence. The bordered, lightly shaded regions highlight the 
sequence differences between the different PCR products generated by inclusion of the degenerate primers in the 
411/869 sequence. The bordered, dark grey regions represent amino acid differences which were generated by a 
sequencing error causing a short frame shift in the LR/795 sequence. The bordered unshaded region represents a 
conservative Serine to Threonine amino acid change which was attributed to stram difference. Clone 462 was 
amplified from T. brucei strain TREU 869 cDNA with a gene specific primer from clone 411 and a primer for the 
spliced leader. Clone 411 was also amplified from T. brucei strain TREU 869 cDNA, with degenerate ras primers. 
LR/795, was the product derived from the long range PCR amplification of T. brucei. rhodesiense EATRO 795 IL 
Tat 1.2 Sau 3A partial genomic library. CW/927 (sequence derived from two chromosomal walks), BS/927 and 
MB/927, full length tbrlp subcloned into pBluescript (BS) and the maltose binding protein vector pMAL-c2 (MB) 
were all amplified from T. brucei strain TREU 927.
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Using the sequences determined for the 5 ’ and 3 ’ ends of the gene, two PCR primers, 5 ’ 
tbrlp and 3’ utbrlp (the full length ras-like gene was named tbrlp i.e Trypanosoma brucei ras- 
like GTP binding protein, hence the use of the names 5’ tbrlp and 3’ “ultimate” tbrlp), were 
designed to amplify the full length gene from T. brucei strain TREU 927 genomic DNA. This 
PCR product was cloned into the Maltose binding protein and pBluescript cloning vectors and
sequenced. The sequence for the full length gene, tbrlp, had a high percentage of amino acid
identity to that of the combination of the fragments i.e clones 462, 411 and the sequence derived 
from the chromosomal walk and long range PCR. The gene was amplified and resequenced from 
a different source of TREU 927 T. brucei genomic DNA; the sequence from this stock was 
identical to the sequence from the full length gene (refer Figure 4.10). This was done so as to 
ensure that the full ras-like gene was not a contaminant peculiar to one source of TREU 927. 
Figure 4.11 is a photograph showing the presence of the amplified gene in three different aliquots 
of TREU 927 (from different sources) and a different strain of T. brucei genomic DNA i.e. 
STIB 247. This was carried out so as to determine whether the ras like gene could be amplified 
from other strains of T. brucei. The sequences of the primers used in the amplification of the full 
length gene were as follows (listed 5’ to 3’ ):
1. 5’ tbrlp- ATG AGG AAT ATT AAC CTC GTC GTT TTG GGT
2 3 ’ utbrlp - TCA GAG CAT AGT GCA TCC CGA TTT CTT TTT CCT A
Figure 4.12 is a summary of the different fragments of the ras gene from T. brucei, the 
primers and the techniques used in the isolation of the full length open reading frame of the ras- 
like gene.
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FIGURE 4.11
1 2 3 4 5 6 Mwt
2.0 Kb
1.0 Kb 
500 bp
Primer dimers
Figure 4.11 shows the presence of tbrlp in three different aliquots of 927 (lanes 1-3), the negative 
control (no DNA) was in lane 4, and two different aliquots of 247 (lanes 5-6). The bands visualized 
in the lower region of the gel are as a result of dimenzation of the primers.
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FIGURE 4.12
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Figure 4.12 (not drawn to scale) shows a summary of the primers and techniques used in the amplification of tbrlp. 
(1) shows the degenerate primers used in the initial amplification of clone 411 (280 bp) from T. brucei strain TREU 
869 cDNA (2). (3) represents the amplification reaction in which a primer for the spliced leader (s) and a gene 
specific primer from clone 411 (5’ GSP 3) were used in the production of a PCR fragment (clone 462, approximately 
195 bp), which contained the 5’ end sequence of 411. (4) - (6) represent the steps taken to produce sequence 3’ of 
411 by means of chromosomal walking with gene specific primers (GSPs) from 411 using TREU 927 DNA as a 
template and long range PCR (7), using a gene specific primer from 411 (GSP 3) and a ADASH vector primer, T 3. 
(8) represents full length tbrlp, amplified from T. brucei strain TREU 927, with gene specific primers derived from 
the 5’ end of clone 462 (5’ tbrlp) and the 3’ end of the long range PCR product/the chromosomal walk sequence (3’ 
utbrlp). ATG - methionine (start codon).
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4.7 Trypanosoma brucei ras-like GTP-binding protein
Based on the general structural features of mammalian H-ras (refer Figure 4.0) the ras 
like gene from T. brucei appears to be a member of the ras GTPase superfamily. It has an open 
reading frame of 681 bp or 227 amino acids and an estimated protein size of 25 kDa which 
classifies it as a low molecular weight GTP-binding protein. The ras-like GTP-binding protein 
was named Trypanosoma brucei ras like GTP binding protein or tbrlp. Figure 4.13 shows the 
full length amino acid sequence of tbrlp, in alignment with 2 ras and 3 rap genes from three 
higher eukaryotes in which the general consensus of the conserved non-contiguous regions are 
highlighted.
In addition, tbrlp has 45 % amino acid sequence identity to human rap 2 genes and 41 % 
amino acid sequence identity to human H-ras genes. Several structural features within the GTP- 
binding domain, define tbrlp as a ras-like gene and are discussed below.
4.71 The phosphate/magnesium ion binding sites
All members of the ras GTPase superfamily have three highly conserved 
phosphate/magnesium ion binding sites within the GTP-binding domain. Each site has well 
conserved amino acid residues which are essential for the proper folding and function of the 
encoded proteins.
The first phosphate/magnesium ion binding site (PM 1), also referred to as the P-loop, 
has a consensus sequence of GxxxxGK S/T (S/T - either an S or a T is found in that position). 
The PM 1 site of tbrlp has a sequence that corresponds with the consensus sequence, 
GDGGVGKS. This site is involved in the maintenance of the GDP conformation of the protein, 
its inactive state. Lysine (K), is involved in binding tightly to the P - phosphate of GDP, while 
the serine residue binds to the cofactor in this case a magnesium ion. This binding site is 
therefore extremely important in enhancing the stability of the GDP or inactive conformation of 
the protein. Almost all members of the ras subfamily have Gly-Gly in positions 12 and 13 (based 
on positions in p21ras , Valencia et al, 1991). tbrlp, has the same sequence arrangement and 
therefore can be classified as a ras subfamily member (positions 12 and 13 underlined).
Phosphate/magnesium ion binding sites 2 (PM 2) and 3 (PM 3), bind the y - phosphate of 
GTP and the co-factor. They are necessary for the maintenance of the stability of the GTP bound 
conformation of the protein. PM 2 is made up of only one conserved amino acid residue.
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threonine (T), this residue is also conserved in tbrlp. PM 3 however has a consensus sequence of 
DxxG Q/T E (where Q/T means either a Q or a T at that position). Members of the ras 
subgroup have a glutamine (Q) at that position whereas those belonging to the rap subgroup have 
a threonine (T). These residues are found to be involved in the GTPase activity of the proteins. 
All of the conserved amino acids are found within the sequence of tbrlp. The sequence that 
corresponds to PM 3 in tbrlp is DTSG 0  D, which suggests, that tbrlp belongs to the ras 
subgroup (see Figure 4.13).
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Figure 4.13
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Figure 4.13 shows an alignment of the full length sequences of tbrlp and ras (or rap) genes from Dicdi - 
Dictyostelium discoideum , disom - Discopyge ommata, hum - Homo sapiens and rhira - Rhizomucor 
racemosus. The highlighted and bordered areas are the conserved sequence motifs found in tbrlp and 
both ras and rap genes. Sequence motifs found in either ras or rap genes and tbrlp are highlighted but 
not bordered.
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4.72 The guanine nucleotide binding sites
There are three guanine nucleotide binding sites within the GTP-binding domains of 
members of the ras GTPase superfamily, G l, G2 and G3. The conserved sequence motifs within 
these domains are responsible for the maintenance and stability of the bonds between the protein 
and the guanine base of the nucleotide. Only one amino acid residue is conserved in the first 
guanine nucleotide binding site or G l. The conserved amino acid is phenylalanine (F) and this 
residue is found in the same position in tbrlp. The conserved residues within G2 are as follows: 
nKxD - where asparagine (n) is conserved in most (not all) ras genes and is therefore denoted by 
a lower case letter, while lysine (K) and aspartic acid (D) are highly conserved and found in all 
ras genes and x is any amino acid (see Figure 4.12). The G2 site of tbrlp has the following 
sequence which contains the two important conserved amino acid residues, lysine and aspartic 
acid - NKXD. G3 is not directly involved in the binding of the base to the protein, but appears to 
be involved in the maintenance of the stability of the bonds formed by residues in G l and G2 and 
the protein. The consensus sequence in this region is ExSA, where E is glutamic acid, x - any 
amino acid, S - serine and A is alanine. The sequence of tbrlp in this region of the GTP-binding 
domain is as follows: EVTA. The presence of a threonine residue where the serine residue should 
be is a conservative amino acid change which may have occurred during the evolution of the 
gene. Based on the conserved sequences motifs in the GTP-binding domain alone, tbrlp can be 
classified as a member of the ras GTPase superfamily and the ras GTPase subgroup.
4.73 C - terminal extension region
This region of the gene, in members of the ras GTPase superfamily, is the variable 
region. There can be as many as 180 or as few as 20 amino acid residues in this region in 
different ras family members and a very low level of conservation is observed. In tbrlp this 
region is 79 amino acid residues long and is found to be completely unrelated to the C - terminal 
regions of other ras-like genes. However, a consensus sequence for a cyclic AMP dependent 
phosphorylation site is found just before the C-terminal CAAX box. The consensus sequence is 
BBxS/T. where B is a basic amino acid, x is any amino acid, and either a serine (S) or a 
threonine (T) is found in position 4 (Lapetina et al 1993). This motif is found to be conserved in 
human rap Vo proteins (Bokoch, 1993). The sequence found at the C-terminal end of tbrlp is 
KKKS. The presence of this motif suggests that tbrlp is a member of the rap subgroup.
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4.74 The carboxyl terminal CAAX box
The CAAX box (where C - cysteine, A - aliphatic residue and X - any amino acid), is 
found at the carboxyl terminal of all ras subfamily genes and is the site for post translational 
modification, essential for the subcellular localisation of the protein. Generally, the presence of a 
methionine or serine at the X position results in the famesylation of the protein. This is normally 
found in members of the ras subgroup. The presence of leucine at this same position suggests 
that the protein undergoes geranylgeranylation and has been observed in members of the rap 
subfamily. The difference in the post translational modification processes account for the 
different subcellular locations of ras and rap proteins. Ras GTPases are normally found on the 
inner surface of the plasma membrane (Lowy and Willumsen, 1991), whereas rap genes are 
found on the endoplasmic reticulum and the endosomal/lysosomal compartments (Zerial and 
Huber, 1995).
The CAAX box of tbrlp has the following sequence - CTML. The fact that the residue at the X 
position is leucine suggests that the protein undergoes geranylgeranylation in the post 
translational modification process and should, therefore, be a member of the rap and not ras 
subgroup.
It appears as though tbrlp has amino acid sequence characteristics of members of both 
ras and rap subgroup members (see section 4.7, Figure 4.13). Due to these mixed features, it is 
difficult to determine the actual subgroup to which tbrlp belongs.
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4.8 Characterisation of tbrlp
In order to determine the copy number of tbrlp, single and double restriction digests were 
carried out on T. brucei strain STIB 247 genomic DNA with the following enzymes: Hind III, 
Xho I, Bam HI, Eco RI and Pst I. The digests were separated on a 0.8 % agarose gel and 
transferred onto a nylon membrane by Southern blotting. Clone 411 representing the inner third 
portion of tbrlp was labelled by random priming using the “Prime-it” random labelling kit 
(Stratagene) and hybridised to the blot at 65° C. Results from the hybridisation of the Southern 
blot suggested that tbrlp is a single copy gene (Figure 4.14).
In order to confirm that tbrlp is a single copy gene and to determine whether or not there 
are any other genes to which it is closely related, Hind III digests of T. brucei strain TREU 927 
genomic DNA were separated in triplicate on a 0.8 % agarose gel and transferred onto a nylon 
membrane. The membrane was cut into three panels (after the transfer) each of which had a lane 
of Hind III digested genomic DNA as shown in Figure 4.15. The full length tbrlp was 
radiolabelled and used as a probe on the three membranes which were then hybridised at 65°, 55° 
and 50° C . After overnight incubation the three membranes were washed 3 times for 15 minutes, 
with a low stringency wash buffer (2x SSC + 0.1 % SDS) at each of the hybridisation 
temperatures, i.e 65°, 55° and 50° C. The results, (Figure 4.16), indicate that no related genes are 
detected at low stringency. Four bands were detected on each of the membranes, these were: 1.3 
Kb, 12 Kb, and two other bands which had molecular sizes greater than 12 Kb. The two topmost 
bands are consistent with the residue of the digested DNA in the wells and partially digested 
DNA respectively. Another Southern blot was carried out using single and double restriction 
enzyme digests of T. brucei strains TREU 927 and STIB 386. The DNA fragments were 
separated on a 0.8 % agarose gel after digestion with the following restriction enzymes, Hind III, 
Pst I and Hind III + Pst I, transferred onto a nylon membrane, and probed with labelled full 
length tbrlp. The pattern for the Hind III digests was consistent with the previous experiment, 
whilst that of Pst I, highlighted the presence of a Pst I polymorphism in the three different strains, 
upstream of tbrlp I.
130
FIGURE 4.14
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Figure 4.14 shows Southern blot of single and double digests T. brucei genomic DNA. 
Results from the hybridisation using radiolabelled 411 as a probe, indicated that tbrlp 
is a single copy gene. The hybridisation was carried out at 65° C. The enzymes used 
were as follows: H ind  III (H), Xho I (X), BamHl (B), Eco RI (E), Pst I (P) and double 
digests of the afore mentioned
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FIGURE 4.15
Mwt A B Mwt
3.0 Kb
,6 Kb
500 bp
Figure 4.15 shows a 0.8 % ethidium bromide stained agarose gel of Hind  III digested T. brucei 
genomic DNA separated in triplicate (A, B and C). The DNA was transferred onto nitrocellulose 
membranes and probed with tbrlp. Mwt - molecular weight marker. The results of the 
hybridisation are shown in Figure 4.16
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FIGURE 4.16
A B C
Figure 4.16 shows an autoradiograph of Hind  III digested T. brucei genomic DNA probed with 
radiolabelled tbrlp . Hybridisations were earned out at 50, 55 and 65° C (from left to right).
Lanes same as Figure 4.14. A number of bands (greater than 10 Kb), can be visualized at the top 
of the gel and the molecular sizes are consistent with partially digested genomic DNA and DNA 
residue in the wells. The 1.6 Kb band is a Gibco molecular weight marker, which was used in the 
determination of molecular sizes of the visualized bands.
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The results from these Southern blots suggest that tbrlp is a single copy gene, but do not 
eliminate the possibility that there may be more than one copy of the gene, as some of the 
fragments are very large and could contain a tandemly linked copy. Figure 4.17 shows an 
autoradiograph of a Southern with Hind III and Pst I single and double digests of T. brucei 
strains TREU 927 and STIB 386. Restriction maps from the three strains of T.brucei are 
presented in Figure 4.18.
Under a specific set of PCR conditions, the amplification of tbrlp from genomic DNA, 
using primers designed for the 3’ and 5’ ends of the gene, resulted in the production of a second 
band of 1.4 Kb in addition to the expected 681 bp band, i.e tbrlp (Figure 4.19). Reamplification 
of the excised and gel purified 1.4 Kb PCR product, using the same primers, produced both the
1.4 Kb and 681 bp fragments. The simplest interpretation of this observation is that two 
tandemly arranged copies of tbrlp exist. These two copies will be referred to as tbrlp I (the 
original, sequenced copy) and tbrlp II (the new gene). A Hind III restriction digest of the 1.4 Kb 
PCR product, produced two predominant fragments of 1 Kb and 400 bp respectively, with the 
400 bp fragment being consistent with the size of the Hind III fragment predicted from the 
sequence of tbrlp I. The sizes of these fragments suggest that the 400 bp fragment must contain 
the sequence from the Hind III site to the 3 ’ end of tbrlp I and also show that tbrlp II (part of the 
1 Kb fragment) is missing this Hind III site. The results from the Southern blots indicate that this 
hypothesis (that there are two tandemly linked copies of tbrlp) is correct so long as the second 
copy (tbrlp II) is upstream of the original (see Figure 4.18). As would be expected the 
amplification of tbrlp I and tbrlp II separately, occurs more readily than the two genes together, 
thus accounting for the high intensity of the 681 bp band relative to the 1.4 Kb band. Direct 
sequencing of short sections from each end of the 1.4 Kb PCR product confirmed the presence of 
two tandemly linked genes and showed that tbrlp II has an identical sequence to that of tbrlp I 
over the sequenced region.
134
FIGURE 4.17
TREU 927 STIB 386
0.5 K b > -
Figure 4 11 shows an autoradiograph of a Southern of single and double digests of two different 
strains of T. brucei, STIB 386 and TREU 927. H 3- Hind  III, P 1 - p st I, El - Eco RI Mwt - 
molecular weight markers (Gibco)
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FIGURE 4.18
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Figure 4.18 is an illustration of Hind IH (H Ht) and Pst I(P I) restriction digest maps of tbrlp I and H using three different 
strains of T. brucei, namely, SUB 247 (B), STIB 386 (C) and TREU 927 (D), based on the autoradiographs shown in 
Figures 4.14 and 4.17. Radiolabelled 411 * (STIB 247 map) and tbrlp I* (STIB 386 and TREU 927 maps) were used as 
probes. The lines next to the probes show the points of hybridisation to tbrlp I and II. (i), (ii) and (iii) are the results 
from the hybridisation of the probes to the Hind HI, Pst I and a double digests of Hind HI and Pst I respectively. The 
numbers above the respective lines (not to scale) denote the observed band sizes. (A) is the consensus restriction map 
showing the presence of Pst I (PI) polymorphisms (**).
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FIGURE 4.19
Figure 4.19 shows an ethidium bromide stained gel of the separated PCR products tbrlp I (681 bp) 
and both tbrlp I and the putative second copy tbrlp II (1.4 Kb) in lane 1. Mwt - 1 Kb ladder 
(Gibco), used in the estimation of molecular sizes.
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4.9 Expression of tbrlp I
To investigate the expression of tbrlp, T. brucei bloodstream and procyclic total RNA 
were separated on an agarose gel, transferred onto nylon membranes and hybridised using 32 P 
labelled 411 as the probe. Figure 4.20 is an autoradiograph of a Northern blot, which shows that 
tbrlp I has a 1.4 Kb message and is expressed in both bloodstream and procyclic life cycle stages 
of T. brucei. The size of the message, when compared to the size of the open reading frame of 
tbrlp I, is indicative of a rather long 3 ’ untranslated region. This phenomenon has been observed 
in a number of small GTPases but the actual significance of the length of this region is currently 
unknown.
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FIGURE 4.20
Figure 4.20 shows the results from a Northern blot of procyclic and bloodstream 
trypanosomes, where P - procyclic and BS - bloodstream. Clone 411 was used in probing 
the blot. Results from the northern show that tbrlp is expressed in almost equal amounts in 
both life cycle stages. RNA molecular weight markers (Sigma) were used in the 
determination of molecular sizes.
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4.10 Summary and Discussion
Using degenerate PCR primers a ras subfamily gene was cloned from T. brucei. Initially 
a fragment (411) was sequenced and then this was complemented with further sequence of the 5’ 
end (462) and the full length gene {tbrlp).
Using degenerate primer PCR, a product of 280 bp (93 amino acids) was amplified from 
T. brucei specific cDNA. Based on mammalian ras gene sizes (Barbacid, 1987), 411 appeared 
to account for approximately a third of the full length gene minus the 5’ and 3’ ends. The 5’ end 
sequence was determined by using the 5’ RACE technique and a primer for the spliced leader. 
PCR products from the reaction were cloned into the TA cloning vector and screened for the 
expected insert size, i.e approximately 200 bp. Using this method a clone, 462, with the expected 
insert size was isolated. Clone 462 has an open reading frame (ORF) of 195 bp (65 amino acids) 
and a short untranslated region of 56 bp precedes the start codon (ATG). The 3’ end of 462 has 
an overlap of 86 bp with the 5’ end of 411. A number of methods were used in the determination 
of the 3’ end sequence of 411. The final sequence was derived from two PCR-based methods: 1) 
Chromosomal walking and 2) Long range PCR. The 3’ sequence obtained by these methods were 
almost identical. The observed differences may have been due to the use of different strains, or, 
sequencing errors. Primers for the 5’ and 3’ ends of 411 were designed and used in the 
amplification of the full length gene from T. brucei strain TREU 927 genomic DNA, which was 
named Trypanosoma brucei ras-like GTP-binding protein or tbrlp.
tbrlp has an open reading frame of 681 bp (227 amino acids) which contains all the of 
the conserved sequence motifs characteristic of the ras GTPase superfamily (i.e 3 
phosphate/magnesium and 3 guanine nucleotide binding sites) and a predicted molecular size of 
25 kDa. The GTP-binding domain has 45 % and 41 % amino acid sequence identity to human 
rap 2 and H-ras subgroup genes respectively. The percentage amino acid identity of tbrlp to 
other members of the ras superfamily is less than 35 %. This is to be expected as the ras 
superfamily is made up a divergent group of genes with an interfamily sequence similarity of less 
than 50 % (Zerial and Huber, 1995). tbrlp is a novel ras-like GTPase, that has not previously 
been cloned from T. brucei. It has several unique features; the presence of glutamine (Q) in the 
PM 3 binding domain classifies it as a ras subgroup member. The C-terminal extension region 
has a sequence preceding the CAAX box, which has the consensus sequence for a cAMP 
dependent protein kinase A phosphorylation site i.e BBxS/T (where B is a basic amino acid, x is 
any amino acid , S is Serine and T is Threonine) (Lapetina et al, 1993). This phosphorylation 
site is characteristic of members of the rap subgroup e.g human rap lb (Bokoch, 1993). Three 
mammalian ras subgroup members are known to undergo phosphorylation by both Protein
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kinases A and C. rap GTPases are phosphorylated solely by Protein kinase A, therefore the 
presence of the consensus sequence for a cAMP dependent phosphorylation site indicates that 
tbrlp has rap subgroup features. The CAAX box is essential for the subcellular localisation of 
members of the ras subfamily members. Members of the mammalian ras and rap subgroups are 
known to exist in an antagonistic relationship (Kitayama et al, 1989; Cook et al, 1993) and are 
never found within the same subcellular fractions (Zerial and Huber, 1995). A general rule to 
determine the exact mode of post translational modification exists for both ras and rap subgroup 
members. If the X of the CAAX box is leucine (L) or phenylalanine (F), the protein undergoes 
geranylgeranylation, which is characteristic of members of the rap subgroup. On the other hand, 
if X is serine (S), cysteine (C), methionine (M) or glutamine (Q), the protein will be famesylated 
(Moores et al, 1991; Bokoch and Der, 1993). Ras subgroup members normally undergo 
famesylation. The X of the CAAX box of tbrlp is leucine, which is characteristic of rap 
subgroup members. Thus there are characteristics of both ras and rap genes interspersed 
throughout the sequence (refer section 4.7, Figure 4.13).
A number of approaches were taken in order to investigate the presence of closely related 
genes and other copies of tbrlp in the T. brucei genome. High stringency hybridisation using 
clone n~ 411 as a probe indicated that tbrlp could be a single copy gene on the basis that multiple 
bands generated from other identical genes were not observed on the autoradiograph (see Chapter 
4, section 4.8, Figure 4.14). However it did not eliminate the possibility that there could be more 
than one copy tandemly linked. Low stringency Southern blotting was used as a second approach 
and the results indicated that there are no other genes related to tbrlp in T. brucei. Southern blots 
of three different strains of T. brucei genomic DNA, namely, STIB 247, STIB 386 and TREU 
927, identified a Pst I polymorphism. Surprisingly, PCR amplification of tbrlp, using a 5’ and 3’ 
primer, generated two fragments, a 681 bp fragment corresponding to tbrlp and a 1.4 Kb 
fragment. Re-amplification of the gel purified 1.4 Kb bands, using the same primers, also 
resulted in two products, the 681 bp and the 1.4 Kb bands. The reamplification of the 681 bp 
band from the gel purified 1.4 Kb fragment suggested the presence of a second tandemly linked 
copy of tbrlp. The putative second copy was named tbrlp II, so as to distinguish it from the 
original gene, tbrlp I. Re-examination of the restriction fragment patterns showed that they were 
consistent with the presence of a second copy as long as tbrlp II was upstream of tbrlp I. The 
DNA sequence of a short region at the 5’ and 3’ end of the 1.4 Kb fragment confirmed the 
presence of an identical second copy. Northern blot analysis was used to determine the stage 
specificity of the expression of tbrlp I and showed that the gene is expressed in both bloodstream 
and procyclic life cycle stages. This suggests that the role of tbrlp I is not confined to the 
bloodstream stage and therefore is unlikely to be involved in host specific signalling systems. The
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result from the Northern blot also suggests that tbrlp might be involved in a basic process which 
is common to both bloodstream and procyclic stages of T. brucei. The ambiguous ras and rap­
like features indicate that tbrlp is an unusual member of the ras subfamily. Its evolutionary 
significance is examined in Chapter 5.
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Chapter 5 
Evolutionary analysis of tbrlp I
CHAPTER 5
THE EVOLUTIONARY ANALYSIS OF tbrlp I
5.0 Introduction
A ray-like gene, tbrlp I, with an open reading frame of 681 bp, was cloned and sequenced 
from T. brucei. It has all the conserved sequence motifs characteristic of a member of the ras 
GTPase superfamily in addition to a number of unusual features. The GTP-binding domain of 
tbrlp I has respectively 45 and 41 % amino acid identity to the GTP-binding domains of human 
rap 2 and H-ras subgroup genes.
Analysis of the nucleotide and peptide sequences of tbrlp I showed that it was difficult to 
determine the exact subgroup to which it belonged. There is one main distinguishing feature 
between ras and rap genes, i.e the presence of a threonine in rap genes instead of a glutamine in 
the PM 3 domain, as is found in ras subgroup genes. This feature is thought to be involved in the 
modulation of the GTPase activity of ras and rap subgroup GTPases (Der et al, 1986a). In 
addition to the difference in the conserved ray-like or ra/7-like amino acid in the PM 3 domain, 
there are a number of conserved amino acids found in either ras or rap GTPases but not both, 
which are essential for normal ras or rap activity. Figure 5.0 is a schematic diagram showing the 
conserved amino acids in the GTP binding domains common to both ras and rap, the amino acids 
essential for normal functioning of ras and rap respectively and the conserved amino acids which 
are either ray-like or ra/?-like in tbrlp I. Due to the rap-like features of tbrlp I, e.g 9L and44VE45 
(numbers in superscript indicate the amino acid positions in tbrlp I’s sequence), it could be placed 
within the rap subgroup, but equally, some ray-like features e.g 61 QD62 and some single amino 
acids that are conserved in ras subgroup genes, e.g 73R and 138F, indicate that it could be placed 
within the ras subgroup. This suggests that it may have an interesting evolutionary relationship 
with the ras and rap genes of higher eukaryotes. The evolution of tbrlp I could have occurred in 
a number of ways. To examine the evolutionary origin of tbrlp I, the possible hypotheses 
explaining the evolution of a ras subfamily member with mixed features, will be presented, tested 
and discussed in the following sections. As functional data is not yet available for tbrlp I, only 
DNA and amino acid sequence analysis will be considered.
143
FIGURE 5.0
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Figure 5.0 is a schematic diagram showing the amino terminus of one ras (c-ras) and one rap gene (Krev-1). These genes 
represent typical sequences of ras and rap genes. On the bar diagram the white areas represent identical amino acids in both 
ras and rap genes, the lightly shaded regions represent amino acid differences between ras and rap and the regions shown in 
black represent amino acids that have undergone conservative changes. A consensus sequence showing the ammo acids common to 
both ras and rap genes is presented below the Krev-1 sequence. The dashes represent the ammo acid differences between the two 
genes. The sequence of tbrlp is presented below the consensus sequence showing the amino acids common to both ras and rap 
genes. The underlined amino acids represent the presence of either ras like (A) or rap like (*) residues in tbrlp and highlights the 
alternation between ras and rap residues essential /Wra/>effector mteractions. •  represents a ras like amino acid which is 
essential for normal ras-effector interactions; ■ residues common to both ras and rap GTP binding proteins and essential for 
normal raslrap effector interactions; 0 rap like residue, essential for normal rap-effector interactions; 0 the amino acid 
tound in this position in both ras and rap GTP binding proteins is also essential (different ammo acids are conserved in 
both cases) for ras/rap-effector interactions. The amino acid at this position in tbrlp is neither ras like nor rap like.
Adapted from Zhang et al, 1990, Valencia et al, 1991 and Marshall, 1993. c-ras and Krev-1 are from mammalian cells.
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5.1 Small GTP-binding proteins in the trypanosomatids
A total of eleven small GTP-binding proteins have been cloned and fully sequenced from 
two members of the order Kinetoplastida. One ypt, has been cloned from Leishmania (Cappai et 
al, 1993), and one ran and nine rab GTPase genes from Trypanosoma brucei (Field and 
Boothroyd, 1995; Field et al, 1995; El Sayed et al, 1995). To date no genes for small GTP- 
binding proteins of the ras subfamily have been cloned from any of the trypanosomatids. Figure
5.1 shows an alignment, created by the GCG PILEUP program, of the protein sequence of the 
GTP-binding domains of four trypanosomatid small GTPases and that of tbrlp I. A list of the 
accession numbers of the genes used in the alignment are shown below (Table 5.0). The 
alignments clearly show that tbrlp I is a novel small GTPase, which is unrelated to those 
previously cloned from T. brucei and the other trypanosomatids. Table 5.1 shows the level of 
amino acid identity between the cloned trypanosomatid genes and tbrlp I. A number of other 
partial sequences (Expressed Sequence Tag sequences) are available for T. brucei GTPase-like 
sequences and tbrlp is clearly not represented by any of them.
TABLE 5.0
List of accession numbers for trypanosomatid monomeric GTPases
ORGANISM GENE ACCESSION N2
Leishmania major ypt L12031
Trypanosoma brucei ran U17085
Trypanosoma brucei rab 4 T26881
Trypanosoma brucei rab 5 T26882
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lypt K . L L I - - T - - - - - C - L L R F A D D S Y T
tbrabA K - I - V - - S - T - - - - - L H R F - E 1) 1 - S
tbrabS T - L - - E s S I A L R F A - - E - S S N
tbran F K . . L V - - - - T - - T T F V K R H L T G E - E
tbrlp N L V V L G D G G V G K S S L I I Q Y V R N R F V V K
lypt I S G V D F F T K I R T L
tbrab4 A Q - - G V E F F T G S K I I
tbrabS T T - - G A A F L S R S - T - S - T L Q S G G G G A V A
tbran V - - V G V - - H P L T F
tbrlp E A T I E D V Y Q K A V E V D A
lypt L E S K V I K - Q - W - - A - - E R - R T I T S S - Y - G
tbrab4 L S G R R I K - Q - w - - A - - E R Y K S V T R s - Y - G
tbrabS A A S G T I K F E - w - - A - - E R Y R s L A P I - Y - G
tbran T N R G K I C F N C w - - A - - E K - - - L - D G - Y I E
tbrlp Q P T V L T I V D T S G Q D V F G G M R Y K Y I R K
lypt A I I D T T M N N V _ T W L S F
tbrab4 A V - C L I - - 0 I T E R T - Y E S V P Q W L N F
tbrabS A C F T - A L V - - D I T S - - - L K K A Q M W M R
tbran G Q C A - I M F D - T s R N T Y K N V P N w - R
tbrlp C H G V I L V Y S V I D A E S F S H I K A I H T Q L C
lypt T E I E K Y A - E N V N K I - - - - - C - L - T K K A V
tbrab4 T D V R Q L A G - D V V V M - I - - - S - M S - M R A V
tbrabS E L R A N A D P T L L I I K - M E s L R Q V S
tbran D I T G V C D N - - I - - - - - - - - C A
tbrlp R A R G S P S I P C V L V G N K V D E V K H R A V
lypt D T Q M A - 0 F - D S L G I - F - T S K
tbrab4 Q H N E A s L F - L E N K L L H F T s S
tbrabS Y E D G A - V A Q F T E E D V N G F F - s -
tbran E R Q V K - K M I T F H Q K G L Q Y Y 0  I s S
tbrlp S s E E A S K F A A Q F M Y p L L E V T A K D
Figure 5.1 shows an alignment of the GTP binding domains of tbrlp I and four other 
trypanosomatid ras like genes, Leishmania ypt, and T. brucei ran, rab A and rab 5. The 
bordered areas correspond to the six highly conserved regions of the GTP binding domain, 
characteristic of members of the ras GTPase superfamily. The dashes indicate identical 
amino acids and the dots indicate gaps in the sequence.
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TABLE 5.1
Level o f amino acid identity of the GTP binding domains o f cloned trypanosomatid
genes to tbrlp I
ORGANISM GENE AMINO ACID IDENTITY (%)
Leishm ania major yp t 26%
Trypanosoma brucei ran 20%
Trypanosoma brucei rab 4 23 %
Trypanosoma brucei rab 5 22%
5.2 Hypotheses explaining the origins of tbrlp I
A number of possible hypotheses could explain the evolutionary relationship of tbrlp I 
with other ras-like GTP-binding proteins. These hypotheses are presented and discussed in the 
following sections.
5.21 Genetic recombination
T. brucei has been shown to be capable of undergoing genetic exchange (Tait, 1983; Tait 
and Turner, 1990; Sternberg and Tait, 1990; Gibson, 1995; Swindle and Tait, 1995). Genetic 
recombination (i.e a recent event in evolutionary terms), therefore, could be a plausible 
explanation of the evolutionary origins of tbrlp I. If the mixed characteristics of tbrlp  I occurred 
as a result of genetic recombination, then the following predictions can be made: (1) Different 
stocks of T. brucei would not necessarily possess tbrlp, but may have ras and rap homologues i.e 
tbrlp  I would be isolated from some stocks but not others; (2) The GTP-binding domain would 
not have interspersed ras and rap-like features throughout, i.e one part of the domain would be 
ras-like and the other part rap-like. Figure 5.2 is an illustration of the results that would be 
expected if the origins of tbrlp I could be accounted for by genetic recombination.
148
FIGURE 5.2
1(A)
ras
rap
Genetic recombination ras
rap
1(B)
ras
rap
no genetic recombination
rap
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GTPBD GTPBD
Figure 5.2 is an illustration of the expected results, which could be used in to explain the 
evolutionary origins of tbrlp I. If tbrlp I originated as a result of genetic recombination, then one 
would expect to find it in one stock (1(A)), but not the other. (1(B)). Genetic recombination would 
most likely result in a gene with a GTP-binding domain arranged in blocks rather than interspersed, 
as illustrated in 2 (A) and (B). r — ~~i - denotes ras like features and ■■■■ - rap like features.
GTPBD - GTP binding domain.
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5.22 Recombination as a result o f  an ancient evolutionary event
The evolutionary origins of tbrlp I could have been as a result of a recombination event 
in an ancestral kinetoplastid. If this hypothesis is true then three predictions can be made, (1) all 
kinetoplastids should have a tbrlp I like gene; (2) other ancient eukaryotes, i.e more ancient than 
the kinetoplastids, (e.g Giardia) should have both ras and rap genes; and (3) the GTP-binding 
domain should have ras and rap features in blocks rather than being interspersed (see Figure 
5.2).
5.23 Ancestral insertion o f a GTP-binding domain
Evolution occurs as a result of the modification of genes. The modification of a gene 
usually occurs as a result of a mutation (or a number of mutations). At the DNA level, four main 
types of mutations occur, transitional, transversional and the insertion or deletion of individual 
nucleotides (or a whole block of nucleotides). Insertions and deletions are found to occur 
frequently in evolutionary time.
The origins of tbrlp I could therefore be explained by an ancient evolutionary event, 
which could have resulted in the deletion and subsequent insertion of a ras GTP-binding domain 
into a rap gene or vice versa. The prediction from this hypothesis is that, a gene with mixed 
features should, for example, have a ras-like amino terminus, a rap-like GTP-binding domain and 
a ray-like carboxyl terminus. Figure 5.3 is an illustration of the result of an ancestral insertion of 
a ray-like or rap-like GTP-binding domain into a rap and ras gene respectively.
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FIGURE 5.3
(A)
ras like amino- like GTPBD ras Iike cartoxyl
terminus    ■ i terminus______
(B)
rap like amino- ras |ike GTpBD raP like carboxyl
t e r m i n u s  , ..i .. ,  terminus______
Figure 5.3 (A) is a schematic diagram of a typical ras gene, with a rap like GTP-binding domain (GTPBD). 
(B) is a schematic diagram of a typical rap gene with a ras GTP-binding domain (GTPBD). Both of which 
could have been as a result of an ancestral insertion of a GTP-binding domain into either a ras or a rap gene 
characteristic of the higher eukaryotes.
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5.24 New member o f the ras GTPase superfamily
tbrlp I could be a new member of the ras GTPase superfamily and co-exist with other 
ras and rap  subgroup members. The prediction of this hypothesis is that, in addition to tbrlp I, 
ras and rap genes would also be detected in T. brucei.
5.25 The evolutionary loss o f either ras or rap
If T. brucei initially had both ras and rap genes, but lost one during the course of 
evolution, then tbrlp  I may have evolved to compensate for the loss of one of the genes. In such a 
case, the sequence of the gene should be predominantly ras or rap-like, with the addition of 
important functional domains of either rap or ras respectively. The PM 3 binding domain of 
members of the ras subfamily is essential for interactions with downstream effectors. Therefore 
if this hypothesis is correct, the resulting gene should have a rap-like sequence with key ras 
residues. The alternative hypothesis would be the loss of a rap gene and the subsequent addition 
of rap functional residues to a ras gene. The result of such a process would lead to a gene 
product with a dual function and should be detected from the gene sequence.
Figure 5.4 (A) is an illustration of a rap gene specific PM 3 binding domain (rap genes 
have a threonine (T) in the PM 3 binding domain, whilst ras genes have a glutamine at the same 
position) with a ras-like carboxyl terminus. 5.4 (B) is an illustration of a ras gene with a ras 
GTP-binding domain, but with the addition of a Protein kinase A specific phosphorylation site 
(characteristic of some rap GTPases), at the carboxyl end.
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FIGURE 5.4
(A)
ras amino- rap GTPBD ras carkoxyl
terminus _____ terminus
I
(B )
ras amino- ras GTPBD mp phosphorylation
terminus ____________________________  Slte
Figure 5.4 A is an illustration of ras gene with a rap specific threonine in the PM 3 binding site 
of the GTP-binding domain (GTPBD) and an additional ras like carboxyl terminus. 5.3 B is an 
illustration of a typical ras gene with a ras specific glutamine in the effector binding domain 
and a rap specific phosphorylation site at the carboxyl terminus. |  - rap specific PM 3 binding 
site; mms& - rap specific (i.e Protein kinase A) phosphorylation site.
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5.26 An ancestral ras subfamily gene
Another hypothesis is that tbrlp I could be a member of an ancestral ras gene subfamily. 
The gene could have been retained in T. brucei, but subsequently evolved by gene duplication and 
divergence into the ras and rap genes of higher eukaryotes. Assuming that, after duplication of a 
primeval GTP-binding domain, the duplicated genes diverged into the ran, rab and ras subfamily 
GTPases, and T. brucei evolved prior to the duplication and divergence of a ras/rap ancestor into 
ras and rap, then T. brucei would possess the ancestral gene in addition to ran and rab GTPases.
The predictions of this hypothesis are: (1) the sequence of the GTP binding domain of 
the ancestral ras!rap gene, should have ras and rap-like features interspersed throughout rather 
than grouped into blocks of ras or rap sequence; (2) Phylogenetic analysis of tbrlp I and the ras 
and rap genes of other eukaryotes, should show a point of divergence intermediate to the ras and 
rap genes and (3) Phylogenetic analysis using rab, ran, ras and rap from higher eukaryotes, 
should show that the ancestral gene diverges from the main evolutionary branch from the ras 
subfamily members to the rab and ran GTPase gene families.
Figure 5.5 is a schematic diagram of the proposed evolutionary pathway of the 
divergence of an ancestral ras/rap gene from a primeval GTP-binding domain, to the ras and rap 
genes of higher eukaryotes. An illustration of the expected results from the phylogenetic analysis 
of tbrlp I (an ancestral ras/rap gene) is shown in Figure 5.6.
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FIGURE 5.5
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Figure 5.5 is a schematic diagram of the evolutionary pathway of an ancestral ras/rap gene, from a 
primeval GTP binding domain (GTPBD) to the rap and ras genes of higher eukaryotes. It shows the 
point of divergence of the ran and rab genes of higher eukaryotes, and the points of evolution of the 
kinetoplastids and other eukaryotes higher up the evolutionary tree e.g Physarum polycephalum. * - 
evolution of the kinetoplastids; ** - evolution of other eukaryotes; | |  - ras like features; J  -rap like 
features.
155
FIGURE 5.6
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Figure 5.6 is a schematic diagram of the expected results from the phylogenetic analysis of 
tbrlp I and other members of the ras GTPase superfamily. If tbrlp I is an ancestral ras/rap 
GTPase gene, then the topology of the tree should show that tbrlp I, diverged from the main 
evolutionary branch from the ras subfamily members to the ran and rab GTPase gene families. 
The point of divergence of tbrlp I (indicated by the arrow), should precede the divergence of ras 
and rap GTPases.
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5.3 Methods used in phylogenetic analysis
The ordered sequence of nucleotide bases, codons and amino acids in genes can be used 
to recover information about the evolution of genes or organisms i.e the phylogeny of those genes 
or organisms. Using phylogenetic methods, the degree of relatedness and difference between 
different genes or organisms can be measured using the basic assumption that closely related 
organisms or genes (based on DNA/protein sequence) are closely related in evolutionary terms. 
The levels of relatedness can be expressed as trees where the branch lengths indicate the degree of 
relatedness and the branch points (or nodes) indicate the possible point of divergence of the two 
branches. Two types of phylogenetic trees can be distinguished: species trees and gene trees. 
Species trees can only be constructed from data originating from functionally homologous genes 
(i.e orthologous genes, Schlegel, 1994). Species trees are meaningless if the data is taken from 
genes which have no proven functional homology. Gene trees, on the other hand, map the 
evolution of a gene (or gene family) and can include other genes with different functions, as long 
as it is clear that those genes have a common ancestor (e.g the GTP binding domain of ras-like 
proteins, Schlegel, 1994). The comparison of the DNA and amino acid sequences of the GTP 
binding domains of tbrlp I and other ras superfamily members, suggests that the genes have a 
common ancestor, i.e the GTP binding domain. Due to this observation, and the current lack of 
knowledge of the function of tbrlp I, only gene trees will be considered for the phylogenetic 
analysis of tbrlp I.
5.31 The process of phylogenetic tree construction
A number of steps must be taken so as to ensure that the results from the analysis will 
produce the maximum amount of information possible. First and foremost, there should be a 
specific hypothesis to test. Based on the hypothesis, one has to determine whether or not, (a) 
there are any suitable sequences available for the analysis, that is to say, are there any closely 
related sequences (i.e with a common ancestor) that can be used in the analysis? (b) a suitable 
outgroup must be picked for the analysis. The use of outgroups in phylogenetic analysis is 
important as it provides both the direction and time scale of evolution on a tree. The divergence of 
the outgroup must antedate the divergence of the branch point in question (Brown and Doolittle, 
1995). Last of all, but not the least, (c) one must choose a suitable tree construction method to 
ensure that the maximum amount of information possible is obtained. To ensure this, the 
following steps must therefore be taken:
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(a) Choice of sequences: The sequences to be used in the analysis should be closely related and 
be able to be unambiguously aligned. With highly divergent genes where considerable levels of 
insertions and deletions have occurred, it is important to use the most highly conserved region of 
a set of closely related genes for phylogenetic analysis (e.g the GTP binding domain of the ras 
superfamily) in order to ensure unambiguous alignment.
(b) Choice of an outgroup: Brown and Doolittle (1995), state that the most suitable outgroup 
would be one from a gene family in which duplication antedates divergence. For the analysis of a 
ras subfamily member, the most suitable outgroup would be any one of the other ras superfamily 
members, e.g. ran or rab.
(c) Choice of a suitable tree construction method: There are three categories of methods 
currently available for tree construction. The first category is made up of a set of methods that 
determine the most parsimonious tree based on the smallest number of mutational changes that 
have occurred between two given extant sequences e.g maximum parsimony (Nei, 1987). The 
second category is made up of the distance matrix methods which are based on a pairwise 
estimation of genetic distance between two or more extant sequences. The pairwise estimation 
normally results in the clustering of related genes based on similar amino acid or DNA sequences. 
The basic assumption of these methods is that all closely related sequences are closely related in 
evolutionary terms. A number of distance matrix dependent tree construction methods are 
currently available e.g UPGMA, neighbor-joining, and Fitch-Margoliash (Nei, 1987). The third 
category is based on a statistical approach. The most commonly used statistical method for 
phylogenetic analysis is the maximum likelihood method. This method determines statistically, 
the tree with the highest maximum likelihood values, based on the minimum number of changes 
required to move from one sequence to another (Schoeniger and von Haeseler, 1993). These 
methods will be discussed in the following sections.
Maximum Parsimony
The maximum parsimony method produces a tree which requires the least number of 
mutational changes (i.e the most parsimonious tree). The most parsimonious tree, is that which 
requires a minimum number of evolutionary changes to explain the observed differences between 
amino acid or DNA sequences. More often than not, several trees are chosen as the most 
parsimonious, this is due to the fact that there are often several ways of going from one sequence
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to another with the minimum number of changes. Maximum Parsimony is a phylogenetic method 
based on one major assumption, which is that evolution occurs in a parsimonious way. A number 
of computer programs are available for maximum parsimony tree construction these include; 
PROTPARS (for protein sequences) and DNAPARS (for DNA sequences). Both programs are 
part of Felsenstein’s PHYLIP package version 3.5c, 1993.
Distance matrix methods:
A number of distance matrix methods are available for tree construction. In the 
following section, three distance matrix methods will be described and the differences discussed.
Neighbour-Joining method
The neighbour-joining method is related conceptually to the UPGMA method (see later). 
The trees are constructed by the successive clustering of lineages and branch lengths are formed 
as the lineages cluster (Saitou and Nei, 1987). However, this method produces unrooted trees 
unless an outgroup is specified and does not have the requirement that all branches evolve at the 
same rate, as does the UPGMA method. A transformed distance matrix is constructed at each 
step of the analysis. The matrix is used to calculate the branch lengths between each pair of 
nodes, based on the nearest neighbour distance from all other nodes. A number of methods are 
available for the computation of distance matrices for the NJ method, such as Jukes-Cantor, 
Kimura two-parameter distance method, Dayhoff PAM or gamma distances. These 
computational methods are needed to correct the observed distances to take into account the 
reversion rate of base or amino acid changes. Any of these distance methods can be used in the 
construction of phylogenetic trees, provided the number of amino acid or nucleotide substitutions 
per site is low (Tateno et al, 1994). The NJ method is found to be more efficient in the 
construction of trees, with the correct topologies, when varying rates of gene substitution occur in 
different branches (Kuhner and Felsenstein, 1994). In computational terms, it is faster than the 
Fitch-Margoliash method.
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Fitch-Margoliash method
This is an additive tree model in which three groups of sequences (also referred to as 
operational taxonomic units or OTUs) are compared at a time. Two OTUs with the least 
evolutionary distance between them are found and designated the letters A and B. The third OTU 
is designated the letter C, which is actually made up of the rest of the OTUs being used in the 
analysis. A and B are then clustered together and subsequently used as a single OTU. A new set 
of three OTUs is picked based on the least evolutionary distance and clustered as previously 
described. This process is continued until all OTUs have been clustered. The Fitch-Margoliash 
method also produces unrooted trees unless an outgroup is specified and can be used in cases of 
varying gene substitution rates (Kuhner and Felsenstein, 1994).
Unweightedpair-group method with arithmetic mean (UPGMA)
Trees constructed using the UPGMA method of Sneath and Sokal, (1973) are rooted, 
distance trees. The rate of nucleotide/amino acid substitution is assumed to be constant and 
therefore the distance measure is proportional to evolutionary time. The evolutionary distance is 
calculated for all pairs of sequences, (which are referred to as operational taxonomic units or 
OTUs). A distance matrix is formed using an average linkage method of clustering, starting from 
the smallest distance. The branch lengths between two clusters is expressed as the average 
distance between all members of the first cluster and all members of the second cluster. A major 
limitation of this method is the lack of compensation for the varying rates of evolution which is 
often observed along different branches.
All of these distance matrix methods are part of the PROTDIST and NEIGHBOR 
programs (for protein sequence) of the PHYLIP package (DNADIST is available for nucleotide 
sequences) (Felsenstein, 1993).
Maximum likelihood method
This a statistical method based on the maximum likelihood of obtaining the actual 
minimum number of amino acid or DNA sequence substitutions required to change from one 
sequence to another. The program chooses the tree with the highest maximum likelihood value.
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Both rooted and unrooted tree can be constructed using this method. The basic assumption of 
this method is that all closely related sequences have unequal rates of evolution. The different 
rates of evolution are therefore taken into consideration when the method is being used. The 
maximum likelihood method for tree construction can be carried out using the PUZZLE program 
(Schoeniger and von Haeseler, 1993; Strimmer and von Haeseler, 1996). The program computes 
maximum likelihood distances in a pairwise manner for amino acid sequences using correction 
methods such as, Dayhoff PAM, Dayhoff (1978).
5.4 Resampling methods
In order to ensure the statistical accuracy of the constructed phylogenetic trees a number 
of resampling methods were considered. Two main methods available for resampling are: 
Bootstrapping and Jackknifmg. Both methods involve the random reassortment of input data 
with the production of trees for each data set. Bootstrapping (Efron and Gong, 1983; Efron and 
Tibshirani, 1991) is the most commonly used method for the statistical analysis of phylogenetic 
trees derived from protein sequences. The method reassorts the input data and produces a tree for 
each set of data . The percentage of the number of times that a particular point of divergence 
occurs in each data set is calculated. High bootstrap values indicate high confidence levels at the 
points of divergence.
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5.5 Procedure for the phylogenetic analysis of tbrlp I
The main concern was to ensure that the results from the phylogenetic analysis were as 
accurate as possible. After considering all the methods available for the inference of phylogenies, 
five of the most commonly used methods for tree construction, and a resampling method were 
chosen for the analysis. Different methods are occasionally known to give different results, I 
therefore decided to use all the methods to ensure that consistent tree topologies and high 
bootstrap values were obtained in all cases.
150 amino acids within the GTP-binding domain were used for the analyses, starting 
from the fifth amino acid after the start codon (methionine) and ending at amino acid number 160. 
This region included all six highly conserved sites within the GTP binding domain. The C- 
terminal extension region of tbrlp I could not be unambiguously aligned with other ras genes, and 
was, therefore, not used in the analysis. Sequences from the GTP-binding domain of ras and rap 
genes from a number of sources were aligned using the PILEUP program. All sequence 
alignments were subsequently checked and manually aligned, if necessary, using the LINEUP 
program of the GCG package. After alignment of the sequences the following steps were taken:
1) TOPHYLIP, an EGCG program was used to format the sequence files into a suitable input 
file for the PHYLIP phylogeny inference programs.
2a) SEQBOOT was used to bootstrap the input file from TOPHYLIP.
2b) Trees were also constructed without bootstrapping and the topologies were compared to the 
bootstrapped ones.
3a) PROTDIST, using the Dayhoff PAM option, was used to generate a distance matrix based 
on amino acid differences.
3b) PROTPARS was used to generate a maximum parsimony tree based on the minimum 
number of amino acid changes between sequences.
3 c) PUZZLE was used to generate a maximum likelihood tree based on the number of amino 
acid changes.
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4) The output files from 3a) and 3c) were analysed using the NEIGHBOR program. Three of 
the options from the NEIGHBOR program were used : NJ, FM and UPGMA. (NJ was used in 
the construction of the maximum likelihood trees).
5) CONSENSE was used to generate consensus trees from the bootstrapped output files of 3b) 
and 4.
6) TREE VIEW, (Page, 1995), was used to redraw the trees to produce slanted cladograms, 
phylograms and radial trees. The data from 3b, 4 and 5 were used to generate trees from 
TREEVIEW. Figure 5.7 is a flow chart of the steps taken in the phylogenetic analysis of tbrlp I.
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FIGURE 5.7
SEQUENCE
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CONSENSE
TREE VIEW
A flow chart of showing the steps taken in the phylogenetic analysis of 
tbrlp I.
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5.6 Testing the hypotheses of the evolutionary origins of tbrlp I.
A number of hypotheses explaining the possible origins of tbrlp I, were presented in 
section 5.2. In order to determine the origins of tbrlp I, these hypotheses were tested to determine 
whether they explain the evolutionary origins of tbrlp I. The results from the tests of each of 
these hypotheses are presented in the following sections.
5.61 Genetic recombination
The hypothesis in this case is that tbrlp I originated as a result of genetic recombination. 
If this is correct then one would expect to find tbrlp I in some T. brucei stocks but not others. 
Tbrlp I has however been isolated and sequenced from two different stocks of T. brucei i.e cDNA 
from strain TREU 869 and genomic DNA from T. brucei strain TREU 927. A PCR product of 
the same molecular size has also been amplified from T. brucei strain STIB 247 genomic DNA. 
One would also expect that the GTP-binding domain of tbrlp I would be made up of a ras-like 
region confined to one end and a rap-like region confined to the other, i.e a hybrid. The sequence 
of tbrlp I does not show such features. The raj-like and rap-like features are interspersed 
throughout the GTP-binding domain. Figure 5.8 is an alignment of the protein sequences of ras 
and rap genes of other eukaryotes, showing the mixed features of the GTP-binding domain of 
tbrlp I.
The results from the test clearly show that the evolutionary origins of tbrlp I are unlikely 
to be attributed to recent genetic recombination.
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5.62 Recombination as a result o f an ancient evolutionary event
If tbrlp I originated as the result of an ancient evolutionary recombination event, the 
following predictions can be made. First, that all kinetoplastids should possess a tbrlp I 
homologue. This is currently not answerable as the presence of tbrlp I has not been examined in 
the other kinetoplastids. The second, that more “ancient” eukaryotes e.g Giardia and 
Trichomonas, should have retained their ras and rap genes. This cannot be currently answered 
as ras family genes have not yet been examined in these organisms. The third prediction is that 
the ancestral recombination event will be recognised as a remnant in the sequence. Thus part of 
the GTP binding domain will have ras-like motifs while the other part will have rap-like ones. 
The sequence of tbrlp I shows that both ras and rap-like features are interspersed, making this 
hypothesis unlikely.
5.63 Ancestral insertion o f a GTP-binding domain
The insertion of a ras GTP binding domain into a rap gene or vice versa would be 
detected from the amino acid sequence. The sequence of such a gene would show a ras (or rap) 
GTP-binding domain flanked by ras (or rap) specific sequence. The sequence of tbrlp I does not 
show such features. The mosaic ras I rap features are interspersed throughout the sequence of the 
GTP binding domain, suggesting that tbrlp I did not originate from an ancestral insertion of a ras 
GTP binding domain into a rap gene, or vice versa.
5.64 New member o f the ras GTPase superfamily
By implication, for tbrlp I to be a new member of the ras superfamily in T. brucei, ras 
and rap homologues would be detectable. Despite the sequencing of 40 PCR products, amplified 
using conserved GTP binding domain primers (see Chapter 4), no other ras-like genes were 
detected. This suggests that no other ras subfamily members were present in T. brucei. The 
possibility exists, however, that the PCR approach may not have detected a ras or rap homologue 
due to small sequence changes. To investigate this a pair of primers were designed which would 
identify and distinguish putative ras and rap homologues. Both primers were designed against 
the PM 3 binding site of tbrlp I. The ras specific primer (named 5’ ras - GAC ACT TCC GGA 
CA) contained an amino acid sequence (CA) which could encode the glutamine residue
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characteristic of ras genes at its 3 ’ end. The rap specific primer, (5 ’ rap - GAC ACT TTC GGA 
AC) contained an amino acid sequence which could encode the threonine residue characteristic of 
rap at its 3’ end. A third primer (3’ con ras - TTT ATT ACC GAC AAG AAC) a conserved ras 
primer, was designed using the highly conserved guanine nucleotide binding site, G2 of the ras 
GTPase superfamily GTP binding domain. Two separate sets of PCR amplifications were 
carried out using 3’ con ras and 5’ ras primers in one reaction and 5’ rap and 3’ con ras primers 
in the second reaction. The distance between the PM 3 and G2 domains is fairly constant 
amongst members of the ras GTPase superfamily and the expected band size from the PCR 
amplification was 200 bp. Figure 5.9 is a diagram showing the primers that were used in the 
amplification and the expected band size which would be produced from tbrlp I, using the ras 
specific primers. In the absence of rap genes in T. brucei. bands would not be expected from the 
PCR amplifications with rap specific primers.
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FIGURE 5.9
GTPBD
NH, COOH
DTSGQ VLVGNK
5’ ras 3 ’ con ras
= 200 bp
The two primers based on the effector domain were the 5’ras shown above and 5’ rap. 5’ 
rap primer had almost the same sequence as the ras specific primer with the exception of 
the last amino acid, which was replaced by threonine, the sequence was therefore 
DTSGT. The sequence of 5’con ras was VLVGNK. The expected band size from both 
amplifications was 200 bp. NH2 - amino terminus; COOH - carboxyl terminus and 
GTPBD - GTP binding domain
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Twelve sets of amplifications were carried out over an annealing temperature range of 35 
- 46° C. Each set was made up of one ras specific and one rap specific reaction. The results are 
shown in Figure 5.10. Using the ras primer, a 200 bp fragment, representing tbrlp I, was 
observed as expected. The rap primer did not produce bands of the expected size showing that a 
sequence corresponding to the rap gene was not present in T. brucei. A high molecular weight 
fragment of approximately 700 bp was observed in a number of tracks when a low annealing 
temperature was used. The fragment was gel purified and sequenced and a subsequent FASTA 
search indicated that it was unrelated to the ras GTPase superfamily and was probably a product 
of mispriming. The reactions which produced the 700 bp fragment were all carried out at 
annealing temperatures of 43° C or below, and therefore, the low annealing temperatures which 
were used could have encouraged the mispriming reaction. This result suggests that tbrlp I is 
probably not a new GTPase subfamily, due to the lack of evidence for the presence of other ras 
or rap genes. However, this cannot be completely ruled out until the entire T. brucei genome is 
sequenced.
5.65 The evolutionary loss of either ras or rap
The predictions of this hypothesis are that tbrlp I would have the basic structure of either 
ras or rap but would have evolved additional domains. The sequence of tbrlp I does not show the 
characteristics of a typical ras gene with a Protein kinase A specific phosphorylation site at the 
carboxyl terminal, nor does it show the features of a typical rap gene with ras-like carboxyl 
terminus. Furthermore the sequence of tbrlp I clearly shows that the ras-like or ra/?-like features 
are interspersed throughout the GTP binding domain. A number of insertions or deletions would 
result in the introduction or removal of blocks of nucleotides and not just single amino acids (see 
Figure 5.0). This hypothesis is therefore unlikely to explain the origins of the mosaic nature of 
tbrlp I.
5.66 An ancestral ras subfamily gene
The last hypothesis considered is that tbrlp I could be an ancestral ras subfamily gene. 
The predictions from this hypothesis are that the phylogenetic analysis of tbrlp I and other related 
sequences should show that, tbrlp I diverges from a point intermediate to ras and rap, and from 
the
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Figure 5.10 is an ethidium bromide stained gel showing the results from PCR reactions carried out to 
determine the presence or absence of ras and rap genes from T. brucei. Two sets of reactions were 
earned out at decreasing annealing temperatures. The annealing temperature range was from 46°C - 
40°C i.e 1 - 7 (Figure 5.10 A) and 39°C -35°C i.e 8-12 (Figure 5.10 B) . Reactions with the ras 
specific pnmers - lanes marked A; and rap - lanes marked B (for each set of reactions). Mwt - 
molecular weight marker.
171
main evolutionary branch to rab and ran GTPases. The final prediction is that the sequence of 
the GTP binding domain of tbrlp I should be interspersed with both ras and rap features. As has 
already been shown, the GTP-binding domain of tbrlp I has interspersed features of both ras and 
rap GTPase genes. The results from the phylogenetic analysis of tbrlp I are presented in the 
following section.
5.66a Phylogenetic analysis o f  tbrlp I
Ras and rap genes, characteristic of those found in higher eukaryotes have been cloned 
and sequenced from a number of lower eukaryotes such as Physarum polycephalum, Entamoeba 
histolytica and Dictyostelium discoideum. These ras and rap genes were used in the 
phylogenetic analysis of tbrlp I. Neither ras nor rap genes have been cloned from any of the 
kinetoplastids with the exception of T. brucei, i.e tbrlp I. The analysis, therefore, could not 
include ras or rap genes from the kinetoplastids. As ras and rap are also found in higher 
eukaryotes, a number of ras and rap genes together with a few other ras superfamily members 
from humans were used in a separate analysis of tbrlp I. Table 5.2 is a list of the genes and 
accession numbers used in the phylogenetic analysis of tbrlp I.
The GTP-binding domain of ras and rap genes (and other ras superfamily members for 
the analysis of tbrlp I and human ras and rap GTPases) from each organism and tbrlp I were 
aligned and used in the construction of four bootstrapped, Neighbor-joining, Fitch-Margoliash, 
UPGMA and Maximum Parsimony trees and four non bootstrapped NJ, FM, UPGMA and MP 
trees for each of the different groups of organisms used in the analysis (trees were also 
constructed using alignments of ras and rap sequences from all the lower eukaryotes used in the 
analyses and tbrlp I). Figures 5.11 - 5.21 show trees constructed by the NJ (non bootstrapped) 
and bootstrapped MP tree building methods. Trees constructed using the FM, UPGMA and 
bootstrapped NJ are not shown. The branch lengths from the trees constructed with the FM and 
UPGMA methods are indicated by non-italics and asterisks respectively at the major points of 
divergence on the NJ trees. The shape of the trees derived from the non bootstrapped trees were 
identical to the bootstrapped trees using the FM, UPGMA and NJ methods and are therefore not 
shown.
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Table 5.2
List o f  the genes and accession numbers used in the phylogenetic analysis o f  tbrlp I
ORGANISM GENE ACCESSION N2
Entamoeba histolytica rap 1 U01051
Entamoeba histolytica rap 2 U01052
Entamoeba histolytica ras 1 U01053
Entamoeba histolytica ras 2 U01054
Physarum polycephalum rap U15594
Physarum polycephalum ras 1 P34729
Physarum polycephalum ras 2 P34726
Dictyostelium rap 1 P18613
Dictyostelium ras M62610
Dictyostelium ras a P03967
Dictyostelium ras ab P03967
Dictyostelium ras b P32252
Dictyostelium ras c P32253
Dictyostelium ras g P15064
Dictyostelium ras s P32254
Human rab la gil31786
Human ral A34387
Human ran P17080
Human rho A P06749
Human rho G S25722
Human yp tz X79780
Human ras h P01112
Human ras k P01116
Human ras 1 PO1118
Human ras n P01111
Human rras P10301
Human rap a P10113
Human rap b P09526
Human rap 2 P10114
Human rap 3 P 17964
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Figures 5.11 and 5.12 show the results of the phylogenetic analysis of tbrlp I and two ras 
and one rap gene from Physarum polycephalum. The tree in Figure 5.11 was constructed using 
the neighbor joining method but other methods generated an identical topology. The numbers on 
each of the branches are the branch lengths derived from trees constructed with (1) the neighbor 
joining method (numbers in italics); (2) the Fitch-Margoliash method (non-italics) and (3) the 
UPGMA method (*) The branch lengths derived from the different methods are almost identical. 
The topology of the tree suggests that tbrlp I diverged at a point which precedes the divergence of 
ras and rap. The maximum parsimony tree construction method, produced a tree which shows 
the same topology as the distance matrix methods. The data were bootstrapped before being used 
in the construction of the tree. The bootstrap values are shown at the points of divergence on the 
tree, (Figure 5.12) and are high, thus indicating a high degree of confidence in branch positions is 
being inferred.
Figures 5.13 and 5.14, are phylogenetic trees derived from using the sequences of the 
GTP-binding domains of tbrlp I and two rap and ras genes from Entamoeba histolytica. The 
branch lengths from the three distance matrix trees i.e NJ, FM and UPGMA (FM and UPGMA 
superimposed on NJ), show approximately the same value for all major branches. The topologies 
of the three distance matrix trees were the same in all cases. Results from each of the trees 
suggest that the divergence of tbrlp I occurred before the formation of the ras and rap subgroups. 
Figure 5.14 is a bootstrapped tree, constructed with the maximum parsimony method. The 
topology of this tree is the same as those of the distance matrix trees. The bootstrap value at the 
point of divergence of tbrlp I into ras and rap is very high. Once again this emphasises a high 
degree of confidence in the trees.
Dictyostelium discoideum has one rap and six ras GTPases. Figures 5.15 and 5.16 
show the results from the phylogenetic analysis of all ras and rap GTPases from D. discoideum 
and tbrlp I. The neighbor joining method was used to construct the tree in Figure 5.15 and 
branch length values derived from the FM - (bold numbers) and UPGMA - (*) methods are 
shown together with the values from the NJ (italics) method. The branch length values are very 
similar and the topologies of the trees are consistent using the different tree construction methods. 
As previously observed, there are two “clusters”, one of ras and the other of rap on either side of 
tbrlp I. This is consistent with tbrlp I being an ancestral ras subfamily gene from which present 
day ras and rap genes diverged. The topology of the tree produced from the maximum 
parsimony analysis of Dictyostelium ras and rap is also consistent with tbrlp being an ancestral 
ras!rap gene. Even though only one rap gene has been cloned from Dictyostelium, the analysis 
shows that it is distinct from the ras genes and therefore clusters away from the ras genes, on the 
opposite side of tbrlp . Bootstrap values of the maximum parsimony analysis of tbrlp I and
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Dictyostelium ras and rap (Figure 5.16) are high and thus provide confidence in the topology of 
the tree.
Trees were constructed by combining data from all the three lower eukaryotes, P. 
polycephalum, E. histolytica and D. discoideum. The results are shown in Figures 5.17 and 
5.18. The branch length values from the FM and UPGMA methods are similar to those from the 
NJ method. The topologies of the trees show a cluster of ras and rap genes on either side of tbrlp 
I and the different tree construction methods gave the same tree topology. The bootstrap values 
are lower than the values on trees obtained when trees are constructed with each of P. 
polycephalum, E. histolytica and D. discoideum separately. This is probably due to the super­
imposition of “gene trees” and “species trees” in this diagram.
The analysis of tbrlp I and human ras and rap was carried out with a number of 
outgroups from the ras superfamily. Figures 5.19 - 5.21 show the results of the analysis. The 
NJ method was used in the construction of the tree (Figure 5.19). The branch lengths from the 
FM and UPGMA methods of tree construction were similar to those from the NJ method, but are 
not shown. The topology of the tree is identical using all methods and shows a cluster of ras and 
rap genes to either side of tbrlp I and it also shows that tbrlp I diverged from the main 
evolutionary branch leading to the divergence of other ras superfamily members. Bootstrap 
values are shown on the maximum parsimony tree (Figure 5.20). Although these values are 
lower, this may be due to the considerable evolutionary divergence of tbrlp I, rab and ran from 
the human ras subfamily members. Figure 5.21 shows the results from the maximum likelihood 
analysis of tbrlp I, showing high bootstrap values and the same topology as has been consistently 
observed. The branch lengths from the NJ method are almost identical to those derived from the 
maximum likelihood method.
The results from the phylogenetic analysis of tbrlp I and ras and rap genes from both 
lower and higher eukaryotes, suggest that the divergence of tbrlp I occurred before the 
duplication and divergence of the ancestral ras I rap gene into ras and rap. The divergence of the 
ran and rab GTPases (and other ras GTPase superfamily members) from an ancestral GTP 
binding domain, occurred before the divergence of tbrlp I from the main evolutionary branch. 
The sequence of tbrlp I shows interspersed features of ras and rap subgroup members. These 
features taken together, satisfy the predictions of the hypothesis that tbrlp I is an ancestral gene 
of ras and rap.
Thus the most likely hypothesis which can be used to explain the origins of tbrlp I is that 
tbrlp I diverged from an ancestral raslrap gene, prior to its duplication and divergence to the ras 
and rap genes of higher eukaryotes.
175
FIGURE 5.11
0.18
0.19
0.24
pprap
ppras
0.24
0.24
0.18
ppras
0.76
0.76
0.77
tbrlp I
0.1
Figure 5.11 shows the results from the phylogenetic analysis of the GTP- binding domains of tbrlp I and all ras and 
rap subgroup members of Physarum polycephalum. The neighbor joining method was used in the construction of 
the tree. The figures shown are branch lengths derived from the analysis of the data, using three different tree 
construction methods. Branch lengths derived from the neighbor joining method (in italics); Fitch-Margoliash 
method (non-italics); and from the UPGMA method (*). ppras land 2 - P. polycephalum ras 1 and 2; pprap 1 and 2 
- P. polycephalum rap 1 and 2.
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FIGURE 5.12
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Figure 5.12 shows the results of the bootstrapped maximum parsimony analysis of the GTP binding 
domains of tbrlp I and all members of the ras and rap subgroups, cloned from Physarum 
polycephalum. The bootstrap values are shown at the major points of divergence. Where ppras and 
pprap refer to P. polycephalum ras and rap.
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FIGURE 5.13
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Figure 5.13 shows the results from the phylogenetic analysis of the GTP-binding domains of tbrlp I and all members 
of the ras and rap subgroups of Entamoeba histolytica (ehras and ehrap, respectively). The neighbor-joining method 
was used in the construction of this tree. The figures indicate branch lengths derived from 1) the neighbor joining 
method (numbers in italics); 2) the Fitch-Margoliash methods (non-italics); and 3) the UPGMA method (*).
178
FIGURE 5.14
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Figure 5.14 shows the results derived from the phylogenetic analysis of the GTP-binding domains 
of tbrlp I and all members of the ras and rap subgroups of Entamoeba histolytica (ehras and 
ehrap, respectively) using the maximum parsimony method. Data was bootstrapped before the 
analysis and the bootstrap values are shown at the points of divergence.
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FIGURE 5.15
tbrlp I
ddrap 1
ddras c
0.24
0.24
0.29*
ddras ab 
ddras a
ddras g
0.05
0.05
0.07*
ddras b
ddras s 0.05
Figure 5.15 shows the results from the phylogenetic analysis of the GTP-binding domains 
of tbrlp I and all members of the ras and rap subgroups of Dictyostelium discoideum (ddras 
and ddrap refer to D. discoideum ras and rap). The tree was constructed using the 
neighbor-joining method. The figures indicate branch lengths 1) from the neighbor joining 
method (numbers in italics); 2) branch lengths from the Fitch-Margoliash method (non­
italics) and 3) branch lengths derived from the tree constructed with the UPGMA method 
(*)■
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FIGURE 5.16
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Figure 5.16 shows the results from the phylogenetic analysis of the GTP binding domains of tbrlp I and all 
members of the ras and rap subgroups of Dictyostelium discoideum (ddras and ddrap refer to D. discoideum 
ras and rap) using the maximum parsimony method. The figures at the different points of divergence are the 
bootstrap values.
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FIGURE 5.17
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Figure 5.17 shows the results from the analysis of all ras and rap subgroup GTP binding domains of tbrlp I and 
three lower eukaryotes, P. polycephalum (pp), E. histolytica (eh) and D. discoideum (dd). The branch lengths 
derived from the use of different tree construction methods are shown on major branches. Branch lengths from 
the neighbor joining method (numbers in italics); Fitch-Margoliash method (non-italics); and branch lengths 
from the UPGMA method (*).
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FIGURE 5.18
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Figure 5.18 shows the results from the maximum parsimony analysis of the GTP binding domains of tbrlp I and 
all ras and rap subgroup members from three lower eukaryotes, namely, P. polycephalum (pp), E. histolytica 
(eh) and D. discoideum (dd). Figures at the major points of divergence are the bootstrap values derived from the 
analysis.
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FIGURE 5.19
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Figure 5.19 show the results derived from the neighbor joining method of tree construction. The GTP binding domains of 
tbrlp I and 15 members of the human ras superfamily (10 of which belong to the ras GTPase subfamily), were used in the 
analysis. Branch lengths preceding major points of divergence are shown.
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FIGURE 5.20
rhoA
rhoG
ran
ypt3
100
rablA
rap2
tbrlp I rap3100
rapB
40
rras
ral
Figure 5.20 shows the results from the maximum parsimony analysis of the GTP binding domains of tbrlp I 
and 15 members of the human ras GTPase superfamily (10 of which belong to the ras GTPase subfamily). 
Bootstrap values are shown at the major points of divergence on the tree.
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FIGURE 5.21
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Figure 5.21 shows results from the maximum likelihood analysis of the GTP binding domains of tbrlp I and 12 
members of the human ras GTPase superfamily (9 of which belong to the ras GTPase subfamily). Bootstrap 
values (in brackets) are shown at the major points of divergence of the tree. Figures for the major branch 
lengths are also shown.
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5.7 Discussion
Six hypotheses were put forward to explain the possible evolutionary origins of tbrlp I. 
Results from the tests on the different hypotheses suggested that the data support only one 
hypothesis for the evolutionary origin of tbrlp I, namely that, it is an ancestral ras subfamily 
gene. Results from the phylogenetic analysis of tbrlp I and ras and rap GTPases from four 
eukaryotes, P. polycephalum, E. histolytica, D. discoideum and humans, confirm that tbrlp I is 
related to an ancestral ras I rap gene. The branch lengths obtained for all sets of trees used in the 
analysis i.e, FM, UPGMA, NJ and ML were almost identical in all cases. The bootstrap values 
on these trees were very high, especially in the case of E. histolytica and P. polycephalum. All 
three predictions of the results from testing this hypothesis were upheld. In all cases, tbrlp I joins 
the tree at a node which designates the divergence point of ras and rap. This suggests that tbrlp 
I diverged from the ancestral ras/rap gene. The trees from the analysis of members of the human 
ras superfamily and tbrlp I showed that tbrlp I diverged from the main evolutionary branch to 
ran and rab GTPase genes (and other ras GTPase superfamily members). The sequence of the 
GTP binding domain of tbrlp I is also consistent with that of an ancestral ras/rap GTP binding 
domain. It has features of ras and rap interspersed throughout the sequence. In addition to this 
unique feature, it also retained all of the sequence motifs of a GTP binding domain, which are 
necessary for its classification as a ras GTPase superfamily member and its function as a 
GTPase protein.
Results from the evolutionary analyses of tbrlp I, therefore suggest that after the 
duplication of a primeval GTP binding domain, the genes diverged into present day rab, ran and 
rho GTPases. Subsequent to that, further duplication and divergence events resulted in the 
generation of ras and rap from a tbrlp I like ancestor. The uptake of endosymbionts (which 
resulted in life forms with mitochondria) possibly also occurred at this point in time, as most 
universal trees show that the kinetoplastids were one of the first organisms to diverge after the 
acquisition of mitochondria (based on the rRNA tree of life, Fernandes et al, 1993; Schlegel, 
1994; Vickerman, 1994; Maslov and Simpson, 1995). T. brucei probably evolved from the main 
lineage before the divergence of the ancestral ras/rap gene into ras and rap. This would account 
for the absence of ras and rap GTPase genes in T. brucei, as they had not diverged at that time, 
and based on this we would predict that they would also be absent from organisms more ancient 
then T. brucei. The higher eukaryotes from the Physarales upwards, therefore must have evolved 
after the divergence of the ancestral ras/rap gene into the current ras and rap genes of higher 
eukaryotes. Both ran and rab GTPases genes have been isolated from T. brucei suggesting that 
both ran and rab GTPase genes had already diverged from a primeval GTP binding domain at
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the time T. brucei evolved. If this hypothesis is correct, tbrlp I homologues should be present in 
all of the kinetoplastids and organisms more ancient than the kinetoplastids, i.e Giardia, and the 
Trichomonids. Based on this hypothesis, one could conclude that ras and rap genes are also 
absent from other kinetoplastids, however, if ras and rap genes are isolated from these organisms 
in the future, it would imply that the hypothesis explaining the origins of tbrlp is invalid.
There is reason to believe that tbrlp I diverged from the ancestral ras/rap gene, but, its 
function still remains unknown. It would be interesting to determine the role of tbrlp I in the 
development of T. brucei. Both ras and rap are known to be involved in growth regulation and 
differentiation of cells in other eukaryotes (Barbacid, 1987). There is also documented evidence 
of the antagonistic relationship between human ras and rap GTPase proteins (Lerosy, 1991; 
Nassar et al, 1995; Sprang, 1995). It would be interesting to find out whether tbrlp I has an 
autoregulatory function (due to the presence of the cAMP dependent protein kinase A 
phosphorylation site at the carboxyl terminus) which results in the initiation or termination of ras 
induced reactions and the physiological processes of T. brucei that it might affect. The sequence 
of the PM 3 binding site, suggests that tbrlp I might interact with downstream effectors in the 
same manner as a “true” ras subfamily member. However, if subsequent biochemical analysis of 
the expressed protein, show that it is phosphorylated solely by Protein kinase A, it would suggest 
that tbrlp I is activated in a ra/?-like manner. The X of the CAAX box of tbrlp I is Leucine (L). 
Rap GTPases normally have a leucine residue at this position and the action of rap GTPases is 
dependent on the translocation of the protein from a membrane to the cytosol. The presence of 
leucine in the same position in tbrlp I suggests that its function is also dependent on the 
translocation of the protein from a membrane to the cytosol. To gain a greater understanding of 
the evolution of tbrlp I and its function, tbrlp I was expressed as a fusion protein and, a 
conjugated peptide was synthesised in order to raise tbrlp I specific anti peptide serum. These 
studies are described in Chapter 6.
188
Chapter 6
Development of tools for functional analyses of tbrlp I
CHAPTER 6
DEVELOPMENT OF TOOLS FOR THE FUNCTIONAL ANALYSES OF tbrlp I
6.0 Introduction
A gene, tbrlp I, with the characteristics of two members of the ras subfamily {ras and 
rap), was cloned and sequenced from T. brucei. Results from the evolutionary analysis of tbrlp 
I, suggest that it is an ancestral ras/rap gene. Studies of the functions of ras and rap subgroup 
members in higher eukaryotes, have shown that the proteins are involved in cellular growth and 
differentiation. Ras and rap GTPases are known to have an antagonistic relationship, i.e ras 
GTPase activity is terminated when rap is activated and vice versa. An example of this 
relationship is the ability of a mammalian rap GTPase to suppress the phenotypic transformation 
of cultured cells induced by K-ras (Kitayama et al, 1989). The sequence of tbrlp I shows that it 
is definitely a ras subfamily member which suggests that it could be involved in cellular growth 
regulation. However, due to its mixed features, it is not clear whether its function is 
predominantly ray-like, ra/7-like or a combination of both.
The aim of this section of the project was to develop tools which can be used for 
functional analysis of tbrlp I. Two approaches were taken: the first approach was the expression 
of tbrlp I as a fusion protein and the second approach was, the production of tbrlp I - specific 
anti -serum. These approaches would provide reagents which could be used for subcellular 
localisation and functional analysis of the native protein.
6.1 Methods available for the production of fusion proteins
A number of systems were considered for the expression of tbrlp I as a fusion protein. It 
was decided to try three of the most commonly used methods, namely, the Glutathione -S- 
transferase (GST) gene fusion system, the maltose binding protein fusion protein system, and the 
Qiaexpressionist (histidine tag) system. These systems are based on the integration of a cloned 
gene into an expression vector and the subsequent expression of the gene as a fusion protein. 
Each system provides a unique domain which forms part of the fusion protein. In the GST 
system, the gene to be expressed is fused with Schistosoma japonicum GST while in the case of
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the maltose binding protein system the gene is fused to the maltose binding protein of E. coli, 
which is encoded by the malE gene. The Qiaexpressionist system allows the expression of 
proteins that are fused to six histidine residues provided in the vector construct. Each system has 
a specific affinity method for the purification of the expressed proteins and the fusion protein can 
be cleaved at a factor Xa or thrombin cleavage site using the appropriate protease, thus allowing 
the preparation of pure recombinant protein. In order to maximise the probability of expressing a 
soluble fusion protein, both the full length tbrlp I gene and a truncated portion lacking the C- 
terminus were inserted into all three expression vector systems.
6.11 Development o f  a PCR method fo r  rapid checking o f  the orientation o f inserts
To facilitate the analysis of transformants, a more cost effective and less time consuming 
method than DNA sequencing was developed for the screening of colonies by direct PCR. The 
colonies were lysed and the DNA denatured in a microwave for two minutes (Kilger and Schmid,
1994) followed by resuspension in an adequate amount of 11. lx  PCR mix (refer Materials and 
Methods) and the gene specific primers required for the amplification of the insert. Using the 
vector forward primer and a gene specific reverse primer, positive amplification of a specific 
fragment indicated the presence of the correct insert in the correct orientation (see Figure 6.0). 
As a negative control, vector forward and gene specific forward primers were used (i.e both 
facing the 5’ —>-3’ direction) so that the presence of a PCR product would indicate that the insert 
was in the wrong orientation. Using this method, many colonies could be screened 
simultaneously and results were normally available at least three hours from the beginning of the 
procedure. Table 6.0 provides a list of all the gene specific primers used in the expression 
analysis of tbrlp I as a fusion protein, some of which were also used in determining the 
orientation of the insert. Figure 6.0 provides a diagram showing the results expected from the use 
of gene and vector specific primers in determining the orientation of tbrlp I within the vector.
190
Table 6.0
List of gene specific primers used in the expression of tbrlp I as a fusion protein.
Gene specific primers Sequence
5’ tbrlp ATG AGG AAT ATT AAC CTC GTC GTT TTG GGT
5’ tbbam CGC GGA TCC AGG AAT ATT AAC CTC GTC
5’ Ecotb CCG GAA TTC ATG AGG AAT ATT AAC CTC GTC
3’ utbrlp TCA GAG CAT AGT GCA TCC CGA TTT CTT TTT CCT A
3 ’ tbrlp TTG CTT GCC TCT TCA CTA CTC ACC GCA CGG
3 ’ tbsph ACA TGC ATG CTC AGA GCA TAG TGC ATC CCG
3’Xbatb CTA GTC TAG ATC AGA GCA TAG TGC ATC CCG
Vector specific primers used:
1 ) 5 ’ pGEX - GGG CTG GCA AGC CAC GTT TGG TG
2) M13/pUC sequencing primer - CGC CAG GGT TTT CCC AGT CAC GAC
3) malE (5’ pMAL-c2 primer) - GGT CGT CAG CAT GTC GAT GAA GCC
4) T7 (3’ end of bluescript) - CGG GAT ATC ACT CAG CAT AAT G
5) T3 (5’ end of bluescript) - AAT TAA CCC TCA CTA AAG GG
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FIGURE 6.0
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An illustration of the results expected from a PCR method which was developed to determine the 
orientation of the insert in the multiple cloning site (MCS) of the vector. Primers used in determining 
the orientation of the insert were v, vector specific i.e. either pGEX. pMAL or pQE specific, A (any of 
the 5' gene specific primers, refer Table 6.0) and B (any of the gene specific primers, refer Table 6.0). 
Two reactions were performed for each colony that was picked. If the insert was in the wrong 
orientation, the reactions carried out with the situation illustrated in B would not produce a fragment of 
the expected band size.
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6.2 The expression of tbrlp I  as a Glutathione-S-Transferase fusion protein
Two types of inserts were used to make GST fusion proteins containing tbrlp I. The first 
was a truncated version of tbrlp I (referred to as t-tbrlp I), containing the amino terminal, and is 
truncated at a point which is 283 bp 5’ of the first stop codon. The truncated form therefore 
lacks half of the carboxyl terminal extension region. The second insert was a full length copy of 
tbrlp I. Figure 6.1 shows an illustration of the PCR products (i.e the truncated and full length 
forms of tbrlp) and the gene specific primers used in their amplification. The PCR products were 
non-directionally ligated into the Eco RI site of pGEX-5X-3 (as described in the manufacturers 
manual, pGEX-5X-l and 2 were also used to ensure that the insert was cloned into the right 
vector). Transformation with t-tbrlp I was successful and 8 colonies were picked. DNA was 
extracted from overnight cultures, digested for 1 hour with Eco RI and the DNA separated on a
1.5 % agarose gel. Figure 6.2 shows that 6 out of 8 clones (lanes 2-7) possessed inserts of the 
expected size (i.e 398 bp). Wizard minipreps of the 6 clones were prepared and each one was 
sequenced to ensure that they were in the right frame. However, the results showed that all 6 
inserts were in the wrong orientation.
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FIGURE 6.1
(A)
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t-tbrlp I
Figure 6.1 is an illustration of the gene specific primers (A, B & C) used in the amplification of tbrlp I, a 681 
bp PCR product and X-tbrlp I, a 398 bp product. A -5’ tbrlp I; B - 3’ tbrlp I; C - 3’utbrlp I (refer section 6.11, 
for primer sequences). NH2 - amino terminus; -COOH - carboxyl terminus; 3’-end - i.e the 3’ end of tbrlp I 
minus the carboxyl terminus. The PCR product illustrated in (A) is tbrlp I and that in (B) is X-tbrlp I (i.e 
truncated tbrlp I).
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IGURE 6.2
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Figure 6.2 shows a 1.5 % ethidium bromide stained agarose gel of 8 EcoR  I digested clones, 6 ot 
which had the expected insert size, i.e 398 bp (lanes 2-7). Mwt - 1 Kb ladder.
195
The procedure was repeated, using non-directional cloning with the full length tbrlp I insert. 
Figure 6.3 shows a photograph of Eco RI digests of DNA (separated on 1.2 % agarose gels) from 
twelve transformants produced from the ligation of tbrlp I into pGEX-5X-2. Ten of the 
transformants (lanes 1 & 2, 4 & 5, and 7-12) had inserts of the expected band size (i.e 681 bp). 
However, sequencing showed that all 10 transformants had inserts in the wrong orientation.
To investigate why the cloning process was only generating clones in the wrong 
orientation, the ligated mixture of DNA was tested to ensure that it contained inserts ligated into 
the vector in the correct orientation. Aliquots of the ligation mix were amplified using the 
polymerase chain reaction method with primer combinations from vector and gene specific 
sequences which allowed the distinction between inserts in either orientation. Figure 6.4 is a 
schematic diagram illustrating the PCR strategy used to determine the orientation of inserts in the 
ligation mix and the expected band sizes. Briefly, the strategy entailed using 3 different primer 
combinations: (1) A vector forward primer (V) and a gene specific forward primer (A) which 
would yield no product if the insert is in the correct orientation. If on the other hand the insert is 
in the wrong orientation, a 700 bp product would be expected. (2) Vector forward primer (V) 
and a gene specific reverse primer (B). The expected size of the product with this combination is 
681 bp if the insert is in the correct orientation; and (3 )  A vector forward primer and a gene 
specific reverse primer (C). The expected product size from this combination is 431 bp, if the 
insert is in the correct orientation.
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FIGURE 6.3
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Fig 6.3 is an ethidium bromide stained gel showing the results of Eco RI digests of 12 
transformants. 10 of the transformant, in lanes 1 & 2, 4 & 5 and 7-12 contained the expected 
insert size i.e, approximately 700 bp . Mwt - 1 Kb ladder.
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FIGURE 6.4
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Three primer combinations were used in the PCR amplifications (1, 2 & 3). No product was 
expected from the first amplification with primer combination (1) if the insert was in the correct 
orientation. A band of 700 bp was expected if the insert was in the wrong orientation. Primer 
combination (1) was 5'pGEX, a vector forward primer (V) and 5 ’tbrlp, a gene specific forward 
primer (A) (see Figure 6.5. lane 1). Product sizes of 681 bp and 431 bp were expected from the 
amplification reactions with primer combinations 2 and 3 respectively, if in the correct orientation. 
(2) 5 ’tbrlp (A), a gene specific forward primer and 3 ’ utbrlp (B), a gene specific reverse primer (see 
Figure 6.5 lane 4). (3) 5’pGEX (vector forward primer (V)) and 3 ’tbrlp (C), a gene specific reverse 
primer (see Figure 6.5. lane 2). See section 6.11 for primer sequences.
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The PCR products from each of the three pairs of primers were separated on 1 % 
agarose gels. Figure 6.5 is a photograph showing the results from the three PCR amplifications of 
l(il of the ligation mix (template). A positive control product (lane 4), was amplified from TREU 
927 genomic DNA and primer combination (3), alongside the three test reactions. The expected 
band size from the positive control {tbrlp I) was 681 bp. The results from this experiment 
showed that there was a ligation product in the wrong orientation in lane 1. The size of the 
product in lane 2 corresponds to that of an insert in the correct orientation. Lane 3 also shows the 
presence of the insert in the ligation mix. Thus, the results suggest that, the cloning had
selectively removed the representation of the sequence ligated into the vector in the correct
orientation.
To investigate whether inserts could be introduced in the correct orientation during 
cloning, a primer was designed with a restriction site at the 5’ end. The primers, 5’Bamtb and 
3’utbrlp (refer section 6.11 for sequences) were used in the amplification of the insert. The 
amplification reaction was performed with Pfu polymerase and therefore the product from the 
amplification was blunt ended. A product with a 5’ Bam HI and a VSma I site was recovered 
after digesting with Bam HI. However, despite the presence of an insert in the ligation mix, I was 
unable to isolate any clones, which theoretically should have been in the right frame and
orientation, due to the failure of the colonies to grow after transformation.
The results from this approach, suggest that a recombinant protein incorporating tbrlp I 
is either toxic to the host cell or inhibits the normal growth of the bacterial host. Only 
transformants that were out of frame or in the wrong orientation could grow. The simplest 
explanation of this is that leaky expression in the vector resulted in the premature expression of 
the fusion protein and a resulting toxic effect on the host prevented growth of all clones 
containing the insert in the right orientation and frame. To overcome these difficulties, a second 
approach was taken using a different expression vector.
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FIGURE 6.5
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Figure 6.5 shows PCR products separated on a 1 % agarose gel and visualized by ethidium bromide stainmg. The 
products were derived from the following primer combinations; in lane 1, 5 ’pGEX + 5 ’tbrlp; in lane 2, 5 ’pGEX + 
3Tbrlp and in lane 3, 5 ’tbrlp + 3’utbrlp (template used for reactions in lanes 1-3 - ligation mix). 5 'tbrlp +
3 ’utbrlp were used in the amplification of the product in lane 4 from T. brucei 927 genomic DNA.
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6.3 The expression of tbrlp I as a maltose binding protein (MBP) fusion protein
The MBP fusion protein system has two expression vectors, pMAL-c2 and pMAL-p2. 
Both vectors allow the insertion of cloned genes and their expression as fusion proteins linked to 
MBP which is a product of the malE gene of E. coli. The polylinker site of the vector is situated 
downstream of the malE gene and upstream of the lacZa gene. The insertion of a cloned gene 
into the multiple cloning site should therefore result in the disruption of the p-galactosidase a- 
fragment activity, normally present in the vector and thus facilitate the selection of positive 
recombinants plated on Xgal/agar. The expressed protein is linked to the MBP via the amino 
terminal of the protein. Each vector contains a recognition site for Factor Xa between the MBP 
and the inserted gene. The MBP can be cleaved at this site leaving the recombinant protein for 
functional analyses unhindered by the presence of the MBP. pMAL-c2 was chosen for the 
expression of tbrlp I because it is generally found to be more efficient at producing fusion 
proteins than pMAL-p2.
Gene specific primers were designed with 5’ {Eco RI) and 3’ {Xba I) restriction sites 
(sites which are present in the polylinker of pMAL-c2). The primers were used in the 
amplification of tbrlp I from genomic DNA of strain TRJEU 927 and ligated into pMAL-c2. 
Transformations were carried out according to the manufacturers instructions. Twelve 
transformants were picked, but only one (pmtb 2.6) was sequenced from both ends, (using the 
malE primer for the 5’ end of the sequence and M l3 for the 3’ end) and shown to contain the 
sequence corresponding to tbrlp I and to be in frame with MBP. The insert was subcloned into 
Bluescript and sequenced from both ends, to ensure that the sequence corresponded to that of 
pmtb 2.6 and tbrlp I. Glycerol stocks of both clones were prepared and stored at -20° C.
Small scale preparations were made of the pmtb 2.6 fusion protein (see Materials and 
Methods) and five different fractions were isolated: uninduced, induced, insoluble matter, crude 
extract and the crude extract bound to the amylose resin (used in the purification of the fusion 
protein). These were all separated on a 12 % SDS-polyacrylamide gel and stained with 
Coomassie blue in order to identify the expressed polypeptide(s). The predicted size of tbrlp I is 
25 kDa while MBP has a molecular size of 42 kDa, thus the expected size of the fusion protein is 
67 kDa. The results, presented in Figure 6.6, show a polypeptide of 69 kDa in lanes 5 and 6 
suggesting that the fusion protein was being expressed. Molecular size estimations, using the 
GCG programs, are normally based on peptide sequences and processes such as isoprenylation 
and glycosylation are not taken into consideration, therefore, the predicted size of the fusion 
protein may be either slightly higher or lower than predicted. In the case of tbrlp I, the size of the 
fusion protein indicated that the predicted molecular size of the product of tbrlp I may have been
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underestimated. Two polypeptides with molecular weights of 50 and 52 kDa respectively were 
also observed on the Coomassie stained gel. The presence of these polypeptides was initially 
attributed to proteinase degradation and a number of measures were taken to eliminate the 
degradation.
In order to carry out GTP-binding activity studies, a large scale preparation of the fusion 
protein was made and protein concentrations were determined using the Biorad Bradford Assay 
Kit (using BSA as a standard). Extracts of the induced fractions were collected from the column 
and the protein concentrations determined. The fractions with the highest protein concentrations 
were separated on 12 % SDS polyacrylamide gels and stained with Coomassie blue in order to 
determine the molecular weight of the expressed proteins. Due to some smaller bands that were 
observed on the gel from the small scale expression of pmtb 2.6, a cocktail of protease inhibitors 
were used to decrease what was suspected to be proteinase degradation. The column buffer 
contained the following protease inhibitors: 5 mM EDTA, 5 mM Benzamidine, 1 jliM Aprotinin 
and 1 pM Leupeptin.
A Coomassie stained SDS PAGE separation, of fractions of the expressed protein (data 
not shown), showed that there was no significant decrease in the number of smaller polypeptides. 
These could, therefore, be due to initiation at sites internal to the start codon and not protein 
degradation or alternatively be due to the lack of inhibition of E. coli proteinases. This would 
account, to some extent, for the lack of change in the number of smaller polypeptides observed in 
the presence of a cocktail of protease inhibitors. However, the presence of the band with a 
molecular weight which was close to that of the expected band size led me to initiate the next step 
of the project, that is, to determine whether pmtb 2.6 binds GTP.
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FIGURE 6.6
Figure 6.6 shows a coomassie blue stained SDS polyacrylamide gel with the following separated 
samples: lane 1, umnduced pmtb 2.6; lane 3, induced pmtb 2.6; lane 4, insoluble matter; lane 5, 
crude extract and lane 6 crude extract bound to the amylose resin. The 69 kDa band can be seen 
in lanes 5 and 6. Protein markers from NEB were used in the determination of molecular sizes 
of the visualized polypeptides.
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6.4 GTP - binding activity of pmtbs 2.1 and 2.6
All members of the ras superfamily have the ability to bind and hydrolyse GTP. It was, 
therefore, essential to establish whether pmtb 2.6 could bind GTP. Two identical gels loaded with 
the following samples were separated by SDS polyacrylamide gel electrophoresis and assayed for 
GTP binding using the method of Coulter and Hide (1995): pmtb 2.1 (from the set of positive 
colonies picked earlier); the putative GTP binding protein pmtb 2.6; MBP (which served as a 
negative control as it is unable to bind GTP), and the spun detergent extract of bloodstream 
trypanosomes (positive control for GTP binding). Biorad SDS-PAGE molecular weight markers 
were used for the determination of molecular weight sizes. One of the gels was Coomassie 
stained in order to establish the presence of all protein fractions on the gel. Samples from the 
second gel were transferred onto a polyvinylidene difluoride (PVDF) membrane, blocked for 1 
hour at room temperature (RT) and subsequently incubated for 2 hours at RT in [a -32P]GTP. 
After the incubation period, the filter was washed and put to film. Results from the assay (data 
not shown) were negative for pmtb 2.1, 2.6 and MBP, while being positive for the extracts from 
bloodstream trypanosomes (positive control). The results suggest that the fusion proteins from 
pmtb 2.1 and pmtb 2.6 do not bind GTP.
The lack of GTP binding by the fusion proteins could have been due to a number of 
reasons such as (1) MBP is a large protein of 42 kDa and the fusion protein may have refolded 
in such a way that access to the GTP - binding domain by [a -32P] GTP may have been blocked 
by the MBP.
(2) The inability of the fusion protein to bind GTP may be due to the expression of a eukaryotic 
recombinant protein in a bacterial expression system. Biological activity of members of the ras 
GTPase superfamily is dependent on post translational modification of the proteins. The 
bacterial host used in the expression of tbrlp I, i.e E. coli, does not produce prenyl transferases 
which are necessary post translational modification. Expression of the gene within a eukaryotic 
host which does produce prenyl transferases might therefore lead to a biologically active fusion 
protein capable of binding GTP. (3) While the assay of Coulter and Hide (1995) measures 
binding of GTP to some polypeptides in trypanosome extracts, there is no evidence to suggest 
that it measures the binding of GTP to the tbrlp gene product. Thus, although the positive 
control demonstrated GTP binding to trypanosome extracts, the assay may not be a suitable 
assay for detecting the binding of GTP to the tbrlp product. It may, therefore, be necessary to 
further develop the assay to detect GTP binding in a greater range of T. brucei GTP binding 
proteins.
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6.41 Development o f conditions fo r  GTP binding in pmtb 2.6
In order to enhance correct folding of the fusion protein, the experiment described in 
section 6.4 was repeated using additional steps known to assist protein folding in other systems. 
Two gels were run and the proteins transferred onto PVDF membranes cut to size and treated as 
follows: membrane 1 was treated with 6 M urea and membrane 2 with 6 M guanidine-HCl for 30 
minutes at room temperature. The initial incubation period ensures the complete denaturation of 
the proteins. The concentrations of the refolding reagents were decreased by a twofold dilution 
every 10 minutes, until a final concentration of 0.94 M was achieved. On achieving final 
concentrations of 0.94 M for both urea and guanidine-HCl, the membranes were rinsed in 
blocking buffer. This step ensured that all traces of the urea (for membrane 1) and guanidine- 
HCl (for membrane 2) were removed. The membranes were then blocked overnight at 4° C and 
subsequently assayed for GTP-binding (as previously described).
An increase in the intensity of the radioactive bands from the control samples, i.e 
bloodstream and procyclic spun detergent extracts treated in urea, suggested that urea is a better 
folding reagent than guanidine-HCl. Therefore, in order to enhance proper folding, it would be 
better to routinely refold the proteins in urea. However, despite the fact that the urea treatment 
resulted in more radioactivity bound to the positive controls (i.e spun detergent extracts of 
bloodstream and procyclic trypanosomes), the fusion proteins still showed no binding activity. 
The results therefore suggest that, the lack of GTP - binding activity of the fusion protein may 
not be entirely due to poor refolding.
6.42 Factor Xa cleavage of pmtb 2.6
As a Factor Xa cleavage site occurs between the MBP and the inserted recombinant 
protein, cleavage using Factor Xa would release the recombinant protein from the MBP. In this 
form the GTP binding domain of pmtb 2.6, could not be stearically hindered by the MBP and 
therefore might be able to bind GTP.
Two expressed purified samples, pmtb2.6, cyp-6 and a negative control (i.e not affected 
by Factor Xa cleavage) MBP, were subjected to Factor Xa treatment over a period of 36 hours 
with samples taken at 2, 4, 8, 24 and 36 hours, cyp-6 is a C. elegans cyclophilin B isoform, 
which has been expressed as a soluble MBP fusion protein (Page et al, 1996), and can be cleaved 
to a limited extent by Factor Xa. This control was added so as to ensure that the reaction had 
actually occurred as Factor Xa cleavage is unreliable in some circumstances.
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Aliquots of the samples after the 36 hour incubation period with Factor Xa, were run on 
12 % SDS polyacrylamide gels and Coomassie stained to detect the polypeptides. Figure 6.7 
shows a photograph of a 12 % Coomassie stained gel, showing the cleaved and uncleaved, 
positive control; cleaved and uncleaved pmtb 2.6 and “cleaved” MBP. Even though the sample in 
lane 4, i.e cleaved pmtb 2.6, appeared fainter than the uncleaved sample, no cleavage product 
was detected at 25 kDa, which is the predicted size of the recombinant protein without the MBP 
domain, nor was there the expected 25 kDa cleavage product from cyp-6. Samples from the 
Factor Xa cleavage reaction, were taken out at the onset of the reaction, 2, 8, 24 and 36 hrs 
respectively. The samples, plus MBP and factor Xa which served as negative controls, were 
separated on 12 % SDS polyacrylamide gels, transferred onto PVDF membrane, treated with 
decreasing concentrations of urea and subsequently assayed for GTP binding activity. Positive 
control spun detergent extracts of bloodstream and procyclic forms of T. brucei showed GTP 
binding while neither MBP nor any of the fractions of the “cleaved” fusion protein (i.e samples 2 
and 3) showed GTP binding. Factor Xa also did not bind GTP (data not shown). The lack of 
cleaved pmtb 2.6 and therefore GTP-binding ability, could be due to the inefficiency of the 
cleavage reaction by Factor Xa. As there was no evidence of a cleaved product from pmtb 2.6 
(or the positive control, cyp-6), the results from the GTP binding assay were not relevant as in the 
absence of total cleavage, the MBP molecule could still block access of the GTP binding domain 
by [a -32P] GTP.
The inability to remove the MBP domain from the fusion protein, suggested the use of 
another vector for the expression of tbrlp I. As the Qiaexpressionist system has only 6 residues 
of histidine attached to the fusion protein the GTP -binding domain is less likely to be obscured 
by the size of the histidine tag.
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Figure 6.7 shows a Coomassie stained gel of the results from the Factor Xa cleavage 
reaction. In lane 1, cleaved cyp-6 (expected size of cleaved recombinant protein - 25 kDa); 
lane 2, uncleaved cyp-6; lane 3, MBP (not cleaved by Factor Xa); lane 4, cleaved pmtb2.6 
and in lane 5, uncleaved pmtb 2.6.
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6.5 The expression of tbrlp I as a pQE fusion protein
The Qiaexpressionist system was the third approach used in the production of a fusion 
protein from tbrlp I. Primers were designed with 5’ Bam HI and 3’ Sph I restriction sites 
(required for cloning into the vector) and used in the amplification of tbrlp I. The ends of the 
PCR product were digested with Bam HI and Sph I and cloned into pQE 30 (one of the 
qiaexpressionist vectors). Two attempts were made, to produce His-tagged fusion protein using 
the pQE 30 expression vector. Small scale preparations were made (according to the 
manufacturers manual), but in both cases did not become translucent on lysing. This is found to 
be characteristic of insoluble pQE fusion proteins.
The Qiaexpressionist system is known to be extremely sensitive to hydrophobic regions, 
particularly transmembrane sequences and signal peptides. In future a more appropriate 
approach might be to use the truncated version of tbrlp I in the production of the fusion protein. 
The truncated version of tbrlp I lacks the carboxyl terminus and is less hydrophobic than the full 
length gene and may be less likely to form an insoluble protein. A second approach to producing 
a soluble protein would have been to solubilise the proteins (from the full length gene) in either 6 
M guanidine hydrochloride or 8 M urea. The refolding reagents have no effect on the affinity of 
the histidine tag for the affinity matrix and therefore purification of the proteins can still be 
achieved. The process of finding the right conditions for the expression of a truncated form of 
tbrlp I and/or the refolding of the solubilised full length fusion protein was not undertaken due to 
time constraints and thus precluded any further attempts to obtain an active fusion protein of 
tbrlp I.
6.6 Generation of antibodies to tbrlp I
One of the strategies that would be of use for further studies of tbrlp, would be the 
production of anti-sera against tbrlp. The use of anti-serum in immunolocalization, 
immunoprecipitation and functional studies is one of the most commonly used strategies in the 
study of proteins. The failure to produce a tbrlp fusion protein prevented this from being used as 
a source of tbrlp for generating antibodies. As an alternative approach a peptide was synthesised 
from which tbrlp specific anti-serum could be raised and used in further studies of the ras-like 
protein.
A synthetic KLH-peptide was produced for the purpose of raising tbrlp specific anti­
peptide serum (hereafter referred to as anti-tbrlp pep). The peptide used in the production of the
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anti-serum was a hydrophilic 12-mer and designed from the amino acid sequence of the carboxy- 
terminal extension region (i.e the unique region) of tbrlp I (refer Chapter 4, section 4.7, Figure 
4.13). The peptide sequence of anti-tbrlp pep is as follows: SEVRDEVHQLEL. Two rabbits 
were used to produce the anti-peptide serum but as testing revealed that only one of them 
produced any anti-peptide antibodies, only this one will be considered in the following sections.
6.61 tbrlp 1-specific anti-peptide serum
Pre-immune serum taken from the rabbit was stored at -20° C until required for blocking 
studies. Immune serum was obtained after immunisation with tbrlp-pep, followed by four boosts 
at 3-4 week intervals. The reactivity of the resulting anti-serum was tested by Western blot 
analysis of bloodstream and procyclic detergent extracts. Initially the optimum conditions 
required for the testing of the anti-serum were determined. A range of dilutions of the anti-serum 
were tested: 1:200, 1:500 and 1:1000. Two dilutions of the second antibody were used, 1:400 
(manufacturers recommendation) and 1:800. Results from these tests showed that 1:200 of the 
first antibody and 1:800 of the second antibody produced results with a minimum amount of 
background to noise ratio (data not shown). These were therefore adopted as the optimum 
dilutions required for determining the specificity of the reactions.
Figure 6.8 shows the results obtained from Western blot analysis of both the supernatant 
and the pellet fractions of spun detergent extracts (SDEs) of bloodstream and procyclic 
trypanosomes, using both preimmune and immune serum. Three bands with the following 
molecular weights, 23.3 kDa, 26.7 kDa and 30.3 kDa, were detected by the anti-serum and were 
not detected by preimmune serum. The expected size of the protein product of tbrlp I is 25 kDa, 
which falls within the range of the peptides recognised by anti-tbrlp pep. In addition to the triplet 
of polypeptides at 23 - 30 kDa, a series of higher molecular weight polypeptides were detected, 
which were not observed using the pre-immune serum, showing that the immune serum is not 
totally specific to the lower molecular weight polypeptides. Anti-tbrlp pep appears to be specific 
for polypeptides found within the pellet fractions of both bloodstream and procyclic detergent 
extracts and would suggest that tbrlp I is membrane localised. The presence of the polypeptides 
in the pellet fractions of both bloodstream and procyclic detergent extracts, confirms that the 
putative product of tbrlp I is not stage specific, as was shown by the results from the Northern 
blot (Chapter 4, section 4.9, Figure 4.20).
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FIGURE 6.8
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Figure 6.8 shows the results obtained from Western blot analysis of the supernatant and pellet 
fractions of bloodstream and procyclic trypanosomes. Membrane A was incubated in 
preimmune serum and membrane B was a duplicate which was incubated in tbrlp specific anti­
serum. In lane 1 of each of the membranes, bloodstream pellet; lane 2, bloodstream 
supernatant; lane 3, procyclic pellet; lane 4, procyclic supernatant. Mwt - protein molecular 
marker.
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6.62 Peptide blocking studies
Peptide blocking studies were carried out on SDEs of both bloodstream and procyclic 
trypanosomes, to determine whether the three polypeptides of 23.3, 26.7 and 30.3 kDa, are 
specifically recognised by anti-tbrlp pep. The peptide is identical to that used in the production of 
the anti-serum, but unconjugated (hereafter referred to as tbrlp-pep). A 1 mg ml'1 stock solution 
of tbrlp I-pep was prepared, stored at -20° C and used when required. Preliminary experiments 
were carried out to determine the most suitable concentration required for the blocking of the 
polypeptides observed in both SDEs of bloodstream and procyclic trypanosomes.
Figure 6.9 shows results of the peptide blocking studies, which clearly show that a 12 |ng 
ml'1 solution of tbrlp -pep, completely blocks the recognition of the three polypeptides (molecular 
weight masses of 23.3, 26.7, and 30.3 kDa respectively). This confirms that anti-tbrlp pep 
recognises polypeptides of approximately the expected molecular size of tbrlp in trypanosome 
extracts. The higher molecular weight polypeptides, were however, not blocked by the peptide, 
which indicates that they are not tbrlp specific polypeptides. The recognition of the higher 
molecular weight polypeptides might therefore be eliminated by affinity purifying the anti serum. 
What remains to be determined is whether the three bands are due to the presence of the two 
different copies of tbrlp (i.e tbrlp I and II); pre-/post-translational modification products or the 
cross-reactivity of anti-tbrlp pep with other related polypeptides
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Figure 6.9 shows the results from the peptide blocking studies on SDS-PAGE separated total bloodstream 
SDE. Panel A was incubated in a 1:200 dilution of preimmune serum; B, 1:200 dilution of tbrlp specific anti 
serum and panel C in a 1:200 dilution of tbrlp specific anti serum preincubated in 12 p.g m l _1 of tbrlp-pep for 
1 hour at 4°C.
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6.7 Discussion
To generate tools for functional studies on tbrlp, experiments were undertaken to 
construct an active recombinant protein and to generate antibodies against tbrlp I. A number of 
attempts were made to produce a fusion protein. The GST system was unsuccessful in 
expressing a viable fusion protein and the only bacterial colonies that were produced were the 
transformants which had inserts in the wrong frame or inserts in the right frame but the wrong 
orientation. This would suggest that the expressed proteins could have an adverse effect on the E. 
coli host
A fusion protein of the expected size was produced by the maltose binding protein 
system. The fusion protein, however, did not have the ability to bind GTP. This may have been 
due to the GTP-binding domain of pmtb 2.6 being obscured by the large maltose binding protein 
domain. To circumvent this, experiments were undertaken to cleave the recombinant protein 
using the Factor Xa cleavage reaction. This reaction is known to be inefficient in some cases, 
and it was therefore not surprising that attempts, at cleaving the maltose binding protein from the 
recombinant, were unsuccessful. Therefore, the lack of GTP-binding activity of tbrlp I could not 
be unequivocally attributed to an MBP blocked GTP-binding domain. An alternative explanation 
could be the lack of proper renaturation or refolding of the proteins. Using two different reagents 
capable of catalysing protein refolding in other systems, namely urea and guanidine-HCl, proteins 
transferred onto PVDF membranes were refolded and assayed for GTP-binding activity. Results 
from the assay of the positive controls (i.e SDEs of bloodstream and procyclic trypanosomes) 
suggest that the refolding of proteins in this system is more efficient in urea than guanidine-HCl.
The only conclusions one can draw from these results are that the lack of GTP-binding 
activity may have been due to the inability of [a -32P] GTP to gain uninhibited access to the GTP- 
binding domain of the fusion protein or that, the lack of GTP-binding activity may be due to the 
lack of machinery necessary for the production of a fully active fusion protein, i.e the lack of 
prenyl transferases due to the expression of a eukaryotic protein in a bacterial expression system. 
This explanation is particularly appealing, as the sequence of tbrlp suggests that it undergoes 
isoprenylation and therefore might need to be post translationally modified in order for it to 
become active, i.e bind GTP.
Due to the inability to cleave the maltose binding protein from the fusion protein, another 
method was employed to determine whether or not GTP-binding activity could be established in 
the absence of the large MBP. The Qiaexpressionist system was used in the production of a 
fusion protein from tbrlp I. This system was employed as the expressed protein has only 6 
histidine residues attached to it, therefore, if the lack of GTP-binding activity was due to an MBP
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blocked GTP-binding domain, the pQE fusion protein might show some activity, as it is less 
likely to block the tbrlp GTP binding domain. Two attempts were made at the expression of 
tbrlp I as a pQE 30 fusion protein. In both attempts the protein was found to be insoluble. Due 
to the limited amount of time available, these experiments were not carried further. To do so 
would have entailed finding the conditions necessary for the production of a soluble fusion 
protein. However, a number of approaches are available for the solublilisation of the fusion 
proteins, such as the use of decreasing molarities of either 6 M guanidine-HCl or 8 M urea. 
Conditions required to enhance proper folding of the proteins will have to be determined. This 
procedure will not in anyway affect the affinity of the His tag for the Ni-NTA resin which is used 
in the purification of pQE fusion proteins. Another approach would be the use of the truncated 
form of tbrlp I in the production of the fusion protein.
An alternative approach would be the use of a baculoviral expression system, as this 
would result in the production of the protein in an eukaryotic expression system, thus allowing 
the post translational modification of proteins. This is required not only for subcellular 
localisation, but also for the full biological activity of the fusion protein (Willumsen et al, 1984; 
Porfiri et al, 1995). A fusion protein produced in this way could therefore be used to define some 
of the functions of tbrlp I.
Anti-peptide serum raised against a region within the unique C-terminal extension 
domain of tbrlp I, recognised three polypeptides in the pellet fraction of both bloodstream and 
procyclic spun detergent extracts. Recognition of all three polypeptides was competed out by a 
12 p.g ml'1 solution of the unconjugated peptide. This suggests that the anti-serum recognises 
more than one polypeptide within the SDEs of bloodstream and procyclic trypanosomes and 
could be due to the expression of the second copy of tbrlp I. Preliminary sequence analysis of 
part of the putative second copy of tbrlp I i.e tbrlp II, shows a high degree of sequence identity 
which would predict cross reactivity. It is possible that tbrlp II is a different size and could be 
modified in a different way to tbrlp I, and, therefore, could represent one of the polypeptides 
detected by anti-tbrlp pep. However, further sequence data are required to determine this. An 
alternative explanation for the three polypeptides could be the occurrence of pre-/post- 
translational modification leading to products of different sizes, all of which contain the epitope 
recognised by the anti-serum but have different electrophoretic mobilities. Another possibility is 
the degradation of the product of tbrlp I, during sample preparation. The expected molecular size 
of the product of tbrlp I is 25 kDa, which is approximately the same size as one of the 
polypeptides detected by the GTP binding assay described in Chapter 3. However, due to the 
occurrence of several small GTP binding proteins of different subfamilies within the same 
molecular weight range, a number of experiments would have to be conducted in order to
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establish that they are actually the same protein. The immunoprecipitation of the HPLC derived 
fractions with anti-tbrlp pep would be good approach to establishing whether the 24 kDa 
polypeptides are indeed ras subfamily GTP-binding proteins. Affinity purification of anti-tbrlp 
pep on a peptide column would produce a highly specific anti-serum which could be used in the 
determination of the subfamily to which the previously isolated 24 kDa polypeptides (see Chapter
3) belong and in the determination of the subcellular location of tbrlp I.
The next line of approach would be to determine whether or not some of the observed 
bands are due to pre-/post-translational modification products, before embarking on subcellular 
localisation studies. The strategy used by Field et al, 1996, highlighting the presence of an 
isoprenylation pathway in T. brucei, can be used (with a few modifications) to identify the 
products recognised by anti-tbrlp pep. Mevalonate is a key intermediate in the isoprenyl 
biosynthetic pathway from acetoacetyl CoA (Hancock, 1995). The inhibition of the synthesis of 
mevalonate is achieved by inhibiting the enzyme hydroxymethylglutaryl-coenzyme A reductase, 
using inhibitors like compactin and mevinolin (Field et al, 1996). Cells deprived of mevalonate 
tend to take up exogenous mevalonate for the synthesis of isoprenoids and squalene (Field et al, 
1996). Briefly, bloodstream (or procyclic) trypanosomes deprived of mevalonate could be 
incubated in culture with exogenous radioactive mevalonate. After the incubation period, the ras 
protein (i.e tbrlp) could be immunoprecipitated and separated by SDS polyacrylamide gel 
electrophoresis. These results would provide information on the size of the isoprenylated proteins 
recognised by anti-tbrlp pep. A second approach would be to separate the hydrophilic 
(unprocessed) and hydrophobic (processed) fractions (Hancock, 1995) of bloodstream or 
procyclic trypanosomes using Triton X-114. The ras GTPase can then be immunoprecipitated 
from the hydrophilic (which represents the unprocessed i.e non isoprenylated proteins) and 
hydrophobic (isoprenylated proteins) fractions, separated on an SDS polyacrylamide gel and 
detected by Western blotting to determine the state of the proteins (i.e processed or unprocessed) 
and the sizes of bands recognised by the anti-serum. The results from such an analysis should 
provide information on the pre/post translational status of the proteins recognised by anti-tbrlp 
pep.
In order to use the anti-serum in the isolation of native tbrlp I, it would be necessary to 
demonstrate that anti-tbrlp pep recognises the expressed product of tbrlp I. Once this has been 
established, the antiserum could be used in the isolation of native tbrlp I (and/or tbrlp II, if it 
recognises both proteins), which could be used in studying the function of the proteins in T. 
brucei. Results from the Northern analysis and anti peptide binding studies have shown that 
tbrlp I is not stage-specific and the amino acid sequence suggests that it is a membrane bound 
protein. These results suggest that the function of tbrlp I may be essential for a process common
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to both life cycle stages of the trypanosome such as growth and differentiation. If tbrlp I 
functions in the same manner as do ras GTPases of higher eukaryotes (i.e if it is involved in the 
regulation of cellular growth and differentiation) then, the development of tools for the analysis of 
the role of tbrlp I would result in the generation of data which may lead to a greater 
understanding of the mechanisms of trypanosomal growth regulation.
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7.0 General Discussion
The aims of this project were to investigate the presence of small GTP binding proteins 
and, in particular, members of the ras subfamily in Trypanosoma brucei and to develop the tools 
and reagents needed to study the role of ras subfamily GTPases in trypanosomal development. 
Studies in higher eukaryotes show that members of the ras subfamily are directly involved in the 
transduction of cellular signals, which result in the regulation of cell growth and differentiation 
(Hall, 1990; Bokoch, 1993; Bokoch, 1996). The isolation of a member of this subgroup from T. 
brucei would, therefore, be the first step towards the development of tools for the study of the 
role of ras subgroup GTPases in cellular signalling in T. brucei.
The project was divided into four concurrently run parts: (1) The development of a GTP 
binding assay suitable for screening large numbers of fractions generated by HPLC column 
purification methods; (2) The identification of ras like GTP binding protein from T. brucei. 
There were two approaches to this stage: a) the isolation of a ras like GTP-binding protein by 
means of HPLC purification of small GTP binding proteins from bloodstream trypanosomes; and 
b) the isolation of genes encoding ras like GTP binding proteins using molecular methods; (3) 
The evolutionary analysis of a ras like GTP binding protein, tbrlp I and (4) The development of 
tools needed for the study of the role of tbrlp I in the signalling pathways of T. brucei.
The presence of low molecular weight GTP binding proteins in T. brucei was confirmed 
by the in situ GTP binding assay of Coulter and Hide (1995) following polyacrylamide gel 
electrophoresis of trypanosome protein extracts. This assay showed the presence of GTP binding 
proteins within a range of 18 - 35 kDa and is consistent with sizes of members of the mammalian 
ras superfamily (Kahn, Der and Bokoch, 1992). Some of the bands were observed solely in the 
bloodstream or the procyclic extracts suggesting that the proteins are stage specific. A routine 
GTP binding assay was developed for the handling and concentration of large numbers of sample 
using conditions similar to the in situ GTP binding assay of Coulter and Hide (1995). This was 
shown to be suitable for identifying HPLC fractions positive for GTP binding. The first step 
used to purify ras like GTP binding proteins from T. brucei was HPLC anion-exchange 
chromatography. Under specific separation conditions a single 24 kDa polypeptide was identified
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which bound GTP. As protein can be detected down to 10 ng by silver staining (Guillemett and 
Lewis, 1983), the fact that this band could not be visualised on a silver stained SDS 
polyacrylamide gel suggested that there was less than 10 ng of the protein on the gel. Thus, there 
was a need to scale up the amount of starting material to recover suitable amounts of this purified 
GTP binding protein. A survey of a number of studies, in which small GTP binding proteins 
have been purified to near homogeneity (e.g from human placenta and bovine brain extracts, 
Evans et al, 1986 and Waldo et al, 1987), showed that large amounts of starting material are 
required for the purification of a workable amount of small GTP binding proteins. Bovine brain 
is known to contain 5-10 fold more ras GTP binding protein than any other mammalian tissue 
(Yamashita et al, 1988) and an initial amount of 858 mg of crude membrane protein from bovine 
brain produced only 11 pg of small GTP binding proteins. This suggests that to achieve purity 
by the use of successive HPLC chromatography methods, the amount of T. brucei starting 
material needs to be scaled up. The initial protein content of 14 mg of the bloodstream spun 
detergent extract (equivalent to 1 ml of packed bloodstream trypanosomes) resulted in less than 
10 ng of the 24 kDa purified small GTP binding protein. Using the values for human placenta 
for comparison 60 ml of packed bloodstream trypanosomes would be required to produce 11 pg 
of purified GTP binding protein. However, the actual amount of material required would be well 
in excess of 60 ml of packed trypanosomes as a purification protocol would also have to be 
developed. The HPLC purification approach was, therefore, discontinued due to the number of 
rats that would have to be infected to produce 60 ml of trypanosomes (approximately 200) and 
success in other areas.
A heterologous anti-human ras antibody was used to investigate the presence of members 
of the ras subgroup of proteins in T. brucei. Due to the cross reactivity of the antibody, it was 
difficult to interpret the results with any certainty. Future approaches using this method should 
be aimed at developing specific conditions under which this ras antibody reacts specifically and 
testing a further range of antibodies.
The next strategy was to isolate genes encoding ras subfamily GTPases, using 
degenerate primer PCR. This resulted in a 280 bp PCR product from T. brucei TREU 869 
cDNA. The PCR product was used to obtain the sequence of a full length gene, tbrlp, which 
encoded a ras subfamily GTP binding protein.
tbrlp has an open reading frame of 681 bp (227 amino acids) and a predicted molecular 
size of 25 kDa, which is consistent with its classification as a small GTPase. In addition to the 
molecular size, tbrlp has all the conserved sequence motifs characteristic of a member of the ras 
GTPase subfamily. High stringency hybridisation, with the full length tbrlp as the probe, 
indicated that the gene is probably single copy, but a putative second copy was subsequently
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identified using tbrlp specific 3’ and 5’ primers, and appeared to be upstream of, and tandemly 
linked to, tbrlp. The possible existence of tbrlp as a multi copy gene is not surprising as many 
housekeeping genes in trypanosomes are found to be multi copy (Hadjuk et al, 1992; Tschudi,
1995). Due to the existence of a putative second copy of tbrlp, the original gene was named tbrlp 
I and the second gene, tbrlp II. The full length sequence of tbrlp II has not yet been determined 
but preliminary sequence suggests that it will be virtually identical to tbrlp I. Northern analysis 
indicates that tbrlp I is expressed in both bloodstream and procyclic life cycle stages of the 
trypanosome and suggests that it is an essential gene which has a role in processes common to 
both life cycle stages of the trypanosome.
tbrlp  is the first member of the ras subfamily to have been cloned from T. brucei. 
Approximately 10 small GTPases have been cloned and fully sequenced from T. brucei: ran 
(Field and Boothroyd, 1995) and at least nine rab GTPase genes (El Sayed et al, 1995; Field et 
al, 1995). An alignment of tbrlp I and these other ras like genes from T. brucei shows that the 
only sequence identity lies within the six conserved sequence motifs of the GTP binding domain. 
tbrlp I is, therefore, a previously undescribed ras like gene from T. brucei. tbrlp I has some 
novel features which make it a unique ras subfamily member. The GTP binding domain of tbrlp 
has 45 % and 41 % amino acid sequence identity to that of human rap  2 and ras h subgroup 
genes respectively. This feature makes it difficult to classify tbrlp  as either a rap or a ras 
subgroup member. In mammalian cells functional studies of ras and rap  indicate that the two 
proteins exist in an antagonistic relationship (Lerosey et al, 1991; Bokoch, 1993; Altschuler et 
al, 1995; Nassar et al, 1995) and together, they seem to be involved in the regulation of cellular 
growth and differentiation (Hall, 1990; Bokoch, 1996). The existence of this “mosaic” ray-like 
protein in T. brucei, an organism which diverged early in eukaryotic evolution, suggests that the 
protein could represent an ancestral ras/rap gene which existed before the divergence of the gene 
into ras and rap. Due to the mixed features of tbrlp I, phylogenetic analysis was carried out to 
determine its evolutionary significance.
Six different hypotheses were put forward to explain the possible evolutionary origins of 
tbrlp  I. On testing, only one of the hypotheses could be used to explain the origins of tbrlp I. 
The results from the phylogenetic analysis of tbrlp I, using a number of tree building methods, 
showed that tbrlp  I is an ancestral ras/rap  gene. Conversely, this evolutionary analysis of tbrlp I 
suggests that the kinetoplastids diverged at a point prior to the duplication and divergence of a 
primeval GTP binding domain to form the ras and rap  genes of higher eukaryotes but after the 
evolution of rab and ran GTP binding domains. This accounts for the presence of ran and rab 
GTPases in T. brucei. The eukaryotes higher up the evolutionary scale, must, therefore, have 
diverged after the duplication and divergence of the ras/rap  ancestral subfamily gene. This
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hypothesis agrees with the findings of Fernandes et a l, 1993 and Maslov et al, 1995, with regards 
to the order of divergence of the eukaryotes on the SSU rRNA tree of life.
The ras/rap like similarities of tbrlp suggest that it has a role in cellular signalling. To 
investigate this role, a series of reagents and tools were required. These were: a tbrlp fusion 
protein with the ability to bind GTP and tbrlp specific anti-sera (from either the whole fusion 
protein or to a peptide conserved in the variable region of tbrlp  i.e unique to tbrlp) which could 
be used in the determination of the subcellular localisation of tbrlp, immunoprecipitation and 
further functional analyses. Two approaches were taken. The first approach entailed the 
expression of a fusion protein using tbrlp I and three different expression systems were used in 
attempts to produce a suitable fusion protein. Only one of the expression systems, the MBP 
fusion system, produced a soluble fusion protein which lacked GTP binding ability. This may 
have been due to the GTP binding domain of the protein being obscured by the large size of the 
MBP. Factor Xa cleavage of the MBP did not succeed in resolving this question. On the other 
hand the lack of GTP binding could have been due to the fact that tbrlp I is a eukaryotic protein 
expressed in a bacterial system which does not contain the enzymes required for eukaryotic post 
translational modifications. To test this, tbrlp I could be expressed in a eukaryotic expression 
system such as a baculovirus system which contains all the machinery necessary for post 
translational modification e.g prenyl transferases which are not present in E. coli. Recent 
experiments have shown that a viable mevalonate pathway exists in trypanosomes (Field et al,
1996) which is necessary for the production of the conjugated isoprene groups involved in post 
translational protein modification, tbrlp has a carboxyl terminal isoprenylation signal which 
implies that, in order to express a viable and biologically functional protein, all the necessary 
cellular machinery must be made available. A fusion protein produced in such a way could be a 
useful tool for biochemical analyses. GTP binding assays could be carried out on the fusion 
protein, as the fully functional recombinant protein is expected to bind GTP. More specific 
functional analyses on tbrlp I can be carried out once the ability of the recombinant protein to 
bind GTP is shown. Such a protein could also be used in antibody production for 
immunoprecipitation and immunolocalisation studies. These studies could shed light on the mode 
of action and subcellular localisation of tbrlp.
The second approach to developing analytical tools was to raise tbrlp  specific anti­
peptide sera. A peptide was synthesised using the amino acid sequence derived from the carboxyl 
terminal extension region of tbrlp I. Using this anti-serum, anti-tbrlp pep, tbrlp I was detected in 
the detergent insoluble fractions of both bloodstream and procyclic trypanosomes. This result 
suggests that tbrlp I is membrane localised. However, due to the recognition of three different 
polypeptides, it appears as though the anti-serum in its current state does not solely recognise
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tbrlp. Results from peptide blocking studies show that the three bands are effectively blocked 
when the antiserum is preincubated in a 12 pg ml"1 solution of the unconjugated peptide. These 
bands fall within the 17-30 kDa range, consistent with the expected size of tbrlp  I. This suggests 
that, in addition to tbrlp I, the anti-serum recognises other proteins. Preliminary sequence 
analysis of tbrlp II indicate that the sequence is identical to that of tbrlp  I. It is unlikely, 
therefore, that the other polypeptides are due to tbrlp  II. One explanation for the multiple bands 
is that the anti-serum might be recognising pre/post translational modification products of tbrlp I 
which might have the same epitopes as the full length protein but have different electrophoretic 
mobilities.
7.1 Future investigations
In order to carry out further studies on the role of tbrlp  I in trypanosomal development, 
the tools currently available for these studies i.e tbrlp specific anti-serum and a fusion protein, 
would have to be further developed in the following manner: The anti-serum in its present form 
cross reacts with a few high molecular weight peptides and so would need to be affinity purified 
in order to reduce the cross-reactivity with other epitopes. Commercially prepared affinity 
purification kits are currently available and can be used in the purification process. The identity 
of the three bands must be established i.e are they a result of pre-/post translational modification 
products of tbrlp I, tbrlp II or degradation products of tbrlp I, which may have been formed 
during sample preparation? The method used by Field et a l, 1996, which showed the presence of 
an isoprenylation pathway in T. brucei, could be modified and used in the determination of 
pre/post translational modification products (see Discussion, Chapter 6). The use of peptide 
sequencing in the determination of the full length sequences of the three polypeptides could also 
be used to determine the pre/post translational modification status of the polypeptides recognised 
by anti-tbrlp pep.
The full length sequence of tbrlp  II remains to be determined. Primers designed from the 
sequence can be used to amplify the full length gene from genomic DNA. The full length genes 
from tbrlp  I and II could then be expressed as fusion proteins in the baculoviral system. A 
eukaryotic expression system should provide all the machinery necessary for post translational 
modification (i.e prenyl transferases) and, therefore, the expressed proteins should be biologically 
functional. The recombinant proteins could be used in antibody production as there is a 
possibility that antibodies to the recombinant proteins may be more specific than the anti-peptide 
serum.
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Having developed the analytical tools and reagents, a number of questions have to be 
addressed in order to shed light on the function of tbrlp: (a) Does it bind and hydrolyse GTP? (b) 
Is tbrlp essential for the viability of both bloodstream and procyclic trypanosomes? (c) Will the 
transfection of trypanosomes with mutant tbrlp affect normal growth patterns of the parasite? (d) 
Where is it localised? Studies of ras and rap  GTPases in higher eukaryotes have shown that the 
two proteins are localised in different cellular fractions, ras proteins are found on the inner 
surface of the plasma membrane (Lowy and Willumsen, 1991) while rap proteins are found on 
the endoplasmic reticulum and endosomal/lysosomal compartments (Zerial and Huber, 1995). As 
tbrlp I has features of both ras and rap it is important to determine its cellular location, (e) Does 
it bind to other molecules such as the trypanosomal equivalent of GTPase activating proteins, 
guanine nucleotide exchange factors or a r a f  protein kinase homologue? (f) Are there any 
significant changes in GTP hydrolysis when trypanosomes are exposed to extracellular signals 
known to be directly involved in trypanosomal growth regulation (e.g TNF-a, IFN-y and EGF)? 
(g) Is the activation of tbrlp dependent on phosphorylation and if so is it a substrate for Protein 
kinase A, C or both? Some studies on the phosphorylation patterns of ras subfamily GTPases 
have reported the phosphorylation of three mammalian ras GTPases by both Protein kinases A 
and C or by protein kinase C alone (Altschuler and Lapetina, 1993). Results from studies on 
mammalian rap 1 GTPases, show that they are phosphorylated solely by Protein kinase A 
(Altschuler and Lapetina, 1993). The phosphorylation patterns of tbrlp should therefore give an 
indication as to whether the function of tbrlp is ras like or rap like.
As preliminary data suggest that tbrlp I and II are identical, it is likely that their 
functions are also identical. Gene knockouts would have to be undertaken in order to determine 
the function of tbrlp I and II. tbrlp is expressed in both bloodstream and procyclic trypanosomes 
indicating that it might be essential for a basic process common to both life cycle stages. A 
double knockout might therefore be lethal. The inducible gene expression system developed by 
Wirtz and Clayton (1995) could be used to determine the effects of single and double knockouts 
on the growth patterns of trypanosomes. Briefly, this system makes use of trypanosomes 
transfected with a tetracycline repressor of E. coli. The DNA of the gene to be studied (in this 
case, tbrlp) can be integrated into the vector, under the control of a PARP promoter containing a 
tet operator. Results from the double knockout of tbrlp I would indicate whether its presence in 
the T. brucei genome is essential for normal trypanosomal development. However, normal 
trypanosomal development in the tbrlp I knockouts would suggest that tbrlp  II may be able to 
function in an homologous manner and therefore might compensate for the loss of tbrlp I. In 
order to determine whether both tbrlp I and II are essential for normal trypanosomal development 
it would be necessary to knockout tbrlp II in the tbrlp I knockouts. A lethal effect on the
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trypanosomes would indicate that the two genes are essential for normal trypanosomal 
development. A tet operator-tbrlp II construct could then be introduced into the knockout strain, 
and used in the maintenance of the expression of tbrlp II, whilst the wild type allele is knocked 
out in order to observe the effect of “turning off’ tbrlp  II. The same process could be repeated 
with the introduction of a tet operator-^/'//? I construct into the knockout strain, so as to observe 
the effect tbrlp I has on trypanosomal development after the elimination of the wild type allele.
Different mutants of tbrlp I and II could be produced, using site directed mutagenesis 
(which would entail the substitution of individual amino acids, within the GTP binding domain, 
known to be essential for normal protein function) and used to determine the effect of particular 
mutations on the viability of the trypanosomes using the inducible gene expression system of 
Wirtz and Clayton (1993).
The binding of guanine nucleotides to mutant tbrlp  can be determined and compared to 
the binding by wild type tbrlp. This can be measured in vitro by determining the amounts of 
GTP and GDP found in immunoprecipitated tbrlp , using both radioactive (based on the amount 
of GDP converted to [y-32P]GTP from [y-32P]ATP and nucleoside diphosphate kinase) and non 
radioactive methods (the amount of GTP present can be measured by determining the amount of 
ATP produced from ADP and nucleoside diphosphate using a luciferase assay, Gibbs, 1995). In 
vitro measurements of GTP and GDP of trypanosomes exposed to extracellular signals known to 
be directly involved in the regulation of trypanosomal growth, should shed light on the effects of 
these signals on GTP-binding proteins. Studies have shown that there is an increase in cAMP 
levels just before the transformation of long slender trypanosomes to short stumpy forms and 
from short stumpy forms to procyclics. The increase in levels are known not to be associated 
with the heterotrimeric G-proteins (Pays et al, 1997) but could be due to other GTP 
binding/hydrolysis reactions of small GTP binding proteins such as tbrlp.
The cellular activity of all ras and rap  GTPases in mammalian cells is under the 
regulation of GTPase activating proteins (GAPs) and guanine nucleotide exchange factors 
(GEFs). It would be interesting to investigate the presence of the trypanosomal equivalents of 
GAPs, and GEFs and their effect on the activation of tbrlp. Studies in mammalian cells have 
shown that GEFs form highly stable complexes with ras proteins in nucleotide depleted media. 
Based on this observation, a number of binding assays are currently available for the detection of 
GEF-ras complexes in nucleotide depleted media using known GEFs e.g yeast Cdc 25. Yeast 
GEF is structurally related to mammalian GEF and has in the past been used in the 
immunoprecipitation of nucleotide depleted mammalian ras proteins. The possibility therefore 
exists that it could also be structurally related to the trypanosomal homologue of yeast GEF. 
Briefly, the procedure would entail the precipitation of Glutathione-S-transferase tagged GEF and
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tbrlp complexes using glutathione-agarose beads. Unbound protein would be washed away and 
the complexes detected by immunoblotting with tbrlp specific anti-serum and visualising by 
enhanced chemiluminesence (Hart and Powers, 1995). A complete absence of bands should be 
observed in the lanes containing nucleotide bound forms of tbrlp. The same approach could be 
used in the detection of GAPs, with the ray-GAP complexes being in the samples containing 
nucleotide bound tbrlp. Both guanine exchange releasing factors and GTPase activating proteins 
bind ras and rap at the effector binding domain (which is identical) and have highly conserved 
structural features (Maekawa et a l, 1993). The effector binding domain of tbrlp I has 
approximately 70 % amino acid identity to human rap  2 and 66 % identity to human H-ras. It 
therefore, might be possible to coprecipitate tbrlp  and GEFs/GAPs, using known 
mammalian/yeast Glutathione-S-transferase tagged GEFs/GAPs. Once the ability of tbrlp to 
bind GEF/GAP has been established the trypanosomal homologues could be isolated by 
immunoprecipitation, using mammalian/yeast GEF/GAP heterologous antisera.
R a f is a serine/threonine kinase known to be involved in signalling pathways essential for 
growth and differentiation of mammalian cells (Zerial and Huber, 1995). It is found downstream 
of ras and physically interacts with a number of molecules including ras, rap  and MAP kinase 
kinase. R a f  kinases have three distinct domains, two of which are found at the amino terminal 
(CR 1 and CR 2) and are conserved between r a f  family members (Rapp et al, 1988), and one 
which is found at the carboxyl terminal end and represents the kinase domain i.e CR 3. CR 1 
appears to be involved in interactions with ras, which are necessary for the regulation of cell 
growth and differentiation. The ras-raf-MAP kinase kinase pathway has been found to be 
functional in a number of cell types and in several organisms including Caenorhabditis elegans 
and Drosophila melanogaster (Dickson et al, 1992; Lu et al, 1993; Han et al, 1993). The 
presence of a ray-like gene in T. brucei suggests, by analogy to other organisms, that a ra/kinase 
may also be present that interacts with the tbrlp  product in a classical signalling pathway. A 
number of approaches could be considered to provide evidence for a r a f  kinase in T. brucei. 
These include attempting to clone a r a f  kinase from trypanosomes and the use of heterologous 
antisera to detect the presence of a ra/kinase activity or polypeptide.
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7.2 Possible roles of tbrlp
Ras GTPases of the ras subfamily are evolutionarily conserved proteins. They are found 
across a wide range of organisms from the slime moulds to humans (Lerosey et al, 1991). 
Studies in mammalian cells have shown that they are involved in the control of several 
physiological processes, such as growth and cellular differentiation (Hall, 1990). The presence of 
a ras like GTPase in T. brucei, indicates that there could be a ras linked signalling pathway 
which could be involved in the regulation of growth and differentiation of the trypanosome.
Currently little is known about cellular signalling pathways in T. brucei and in the light 
of this one can only speculate on the role of tbrlp I in these pathways. An adenylate cyclase 
receptor has been isolated from T. brucei, is encoded by ESAG 4 (Paindavoine, 1992) and is 
found to be activated by calcium. The activation of adenylate cyclase results in the initiation of 
the cAMP cascade, which is known to be linked to a number of physiological changes in other 
organisms, such as growth and differentiation in mammalian cells. Studies have shown that 
mammalian (Milligan, 1995; Neer, 1995) and Phytomonas (Farber et al, 1995) adenylyl cyclases 
are activated by heterotrimeric G proteins and this in turn results in the initiation of the cAMP 
cascade. Studies of the effect of heterotrimeric G proteins (with nonhydrolysable analogs of 
GTP) on the activation of adenylyl cyclase, show that the heterotrimeric G proteins are not 
involved in the stimulation of trypanosomal adenylate cyclase. Yeast adenylyl cyclases are found 
to be stimulated by monomeric G proteins. Based on these observation, the possibility exists that 
the trypanosomal adenylyl cyclases might also be stimulated by ras GTPases. In T. brucei, the 
cAMP cascade is known to be involved in the regulation of cell growth and differentiation 
(Mancini and Patton, 1981; Reed et a l, 1985), and if ras GTPases (i.e tbrlp) are involved in the 
stimulation and inhibition of this cascade, then it would suggest another possible role for tbrlp. 
tbrlp  I has a C-terminal cAMP dependent protein kinase (Protein kinase A) phosphorylation site, 
with 75 % amino acid identity to that of human rap lb. The activation of human rap lb is 
dependent on phosphorylation by cAMP (Altschuler and Lapetina, 1993; Altschuler et al, 1995). 
The activity of tbrlp might therefore be regulated by the cAMP cascade in T. brucei and thus 
might play a regulatory role in the proliferation and differentiation of the parasites.
Homologues of some of the components found in the mammalian MAP kinase pathway 
have been identified in T. brucei. Studies from higher eukaryotes have shown that the activation 
of ras is an important intermediate in the stimulation of the MAP kinase cascade. If tbrlp I and 
II are involved in either the cAMP or MAP kinase pathways then it would suggest that tbrlp is 
important for growth and differentiation in T. brucei. This might make it a suitable drug target.
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Figure 7.0 is schematic diagram of a model showing the possible mode of activation of 
membrane bound tbrlp, based on the presence of the effector binding domain which has 70 % 
amino acid identity to that of human rap 2 and 66 % identity to human H-ras, and is involved in 
signal transduction based on the activation of ra f (in mammalian cells), the presence of a GTP 
binding domain, a cAMP dependent phosphorylation site and the assumption that a ra f 
homologue (tbraf) exists in T. brucei and is involved in trypanosomal cell signalling.
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Figure 7.0 represents a schematic diagram of a proposed model for the activation of tbrlp (% ), in the presence of a 
putative trypanosomal ra f serine/threonine kinase homologue (tbraf -O ). (1) In the absence of an appropriate 
stimulus, tbrlp is membrane bound and inactive, i.e bound to GDP. (2) On stimulation tbrlp is activated by the 
physical replacement of GDP by GTP. In this state it binds to and recruits ra f  to the membrane (as do activated ras 
proteins in mammalian cells) and activates effectors downstream of ra f  This activation could cause the stimulation 
of a Protein kinase A pathway which results in the phosphorylation of tbrlp, at the C-terminal cAMP dependent 
phosphorylation site (3) and the dissociation of the tbrlp-tbraf complex from the membrane, thus breaking contact 
with the external stimulus and its receptor. The binding of ras to ra f  in mammalian cells is known to cause the 
inhibition of the guanine nucleotide exchange reaction (Sprang, 1995), thus in this state the hydrolysis of GTP is 
the favoured reaction. The change to the inactive state causes a conformational change which decreases the affinity 
of tbrlp for tbraf and thus reverts to its membrane bound state (4).
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7.3 tbrlp, a putative anti-trypanosomal drug target
The main requirements of a good trypanosome drug target are (1) The target should be 
essential for the survival of the organism (2) It should have structural and functional differences 
or absent in the mammalian host. (3) It should be a low abundance molecule, such that only 
small doses of inhibitors are needed. (4) The availability of a detailed knowledge of structural 
features and effects of inhibitors. If it is essential to the survival of the trypanosome, tbrlp would 
be a potentially good drug target because, it is sufficiently different from the mammalian host ras 
subfamily GTPases, it is probably a low abundance protein and much is known about the 
structure, function and inhibitors of ras proteins in mammals. Furthermore, drugs could be 
designed to inhibit its action but not have a detrimental effect on the mammalian host.
The question as to whether a tbrlp I like gene exists in the other kinetoplastids remains to 
be determined. The results of the evolutionary analysis of tbrlp I suggest that a tbrlp I like gene 
might be present in all the kinetoplastids. Thus it could also be a potential drug target for the 
treatment of Leishmaniasis and South American trypanosomiasis. Pharmaceutical companies 
might therefore find the prospect of producing a single drug for the treatment of three different, 
but equally devastating diseases, more appealing.
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